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QUILL ON SCALPEL
This section provides a medium through which Canadian surgeons can declare themselves, briefly 
and informally, on the day-to-day affairs of surgery.
The Urology Papers
On several occasions, the Canadian 
Academy of Urological Surgeons dis­
cussed the scarcity of urological arti­
cles published in the Canadian Journal 
of Surgery. The academy recognized 
that urological investigators had a 
natural tendency to publish their work 
in journals that were more likely to be 
read by their peers in the specialty, 
but it also believed that its responsibil­
ity towards the only national surgical 
journal was not being discharged. 
Probably other surgical bodies have 
addressed themselves to the same issue.
In the present era of specialization 
there is a risk that specialists will be­
come increasingly less aware of progress 
made in other disciplines. Although it 
is impossible to keep abreast of all the 
new discoveries in all the disciplines, 
specialists would be deficient if they did 
not attempt to be apprised of pertinent 
developments, particularly by their col­
leagues. Several institutions have jour­
nals that tie their members together and 
allow communication and exchanges 
between the members, and “Canadian 
surgery” as an institution is no excep­
tion. Obviously some discretion should 
be applied by individuals submitting 
articles in selecting appropriate topics 
that are of wide interest, in order to 
have a larger number of readers and 
to give credence to their work.
Because of the concerns expressed 
above, it was suggested that the initial 
step could be more readily accom­
plished if it was undertaken collective­
ly. This notion met with success and 
most urologists who were approached 
showed an immediate willingness to 
contribute. The articles submitted were 
too numerous to be included in one is­
sue and the coeditors have decided to 
split them between the current issue 
and the November issue.
Although the collective spirit of this 
project generated enthusiasm, the suc­
cess of the Canadian Journal of Sur­
gery will depend on the initiative of 
individual investigators and their 
continuing support.
Besides being a vehicle for the pub­
lication of scientific articles, the Cana­
dian Journal of Surgery is a forum for 
discussion of subjects of mutual inter­
est to many Canadian surgeons—un­
dergraduate and postgraduate teaching, 
continuing education and research, for 
example. It would be a sad reflection 
on “Canadian surgery” if this journal 
was not adequately supported and we, 
the urologists of Canada, show our 
support through the publication of 
the articles that appear in this issue 
and in the November issue.
Said A. A w ad , m b , b ch frcs[c]
Department of urology,
Queen’s University,
Kingston, Ont.
Prognostication or Biology: Acquired Abnormalities 
of Host Defence Mechanism in Surgical Patients
When discussing the role of acquired 
defects in host defence in the devel­
opment or prediction of clinical out­
come one must question which came 
first, the septic process or the defect 
in the immune system. It is increasing­
ly apparent that sepsis can be both 
the cause and the result of acquired 
defects in host defence.1'3 The value of 
any measurement which predicts pa­
tient outcome is twofold. First, partic­
ular measures can be taken to improve 
results in an individual patient. Second, 
certain patients known to be at risk
can be assessed to determine the 
biologic processes that contribute to 
their poor outcome. It is only by 
defining specific defects that an ap­
proach to management can be devel­
oped which will contribute to im­
proved survival.
In this issue (page 447), McCredie 
and colleagues have described some 
immunologic abnormalities in patients 
with sepsis who subsequently died. 
Their results demonstrate that the ac­
tivity of K cells (nonimmune lympho­
cytes) as measured by an antibody
dependent cellular cytotoxicity (ADCC) 
test is reduced, as is the total number 
of lymphomononuclear cells, and that 
adherence of polymorphonuclear leu­
kocytes is decreased in all patients 
with sepsis, particularly in those who 
died. It appears therefore that patients 
with these markers should be watched 
particularly closely and treated urgent­
ly for all correctable causes of possible 
morbidity. These are interesting results 
and may help to clarify why some 
patients do poorly. The balance of 
McCredie’s study indicates a number
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of negative findings, not all of which 
are in agreement with data in the 
literature.
The design of the study has some 
worrisome aspects. The study popula­
tion, consisting of 34 patients all of 
whom are stated to have had sepsis, is 
not well defined. A description of the 
nature and type of their infections 
and the microbiologic causes would 
have been interesting. Ten of these 34 
patients were not receiving antibiotics 
although that may have been the case 
only at the time the investigation was 
carried out. In the study of patients 
with sepsis, it is critical that strict 
criteria (e.g., a positive blood culture, 
a confirmed abscess or other totally 
objective assessment) be utilized so 
that data from one series can be 
compared with those from another.
The definition of the numbers of 
B and T cells is occasionally confus­
ing. With lymphocytopenia the num­
bers of B and T cells circulating are 
reduced. The ADCC test is a com­
plicated test to do and to interpret. It 
depends upon the recognition of an Fc 
fragment by an Fc receptor on the 
specific K cell. Cells that contain these 
Fc receptors include neutrophils, mo­
nocytes, B and T lymphocytes, baso­
phils and possibly eosinophils. There­
fore, unless the cell populations are 
highly purified and defined, the num­
ber of lytic units demonstrated by 
ADCC testing may not reflect lympho­
cyte function but rather the function 
of an altered Fc receptor or any num­
ber of leukocytes. This would suggest 
that a circulating factor was affecting 
this receptor, a finding which would 
be consistent with immunosuppressive 
factors reported by others.3"5
The data on neutrophil adherence 
are at variance with those of Mac­
Gregor’s group6 and of our own.7 
There does not seem to be an ex­
planation for this and it may depend 
entirely upon the definition of the 
patient population. The neutrophil bac­
tericidal studies against Pseudomonas 
aeruginosa may be statistically differ­
ent but it is hard to be convinced that 
they differ biologically. The percent­
ages of colony forming units at 120 
minutes were 97.7% versus 99.3%. 
This difference of approximately 1.6% 
or 32 000 colony forming units is not 
large when the original population was 
2 million bacteria. Most laboratories 
performing bactericidal assays require 
a difference in killing of at least 
half a log to ascribe any statistical 
significance to it.8 In the chemotactic 
studies' a relatively nondiscriminating 
end point (i.e., the number of cells 
on the far side of the filter) was used, 
which may account for the differing 
results obtained by McCredie and as­
sociates from those of other laborato­
ries.9"11
The ADCC test appears to be the 
most discriminating. The mechanism 
for reduction is not clear since drugs 
may also affect Fc receptor func­
tion. The question arises: Were pa­
tients in McCredie’s study treated 
differently (i.e., 10 patients did not 
receive antibiotics, 7 patients received 
steroids and 9 patients had total paren­
teral nutrition)? The use of the term 
predictive in this setting without graph­
ic presentation of the actual data is 
difficult as the sensitivity of the test 
cannot be evaluated. To be effectively 
predictive, a test must be sensitive as 
well as discriminating. Regardless of 
their prognostic value, the ADCC ab­
normalities provide data that are useful 
in defining acquired host defects in sur­
gical patients. The results of the test 
suggest that there is a factor either 
circulating or upon the cell membrane 
which affects the Fc receptor.
It is unfortunate that skin testing 
with a variety of recall antigens was 
not performed. This approach to the 
identification of the patient with al­
tered host defences and as a predictor 
of outcome is becoming well estab­
lished. '■’•1*,,s The specific value of skin 
testing is twofold. First, it is prognostic, 
it identifies the patient at risk of sepsis 
and death. Second, and perhaps more 
important, when the population at risk 
has been identified, the biology of the 
increased frequency of sepsis and mor­
tality in this group can be intensively 
studied to define the acquired defects 
and to develop therapeutic approaches. 
The causative factors contributing to 
anergy include sepsis, hemorrhage, 
trauma, surgery, malnutrition, cancer 
and a variety of other factors.2,4 The 
relating of clinical events with biologic 
processes in anergic patients has 
facilitated the development of thera­
peutic strategy. Malnutrition clearly 
plays a role but is not the only factor. 
Drainage of sepsis, biliary tract sur­
gery, resection of colonic cancer, re­
storation of blood volume with control 
of hemorrhage are all associated with 
rapid restoration of skin test responses 
and improvement of neutrophil chem- 
otaxis.2 Levamisole, effective in vitro 
against circulating inhibitors of neutro­
phil chemotaxis,14 can in vivo reduce 
morbidity from sepsis but could not be 
shown statistically to have an effect 
upon mortality, anergy or neutrophil 
chemotaxis.2
It is only by defining immunologic 
processes, as McCredie and his group 
have done, that ultimately the biology 
of altered host resistance to infection 
can be adequately described and treat­
ment delineated. There are a number 
of areas to which much research must
be directed. These include: circulating 
factors; the speed with which these 
defects can appear following sepsis or 
trauma, or both; whether or not plas­
mapheresis or the administration of 
anti-inhibitors may play a role; phar­
macologic manipulation with drugs such 
as levamisole, aspirin and other pres­
ently unidentified drugs; and a preop­
erative method to assess accurately the 
risk and to pinpoint its correction.
Prognostication is important for the 
individual patient. However, it is only 
by description and definition of the 
altered biology of patients with ac­
quired defects in host resistance to 
infection that therapeutic strategies 
can be developed to improve the 
prognosis.
J.L. M eakins, m d , frcs[c]
Department of surgery 
Royal Victoria Hospital,
Montreal, PQ
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Early Surgical Management of Acute Cholecystitis
The object of therapy in acute chole­
cystitis is definitive treatment with mi­
nimal mortality and morbidity. Over 
the years, considerable literature has 
accumulated concerning both merits 
and disadvantages of early versus de­
layed cholecystectomy for acute chole­
cystitis.
According to Hinchey, Elias and 
Hampson,1 a survey of American sur­
geons showed that 70% favoured early 
operations for acute cholecystitis.
In this issue of the Journal (page 
464) Archibald, Colapinto and Frost 
confirm that early cholecystectomy in 
acute cholecystitis can be done safely 
with low morbidity and mortality. Un­
fortunately, because it is not a prospec­
tive randomized study, this paper does 
not analyse many aspects of the pre­
operative, intraoperative and postop­
erative complications (e.g., jaundice, 
liver profiles, cultures of bile and gall­
bladder wall, frequency of explorations 
of the common bile duct that yield no 
abnormality or of retained stones in 
the common bile duct). The clear ad­
vantage shown by this study is the 
economic one: the patient’s stay in the 
hospital is shorter with early operative 
intervention.
The authors are to be congratulated 
on the low mortality and complication 
rate they achieved for the entire 
group, particularly since approximately 
40% of the patients belonged to groups 
2 or 3, in which the operation was 
performed 72 hours after admission, 
regardless of when the symptoms 
began.
Some workers2"7 have reported an in­
creased frequency of major intra-ab­
dominal complications (bacteremia, 
wound infection or dehiscence, or both) 
when cholecystectomy is delayed or 
when bile or gallbladder-wall cultures 
have given positive results. Interest­
ingly, this correlation was not found 
in Archibald’s paper, and the obvious 
and important message is the insignifi­
cant increase of major complications 
in patients who underwent cholecys­
tectomy up to 7 days after admission.
Cholecystostomy has been advo­
cated for patients deemed to be too 
ill for cholecystectomy, usually the 
elderly with decompensated heart dis­
ease, poorly controlled diabetes, pul-
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monary or renal insufficiency, or evi­
dence of cerebrovascular disease in as­
sociation with acute gangrenous or per­
forated gallbladder. The authors have 
reaffirmed that the mortality associated 
with cholecystostomy is 5 to 10 times 
higher than that for cholecystectomy. 
A cholecystectomy can be completed 
safely on most occasions.
It is important to emphasize the fre­
quency of false-negative results of intra­
venous cholangiography in the presence 
of acute cholecystitis. Although 3.6% of 
Archibald’s patients had false-negative 
results of cholangiography, the diag­
nosis of acute cholecystitis was con­
firmed at operation. In one study,8 80 
of 152 patients with no opacification 
of the gallbladder on two consecutive 
oral cholecystograms, and evidence of 
disease at operation, also underwent 
intravenous cholangiography. In 14 
(approximately 17%) the gallbladder 
filled and was interpreted as normal, 
an obviously erroneous diagnosis in 
view of the subsequent findings of 
cholelithiasis in 12 patients, chronic 
cholecystitis in 1 and acute chole­
cystitis in 1.
Previously we7 reported a 6% fre­
quency of normal oral cholecystograms 
in patients with acute cholecystitis, 
confirmed by pathological examination 
of the resected gallbladder. This and 
other studies8,9 demonstrated that a sub­
stantial number of patients with chole- 
lithasis or acute cholecystitis, or both, 
show no abnormality on cholecysto­
graphy. In order to avoid an erroneous 
diagnosis, the suggested alternative 
method at present is ultrasonography10 
or technetium scanning9 of the gall­
bladder, which has a diagnostic ac­
curacy of 95% to 98%.
Treatment of patients with acute 
cholecystitis should include administra­
tion of fluids intravenously and routine 
use of broad spectrum antibiotics, 
urinary monitoring by means of a 
Foley catheter if necessary, recording 
of central venous pressure and an 
intensive effort to evaluate and treat 
associated diseases. The operation 
should be considered urgent but 
seldom an emergency measure. The 
degree of risk associated with chole­
cystectomy is small and it is the 
procedure of choice in the absence of
signs or symptoms of common duct 
stones or cholangitis, both of which 
require, in addition, common bile duct 
exploration or decompression.
Should the patient’s clinical condi­
tion deteriorate, cholecystostomy can 
be a safe operation if the following 
precautions are taken: there can be 
no free perforation of the gallbladder; 
clear bile must be seen returning 
through the cystic duct and if not, the 
common bile duct must be decom­
pressed; the common bile duct must 
also be decompressed in all patients 
with jaundice, chills and fever, and 
those in whom common bile duct 
stones are demonstrated.11
N enad M. G agic, m d , fr c s[c]
Department of surgery,
McMaster University,
Hamilton, Ont.
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Symposium on Vascular Surgery
The vascular surgical service of the 
department of surgery, and extended 
programs in medical education of the 
University of California School of 
Medicine, San Francisco, will present 
a conference on vascular surgery from 
Feb. 7-9, 1980. This course has been 
designed to focus on and elucidate 
areas of current controversy in the 
field of vascular surgery. There will be 
discussions on surgical shunting in 
portal hypertension, the surgical ap­
proach to vascular disorders of the 
abdominal aorta and its branches, 
femoropopliteal occlusive disease and 
the surgical management of cerebro­
vascular insufficiency. The guest 
faculty includes Dr. Allan Callow, 
chief, general and vascular surgical 
services, Tufts New England Medical 
Center, Boston; Mr. H.H.G. Eastcott, 
consultant surgeon, St. Mary’s Hos­
pital, London, England; Dr. Jesse E. 
Thompson, surgeon, private practice, 
Dallas; and Dr. Robert Zeppa, profes­
sor and chairman, department of 
surgery, University of Miami. Registra­
tion will take place on Thursday 
morning, Feb. 7, 1980, from 700 to 
800 hours in the Emerald Ballroom, 
Golden Gateway Holiday Inn, 1500 
Van Ness Ave., San Francisco. The fee 
is $185 for physicians and $95 for 
non-UCSF interns, residents and 
fellows with letter of verification. It is 
recommended that registration be made 
in advance. For more information ad­
dress inquiries to: Extended Programs 
in Medical Education, University of 
California, 1308 Third Avenue, San 
Francisco, CA 94143.
The 5th International Symposium 
on Atherosclerosis
This conference will be held in 
Houston, Texas, from Nov. 6-9, 1979. 
Registration takes place on Monday, 
Nov. 5, 1979 from 1200 to 2100 hours 
at the Shamrock Hilton Hotel. The 
registration fee is $100 for active par­
ticipants, $25 for students and $10 for 
accompanying guests. For more in­
formation on topics for plenary ses­
sions, workshops and oral presenta­
tions, address correspondence to: Dr. 
A.M. Grotto, The 5th International 
Symposium on Atherosclerosis, De­
partment of medicine, Baylor College 
of Medicine, The Methodist Hospital, 
6516 Bertner Ave., Mail Station A 601, 
Houston, TX 77030.
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UROLOGY PAPERS
Results of Radical Nephrectomy in 178 Cases 
of Renal Cell Adenocarcinoma
J.A. Oliver, md, frcs[c], M.P. Laplante, md, frcs[c], E.C. R eid, md, frcs[c] and R.S. Schual, md
One hundred and seven ty-e igh t patients 
w ith  renal ce ll adenoca rc inom a were 
c la s s if ie d  by stage and trea ted  by 
rad ica l nephrectom y. A  transabdom ina l 
approach w as used in 92% o f cases 
and lym phadenectom y w as no t per­
form ed un le ss ip s ila te ra l h ila r nodes 
w ere  invo lved . Su rv iva l ra tes are 
p resented in the form  o f life-tab le  
cu rves. These cu rves ind ica te  that 
su rv iva l depends on the  stage  of the 
d isease  at the tim e  o f in it ia l treatm ent; 
about 80% of pa tien ts w ith  stage  1 
le s ion s  (tum our con fined  to the  kidney) 
su rv ived  fo r 10 yea rs com pared  with 
on ly 30% to 35% of stage  2 (invo lve­
m ent o f pe rinephric  fat) and stage 3 
(invo lvem ent o f renal ve in  o r reg ional 
lymph nodes) pa tien ts and le s s  than 
10% of stage 4 (m etasta tic  spread) 
patients. Rad ica l nephrectom y appears 
to be the best m ethod o f treatm ent 
fo r pa tien ts w ith  stage 1, 2 o r 3 lesions. 
S im p le  pa llia tive  nephrectom y may 
be ind ica ted in se le c ted  pa tien ts w ith 
stage 4 le s ions.
Cen t so ixante-d ix-hu it pa tien ts 
sou ffran t d ’un adenoca rc inom e des 
ce llu le s  rena les ont ete c la s s if ie s  
pas stade c lin ique  e t  tra ite s  par 
nephrectom ie rad ica le . Un abord trans­
abdom inal a ete u t il is e  chez 92% 
des cas et une lym phadenectom ie  
n'a pas ete pratiquee a m o ins qu’il 
n ’y a it une atte in te  ip s ila te ra le  des 
gang lions h ila ire s. Les taux de su rv ie  
son t p resen tes sous fo rm e de 
courbes a c tua rie lle s . C e s  cou rbes
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ind iquent que la su rv ie  depend du 
stade de la m alad ie  au m om ent du 
tra item ent in it ia l; env iron  80%  des 
patien ts ayant une le s ion  de stade  
1 (tum eur lim itee  au rein) ont 
su rvecu  10 ans, com para tivem ent a 
seu lem ent 30%  et 35% pour le s  
pa tien ts de stade  2 (atteinte du t is s u  
ad ipeux perinephrique) e t de s ta de  3 
(atte in te  de la ve ine  renale e t d e s  
gang lions lym phatiques reg ionaux), 
et m o ins de 10%  pour les pa tien ts  
de stade 4 (envah issem en t m etastatique). 
La nephrectom ie  rad ica le  sem b le  e tre  
la m e illeu re  m ethode de tra ite ­
m ent pour le s  pa tien ts ayant des 
le s ion s  des s tades 1 ,2  ou 3. Une 
nephrectom ie  pa llia t iv e  s im p le  peut 
e tre  ind iquee chez d e s  patients c h o is is  
ayant des le s io n s  de stade 4.
Between Jan. 1, 1965 and Dec. 31, 
1977, 178 patients with renal cell 
adenocarcinoma were treated by radical 
nephrectomy at two McGill Univer­
sity teaching hospitals. This paper 
presents the clinical aspects and re­
lates the results of radical surgery to
the stage of the disease using life-table 
survival curves.
Patient Data and Methods
Staging of the disease was by the 
Robson modification1 of Flocks and 
Kadesky’s classification as follows: 
stage 1— tumour confined to the kid­
ney, stage 2—perinephric fat involved 
but tumour confined to Gerota’s fascia, 
stage 3— involvement by tumour of 
renal vein or regional lymph nodes
80
60
40
20
T
1 2 3
STAGE
FIG. 1—Distribution of patients by stage.
FIG. 2—Age and sex distribution. Male:female ratio was 1.4:1.
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with or without involvement of vena 
cava and stage 4—metastatic spread 
distantly or to adjacent visceral struc­
tures. Fig. 1 illustrates the percentage 
distribution by stage of the 178 pa­
tients and is in keeping with that re­
ported in other large series.1-3 There 
were 82 patients with stage 1 lesions, 
22 with stage 2, 45 with stage 3 and 
29 with stage 4 disease.
The age and sex distributions are 
shown in Fig. 2; they correspond to 
those reported in other series.
Table I lists the major presenting 
signs and symptoms. Renal cell adeno­
carcinoma may present in a variety of 
ways, and while the members of the 
“clinical triad” (hematuria, pain and 
palpable mass) were often noted, 24% 
of patients presented with nonspecific 
systemic symptoms such as fever, 
weight loss, anorexia and severe ma­
laise. In 17% of the patients there 
were no presenting symptoms or signs 
and the tumour was discovered dur­
Table 1— Presenting Signs and Symptoms
Sign or symptom C ases,%
Hematuria 53
Pain 24
Mass 19
None, but incidental finding of mass
on intravenous pyelography 17
Systemic 24
Table I I— Percentage of Patients with 
Abnormal Laboratory Findings
Laboratory finding Patients, %
Hemoglobin, >  16 g/dl 8
< 1 0  g/dl 12
Lactic dehydrogenase (elevated  
above upper lim it of normal) 18
A lkaline phosphatase (elevated  
above upper lim it of normal) 16
Proteins, increase in a 2 glo­
bulin 41
Calcium, > 1 1  g /d l (2.74 fj.mol/1) 
or < 9  g /d l (2.25 ^m ol/l) 26
Serum glutam ic oxaloacetic 
transam inase (elevated above 
upper lim it of normal) 1
Table I I I — Sites of Metastases in the 29 
Patients w ith  Stage 4 Lesions at the Time of 
Nephrectomy
Site Patients, %
Lung 48
Bone 31
Liver 14
Brain 3
Other 7
ing other surgical procedures or as an 
mcidental finding on intravenous pye­
lography done for other reasons.
The abnormal laboratory findings 
at the time of presentation are shown 
in Table II. Although these findings 
may alert the clinician to the possibil­
ity of a serious pathologic condition, 
no relationship has been reported be­
tween abnormal laboratory findings 
and survival rate3'4 and this was sup­
ported in our series.
Surgical Treatment
In radical nephrectomy a “pedicle 
liist approach is used in which the 
renal vein is mobilized and the under­
lying renal artery is ligated primarily, 
followed by ligature of the vein. The 
kidney, and sometimes the adrenal 
gland, is removed leaving overlying 
peritoneum and Gerota’s fascia intact. 
Hilar nodes are dissected, but if spread 
to these nodes is not evident, complete
Table IV—Cause of Death by Stage
Stage, no. (% * )
Cause of
death 1 2 3 4 Total
Operation
Cancer
Other
1 (1) 
9 (1 1 )  
6 (7)
0
7 (3 2 )  
2 (9)
2 (4) 
20 (44)
3 (7)
4 (1 4 )  
23 (80) 
0
7 (4) 
59 (33) 
11 (6)
A live 66 (81.8) 13 (59) 20 (44) 2 (6) 101 (57)
♦Crude percentages, not based on life -table curves.
FIG. 3— Sites of late metastases developing in each stage expressed as percentage 
of cases in each stage.
FIG. 4— Life-table survival curve for all stages (SE =  standard error).
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FIG. 5__Comparison of survival curves of stages 1, 2 and 3 patients with that
of entire series (49 and 52 =  number of patients at risk at 6 years).
FIG. 6— Life-table survival curves plotted separately for each stage. Numbers 
at risk at 6 years are shown by figures above curves themselves.
FIG. 7— Comparison of survival curves for stages 3A, 3B and 3C.
para-aortic or paracaval node dissec­
tion is not routinely done. In our hos­
pitals, a transabdominal incision is gen­
erally used with full kocherization for 
right-sided tumours and preaortic dis­
section for left-sided lesions as de­
scribed by Scott and Selzman.5 When 
necessary, the inferior mesenteric vein 
is divided together with the ligament 
of Treitz. This approach provides good 
exposure for most tumours although for 
large upper pole lesions, the thoraco­
abdominal technique is used.6'7 In our 
series the transabdominal approach 
was used for 165 patients and the 
thoracoabdominal for the remaining 
13.
R esults
The sites of metastases in the 29 
stage 4 patients are shown in Table 
III; late metastases developing in each 
stage are shown in Fig. 3 and are ex­
pressed as a percentage of all cases in 
each stage. As expected, lesions classi­
fied clinically as stage 1 rarely metas­
tasized, and these rare instances of 
metastasis were attributable to staging 
errors. Stage 2 and stage 3 lesions 
showed little difference in their meta­
static activity either in site or in fre­
quency.
The causes of death by stage are 
shown in Table IV. Operative death 
refers to that which occurred while 
the patient was still in hospital follow­
ing nephrectomy, regardless of length 
of stay and cause of death. The over­
all operative mortality was 3.9% but, 
when the stage 4 patients were ex­
cluded, it was 2.2%.
Survival Figures
The survival figures were evaluated 
from the life-table curves. The survival 
curve for all stages (Fig. 4) shows a 
flattening at 4 years with a slight fall- 
off between 6 and 7 and 11 and 12 
years. Fig. 5 compares the survival of 
patients with stages 1, 2 and 3 (po­
tentially “curable”) lesions with that 
of the entire series. Given the poor 
prognosis of stage 4 patients, the im­
provement in the mortality when these 
patients are excluded is expected.
The survival curves for each stage 
are shown in Fig. 6. The curve for 
stage 1 patients indicates an extremely 
good prognosis. The fall-off at 11 years 
represents death from causes other 
than cancer. There was no statistically 
significant difference in the survival 
of stage 2 and stage 3 patients in this 
series. The curve for stage 4 patients 
was predictable.
Stage 3 patients were subdivided for 
analysis as follows: stage 3A—disease 
involving the renal vein with or with­
out vena caval extension (30 patients),
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stage 3B—disease involving the lymph 
nodes (8 patients), and stage 3C—dis­
ease involving both the renal vein and 
the lymph nodes (7 patients).
The survival rate of these patients 
is shown in Fig. 7. There was no sig­
nificant difference between these curves. 
It is worth noting, however, that 
whereas the overall survival of pa­
tients in stages 2 and 3 was not sig­
nificantly different, the curve for stage 
3C does suggest a significant differ­
ence in prognosis between those having 
involvement of both the vein and re­
gional lymphatics (3C) and stage 2 
patients. Certainly invasion of the renal 
vein by tumour leads to a significant 
reduction in estimated survival com­
pared with stage 1 patients; this is 
the finding of most series though it is 
contrary to that of Skinner, Vermillion 
and Colvin.3
Discussion
The prognosis in this series of pa­
tients conforms fairly closely to that 
of other comparable series. Survival 
depends on the stage of the disease 
at the time of primary management.
Patients whose tumours are diag­
nosed and treated in stage 1 do 
well and have an estimated 10- 
year survival rate of approximately 
80%. Barely 35% of patients with 
stage 2 and stage 3 tumours survive 
10 years and, for the stage 4 patients, 
less than 10% survive that long.
The average duration of symptoms 
for patients with stage 1, stage 2 and 
stage 3 lesions was almost identical 
which is discouraging in terms of im­
proving overall survival rates, particu­
larly since, given the great difference 
in survival between stage 1 patients 
and those in more advanced stages, 
improved techniques for early diag­
nosis are of greatest importance.
As far as operation is concerned, 
radical nephrectomy results in higher 
survival rates in stages 1, 2 and 3 
than any other method. Radical 
nephrectomy is not indicated in 
stage 4 and simple palliative nephrec­
tomy in selected cases is the most that 
should be done. The surgical approach, 
either transabdominal or thoracoabdo­
minal, depends on the size and loca­
tion of the tumour. The transabdomi­
nal approach gives excellent results in
most cases. Node dissection in the ab­
sence of positive hilar nodes does not 
improve survival rates. Despite the low 
mortality associated with the proce­
dure, it is not a necessary part of 
radical nephrectomy.
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Renal Cell Carcinoma in Children
S. H er sc h o r n , b sc , m d , c m , f r c s [c ], B.E. H ardy, m b , ch  b , fracs and  
B.M. Ch u r c h il l , m d , f r c s [c ]
The authors reviewed the records of 
eight children with renal cell carcinoma 
and correlated the clinical presentation, 
pathological and radiologic findings, 
stage and treatment of the disease with 
patient survival. Angiography revealed 
tumours of sparse neovascularity, 
associated with varied histologic 
patterns. Patient survival was dependent 
on the stage of the disease at the time 
of treatment; treatment of localized 
disease was effective but of metastatic 
disease was generally poor. Tumour 
staging appeared to be the only reliable 
indicator of prognosis. Children with 
renal cell carcinoma differ from adults 
in that a palpable mass in a child does 
not necessarily indicate that there 
is metastatic disease.
From the department of surgery, division 
of urology, The Hospital for Sick 
Children, Toronto, Ont.
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Les auteurs ont etudie les dossiers 
de huit enfants ayant un carcinome 
des cellules renales et ont etabli une 
correlation entre le tableau clinique, 
les observations pathologiques et 
radiologiques, le stade et le traitement 
de la maladie d'une part, et la survie 
du patient d'autre part. L’angiographie 
a revele des tumeurs ayant une 
neovascularite rare, associees a des 
morphologies histologiques variees.
La survie du patient a ete dependante 
du stade de la maladie au moment 
du traitement; le traitement d’une 
tumeur localisee a ete efficace mais 
celui d’une atteinte metastatique a 
generalement ete pauvre. L'etablissement 
du stade de la tumeur a semble etre 
le seul indicateur fiable du pronostic. 
Les enfants ayant un carcinome des 
cellules renales different des adultes en 
ce que la presence d'une masse 
palpable chez I'enfant n’est pas 
necessairement I'indice d’une maladie 
metastatique.
Renal cell carcinoma in children is rare. 
In the review by Riches, Griffiths and 
Thackray1 of 1500 cases of kidney tu­
mour, only 0.5% of the patients were 
children; others have reported an in­
cidence of 2.3% to 6.6%.2 We can 
trace fewer than 100 well-documented 
cases reported since 1934 in which the 
follow-up was longer than 5 years.
In reviewing the records at the Hos­
pital for Sick Children in Toronto, we 
found eight patients in whom renal cell 
carcinoma had been diagnosed. This 
report correlates survival of these chil­
dren with their clinical presentation, 
tumour stage and treatment, and de­
scribes similarities to and differences 
from renal cell carcinoma in adults.
Patients and Methods
Eight patients (five boys and three 
girls) with renal cell carcinoma were 
treated at the Hospital for Sick Chil­
dren or at the Princess Margaret Hos­
pital, Toronto, between January 1961
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and December 1977. Age at presenta­
tion ranged from 5 to 15 years (mean 
9.75 years). The tumours were left 
sided in six of the children; no patient 
had bilateral tumours. All underwent 
routine investigations for metastases. 
Intravenous pyelography (IVP) was 
performed in all patients, arteriography 
in five, radionuclide renal scanning in 
three, inferior vena cavography, cysto­
scopy and retrograde pyelography in 
two each, and computerized axial tomo­
graphy in one.
Primary treatment was radical ne­
phrectomy in seven cases and simple 
nephrectomy in one, with ipsilateral 
lymph-node dissection in three. Five 
children received radiation therapy 
(3500 to 4500 rads) to the abdomen 
and affected kidney bed postoper- 
atively. Chemotherapy was not used 
routinely, although one child, thought 
initially to have a Wilms’ tumour, was 
given actinomycin D, 300 /zg/ d for 5 
days, starting 1 day before operation. 
In two other patients who had metas­
tatic disease, chemotherapy was started 
shortly before they died.
All surviving patients are being fol­
lowed up.
Findings
Clinical
The presenting symptoms and signs, 
and their relation to survival, are shown 
in Table I. Two patients (nos. 1 and 5) 
had sustained trauma to the flank, re­
sulting in retroperitoneal rupture of the 
tumour. Of the two patients with fever, 
one (no. 2) had a localized tumour and 
one (no. 1) had metastatic disease. Two 
of the three patients who had a pal­
pable mass on presentation have sur­
vived for more than 5 years (nos. 2 and 
3).
Radiologic (Table II)
Intravenous pyelography demon­
strated a mass in seven children and 
decreased renal function in one; calci­
fication was seen in only one patient.
Retrograde pyelography, performed in 
two cases, confirmed the IVP findings. 
Radionuclide renal scanning showed 
filling defects in all three cases in 
which it was done, including the patient 
(no. 8) whose IVP demonstrated de­
creased function. Computerized axial 
tomography was also performed in 
this patient and showed enlargement of 
the affected kidney.
Arteriography demonstrated sparse 
neovascularity in three patients and 
none in two. Inferior vena cavography 
showed compression by the tumour in 
one of two patients.
Laboratory
Two patients were anemic due to 
blood loss after trauma (nos. 1 and 5) 
and in one child (no. 8) with metas­
tases, the erythrocyte sedimentation 
rate was 69 mm/h. Results of all other 
hematologic, renal and liver function 
tests were normal.
Pathological
The staging system used is shown 
in Table III and its relation to pathol­
ogical findings and survival in Table 
IV.
Tumour size did not correlate with 
survival: two survivors had large tu­
mours (diameter, 10 cm in patient 2 
and 8 cm in patient 3) and both had
stage I disease on presentation. All 
survivors had better differentiated tu­
mours with clear cell elements as well 
as pseudocapsules; however, these char­
acteristics were also seen in nonsur­
vivors.
Treatment
Three survivors had disease confined 
to the kidney and one had positive hilar 
lymph nodes. Each had a radical ne­
phrectomy; two (nos. 4 and 6) under­
went lymph-node dissection, and two 
(nos. 3 and 6) had radiation therapy.
Table I I I—Tumour Staging* and 5-Year
Survival in 30 Children
Survival
at 5 yr,
Stage %
1 -  Intrarenal tumour 79
I I -  Extrarenal tumour with local
extension
a -  direct extension 80
b -  vascular extension 30
c -  local lymphatic
(lymph-node) extension 75
I I I -  Extrarenal tumour with
distant metastases 10
*From Castellanos, Aron and Evans.2
Table II— Roentgenographic Findings
No. of 
patients Investigation
Case
no. Findings
8 Intravenous pyelography 1 - 7 Mass
8 Decreased renal function
2 Retrograde pyelography 2 Mass
8 Thin calyces, upper pole
3 Radionuclide renal scanning 4 , 6 , 8 Filling defect
5 Arteriography 5 -  7 Hypovascular tumour
4 ,8 Avascular tumour
2 Inferior vena cavography 6 Normal
8 Compressed by tumour
1 Computerized axial tomography 8 Enlarged affected kidney
Patient
no. Age, yr Sex
Table I—Relation between Clinical Presentation and Survival
Pain
1 13 M +
2 6 F +
3 5 F —
4 6 F —
5 9 M +
6 11 M +
7 13 M —
8 15 M +
+  =  present, — =  absent.
Symptoms and signs
Mass Hematuria Fever
Other
features
Duration 
of symptoms Outcome
+
+
+
+++++
Duration of 
follow-up
+ Trauma, 
weight loss
Acute, 3 mo Dead 3 mo
+ Pain for 1 yr Alive 14 yr
Acute Alive 11 yr
_ 2 mo Alive 7 yr
_ Trauma Acute Dead 4 yr_ 3 wk Alive 5 yr
_ Acute Alive 3 yr
— Weight loss 2 mo Dead 2 mo
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Table IV— Relation of Pathological Findings to Stage, Treatment and Outcome
Patient
no.
Tumour Degree of 
pseudocapsule differentiation
Pattern and 
granularity Stage
Extent of 
disease Operation Radiotherapy Chemotherapy Outcome
i No Moderately Papillary, G lib Renal vein N Yes No Died, 3 mo 
NED, 14 yr2 Yes Well Alveolar, C and G
1 No metastases RN No No
3 Yes Moderately Papillary, C 1 No metastases RN Yes Yes NED, 11 yr 
NED, 7 y r  
Died with liver 
metastases after
4 Yes Well Papillary, C 1 No metastases RN and LND No No5 Yes Well Alveolar, C lla Capsular
lymphatics
RN and LND Yes Yes
6 Yes,
partial
Well Papillary, C lie Hilar nodes RN and LND Yes No
4 yr
NED, 5 yr
7 ' No Moderately Papillary 
and tubular, 
c
ill Distant peri­
aortic nodes
RN Yes No Alive with 
metastases, 3 yr
8 No Poorly Pleomorphic III Diffuse disease RN No Yes Died, 2 mo
C -  clear cell, G -  granular, N =  simple nephrectomy, RN =  radical nephrectomy, LND =  lymph-node dissection and NED =  no evidence of disease.
The patient with hilar node involve­
ment (no. 6) had both node dissection 
and radiation therapy.
Discussion
Clinical Findings
The mean age of the children at the 
time of presentation in our series (9.75 
years) is similar to that in a previous 
review.2
Renal cell carcinoma in children 
shows no bias for either sex,2 unlike 
its 3:1 male predominance in adults.3 
More right-sided tumours were re­
corded in a 1974 review,2 but a later 
report gave contrary findings4 and the 
tumour was left sided in six of our eight 
patients. Bilateral tumours have been 
reported5 but, as in adults, it is not 
known whether these are coexisting pri­
maries or represent metastatic di­
sease.6
No correlation has been demon­
strated with developmental defects, al­
though some patients have had uro­
genital anomalies such as imperforate 
anus with rectourethral fistula,6 ectopic 
ureter7 or horseshoe kidney.8 Some pa­
tients have been reported to have other 
primary tumours, such as retroperi­
toneal teratoma, ependymoma2 and 
neuroblastoma;4 von Hippel-Lindau di­
sease has been reported in some adults3 
but not in children.
One third of adult patients present 
with systemic symptoms such as weight 
loss and weakness with or without ane­
mia and two thirds have one or more 
features of the classic triad of hema­
turia, pain and a mass. Most adults who 
have a palpable mass on presentation 
already have metastases.3 Many chil­
dren with renal cell carcinoma also 
have systemic initial symptoms (two 
of our patients presented with weight 
loss and two others with fever). The
commonest urologic signs are a pal­
pable mass and hematuria.2 The major 
difference from adult cases is that a 
palpable mass is not necessarily as­
sociated with metastatic disease9 (which 
may reflect the ease with which a mass 
in a child’s abdomen and flanks can be 
detected by palpation10); indeed, two of 
our three patients with stage I disease 
had a palpable mass.
Trauma may call attention to the 
tumour.2 One survivor had sustained 
tumour rupture secondary to trauma,11 
but in that report the follow-up was less 
than 5 years. Neither of our patients in 
whom trauma was a major feature of 
their presenting history survived; pa­
tient 1 died 3 months after treatment 
and patient 5 died with liver metastases 
4 years after apparent cure.12
Duration of symptoms is not neces­
sarily related to survival.9 Patient 2 had 
had pain for 1 year, but had no 
evidence of disease 12 years after 
primary treatment. Others2,4 have re­
ported survival of patients who had had 
symptoms for 1 to 2 years before 
treatment.
Hypertension has been noted in 6% 
of cases2 but was not found in our 
series. No endocrine effects have been 
recorded, but liver dysfunction has 
been described.13
Six per cent of pediatric patients2 and 
a similar percentage of adults3 present 
with symptoms of metastases.2 None of 
our patients gave evidence of me­
tastases initially.
Radiologic Findings
The accuracy of roentgenography in 
the diagnosis of renal cell carcinoma 
in adults is almost 95%.3 Renal masses 
in children can be demonstrated by 
IVP and retrograde pyelography in 
97% of cases,2 but until now, diagnosis 
has been made at the time of operation.
In adults, arteriography is an excel­
lent diagnostic tool. The typical appear­
ance is of multiple tumour vessels, ar­
teriovenous shunts and microaneu­
rysms.14 Hypovascular or avascular 
masses, which have been reported in 
5% to 22%14,15 of adult cases, reflect 
poor blood supply or necrosis. Until 
recently, tumours with poor blood sup­
ply were thought to be papillary in 
type,14 but other histologic patterns have 
been described with this angiographic 
appearance;16,17 moreover, not all papil­
lary tumours are hypovascular.16
Arteriography has been little used in 
the diagnosis of renal cell carcinoma 
in children. Love and associates18 used 
arteriography to diagnose renal cell car­
cinomas in three of five children with 
renal masses, and Shanberg, Srouji and 
Leberman19 reported one case in 
which it was used. Others2,4,20 have 
mentioned using arteriographic find­
ings. Fisher and associates8 described 
two patients who had renal angiography. 
Five of our patients had arteriography. 
Table V8,18,19,21 (igSCribgS angio­
graphic and pathological appearances 
in all 12 traceable patients. In only 2 
patients did the tumours have the char­
acteristic appearance seen in adults; 
the other 10 patients had hypovascular 
or avascular tumours of varied histology.
Inferior vena cavography has not 
previously been reported in the diag­
nosis of this tumour. No inferior vena 
caval invasion was demonstrated in 
our two patients who had this study, 
but extrinsic compression by tumour 
was apparent in one.
Pathological Findings
Dehner, Leestma and Price9 showed 
a correlation between histology and 
survival. Of their few patients whose 
tumours were of mixed trabecular and 
tubular pattern with clear cells, 80%
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survived. In their series the prognosis 
was better with clear cell tumours than 
with granular tumours, and a tumour 
pseudocapsule was a favourable sign.
In our series more survivors had 
clear cell tumours (Table IV) than had 
granular ones, but this histologic pat­
tern did not guarantee survival. Fur­
thermore, although all four survivors 
had tumour pseudocapsules, so did one 
nonsurvivor. Histologic grading cor­
related to some degree with survival: 
seven of the eight tumours were well or 
moderately well differentiated and four 
of the seven patients survived more 
than 5 years; the only patient with a 
poorly differentiated tumour died 2 
months after admission. Thus we agree 
that pathological criteria are not con­
sistent indicators of prognosis.2 This 
finding is similar to that in renal cell 
carcinoma in adults:22 cellular granular­
ity and patterns of organization are not 
generally considered useful indicators 
of prognosis.3
Staging, Treatment and Survival
Tumour staging based on surgical 
and pathological criteria is at present 
the best method for predicting and 
comparing survival rates.3 Castellanos, 
Aron and Evans2 were the first to use 
staging to analyse reported cases. A 
summary of their findings in 30 pa­
tients followed up for more than 5
years (Table III) shows a good 5-year 
survival rate for patients with tumours 
localized to the kidney, with locally 
invasive tumours or with spread of the 
disease to the regional nodes only, and 
a poor survival rate for those with vas­
cular permeation and distant metas- 
tases. In adults, renal vein extension is 
associated with a better prognosis than 
nodal metastases23 and large tumours 
commonly are associated with a higher 
stage;3 the latter does not hold for 
children.10 In both age groups, stage III 
disease has a poor prognosis.
Additional reports of children fol­
lowed up for more than 5 years are 
summarized in Table VI.4'8'21,23,24 Good 
survival is noted for stages I and lie, 
and poor survival for stages lib  and 
III, as in adult series.25
Our results in relation to stage and 
treatment (Table IV) show that survival 
usually was related to stage. The stage 
lie survivor (patient 6) underwent 
lymph-node dissection and received 
radiation therapy in addition to radical 
nephrectomy.
Cassady and associates4 in a series of 
eight cases, achieved better results than 
those previously reported.2 Their sur­
vivors (the exact duration of follow-up 
was not specified) included some who 
had had vascular invasion. They 
treated every patient by nephrectomy, 
radiation therapy and long-term
Table V—Angiographic and Pathological Appearances Reported in 12 
Children with Renal Cell Carcinoma
Pathological
Angiographic appearance No. of patients findings (when stated)
Neovascular with arteriovenous shunts 218-19 Papillary, glandular19
Hvpovascular 8818.21 Papillary with necrosis8
Necrosis18 
Alveolar (patient 5) 
Papillary (patients 6 and 7)
Avascular 2 Pleomorphic (patient 8)
Papillary (patient 4)
Table V I—Staging, Treatment and Survival in 12 Reported Cases of Renal Cell 
Carcinoma in Children in Addition to Those Reviewed by Castellanos, Aron and Evans2
Stage Authors Treatment Outcome
1 Lynne and Machiz21 N NED, 8 yr
1 Nygaard and Simon23 RN NED, 25 yr
lib Schellhammer and Smith24 RN Died, 1 yr
lie Fisher and associates8 N Alive with disease, 5 yr
lie Cassady and associates,4 2 cases RN and LND 
CT and RT
Case 1: NED, 10.25 yr 
Case 2: NED, 13.5 yr
III Lynne and Machiz,21 2 cases Biopsy only 
Biopsy and RT
Died in less than 1 yr 
Died, 9 yr
III Cassady and associates4 RN, CT and RT Died in less than 1 yr
III Fisher and associates,8 2 cases Biopsy only Both died in less than 1 yr
III Schellhammer and Smith24 N Died in less than 1 yr
CT = chemotherapy, RT =  radiation therapy.
chemotherapy; their impressive results 
may be related to the intensive and 
prolonged use of chemotherapy.
Late recurrence after apparent cure, 
which is well described for adults, has 
been reported in some cases of renal 
cell carcinoma in children.26 Also, cases 
of prolonged survival with disease have 
been reported.16 The erratic behaviour 
of this tumour is therefore the same in 
adults and children.
Conclusions
The clinical presentation of renal 
cell carcinoma in children may dif­
fer from that in adults: fewer chil­
dren have advanced disease when they 
have a palpable mass, and symptoms 
may be present for some time with­
out the development of metastases. 
Traumatic rupture of the tumour be­
fore treatment carries a poor prognosis.
Arteriographic findings have dif­
fered in the two age groups in that 
neovascularity is usually sparse in chil­
dren. This angiographic picture is seen 
with different histologic patterns.
The significance of pathological find­
ings in regard to prognosis in both age 
groups is confusing. However, longer 
survival has been recorded with better 
differentiated, clear cell tumours.
Tumour staging is most reliable in 
predicting prognosis. Patients with in- 
trarenal disease, minimal local exten­
sion and regional nodal disease at the 
time of presentation had good survival 
rates. Vascular extension in children, 
in contrast to its occurrence in adults, 
was an ominous finding.
Aggressive surgery has yielded good 
results in patients with local and re­
gional nodal disease. The reports on 
chemotherapy and radiation therapy 
have not been detailed enough to allow 
comparison of their efficacy in treating 
distant disease.
Although it may differ in clinical 
presentation, renal cell carcinoma in 
adults and in children is similar in 
pathological appearance and in be­
haviour. In both age groups metastatic 
disease responds unpredictably to 
various treatment modalities.
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Management of Disseminated Testicular Cancer
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Thirteen patients with disseminated 
nonseminomatous germ cell tumours 
of the testis were treated with a 
three-drug combination (vinblastine, 
bleomycin and cis-diamminedichloro- 
platinum). Of 12 patients with meas­
urable disease, 8 had complete and 
3 partial remission. One patient 
with a solitary metastasis failed to 
respond but is disease free following 
surgical excision. Toxicity was moderate 
but no drug-related deaths occurred 
and there were no apparent lasting 
side-effects. No patients with 
complete remission have relapsed. Ten 
of the 13 patients are without evidence 
of disease from 9 to 36 months after 
treatment, 6 of these for 2 years or 
more. One patient died after a partial 
remission of 16 months. One is 
undergoing further treatment for relapse
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with liver metastases and one remains 
in partial remission at 30 months. These 
results demonstrate the efficacy of 
this drug combination in testicular 
cancer.
Treize patients souffrant de tumeurs 
testiculaires germinales non seminoma- 
teuses ont ete traites avec une 
association de trois medicaments 
(vinblastine, bleomycine et cis-diammi- 
nedichloroplatine). Chez les 12 
patients ayant une atteinte mesurable,
8 ont eu une remission complete 
et 3, une remission partielle. Un 
patient porteur d'une metastase 
solitaire ne repondit pas mais il est 
maintenant exempt de lesion suite 
a une excision chirurgicale. La 
toxicite a ete moderee mais aucun 
deces attribuable aux medicaments 
n’est survenu et il n'y a eu aucune 
reaction indesirable persistante.
Aucun patient ayant beneficie d'une 
remission complete n'a rechute. Dix 
des 13 patients n'ont aucun signe 
de maladie apres 9 a 36 mois, dont 
6 apres plus de 2 annees. Un 
patient est decede apres une remission 
partielle de 16 mois. Un patient repoit
plus de traitement pour une rechute 
avec metastases du foie et un autre 
patient est en remission partielle apres 
30 mois. Ces resultats demontrent 
I’efficacite de cette association 
medicamenteuse dans le cancer 
testiculaire.
Testicular cancer is the most common 
malignant condition occurring in men 
from 20 to 35 years of age.1 It is there­
fore an important disease although ac­
counting for only 1% of all cancer in 
males. Seminoma, which accounts for 
about 40% of testicular cancer, is 
highly radiosensitive. Cure rates ap­
proach 100% in stage I disease (con­
fined to the testis) and are 70% to 
80% in stage II (regional nodes in­
volved).2 Nonseminomatous germ cell 
tumours are less radiosensitive and the 
relative roles played by surgery and 
radiation therapy are controversial. 
The 3-year survival rate for patients 
treated by retroperitoneal lymphadenec- 
tomy or by irradiation is 80% to 90% 
for stage I and 40% to 80% for stage 
II tumours.3-5
Although a 5-year survival rate of 
55% has been achieved for metastatic
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seminoma treated by radiation therapy,6 
the majority of patients with dissemin­
ated testicular cancer require chemo­
therapy. Progress in the treatment of 
this disease has included the develop­
ment of new active drugs and their use 
in combination. In 1976, Einhorn, 
Furnas and Powell7 presented their in­
itial results using vinblastine, bleomycin 
and cis-diamminedichloroplatinum (cis- 
platinum). In this paper we report our 
experience with a similar drug regimen 
in patients with nonseminomatous germ 
cell tumours of the testis.
Patients and Methods
We studied 13 patients with disse­
minated nonseminomatous germ cell 
tumours. Seven had disseminated di­
sease at the time of initial presentation 
and in five metastases developed within 
4 months of completing treatment to 
the regional nodes. One patient had had 
a relapse following previous complete 
response to chemotherapy. Six patients
Fig. lb
FIG. 1— (a) Chest film before treatment 
showing extensive pulmonary metastases 
and (b) 30 months later, showing partial 
remission of disease.
had embryonal carcinoma, six had em­
bryonal carcinoma and teratoma and 
one had embryonal carcinoma and 
choriocarcinoma.
Cis-platinum was given at a dosage 
of 20 mg/m2 body surface daily for 
5 days, repeated at 3-week intervals for 
three courses. One patient received a 
fourth course. Patients were hydrated 
before infusion and mannitol (20 g) was 
given with the cis-platinum. Vinblastine 
(0.2 mg/kg body weight daily) was 
given on days 1 and 2, for a total of 
five courses every 3 weeks. More re­
cently, the dose of vinblastine has been 
reduced to 0.15 mg/kg. Bleomycin 
(30 units intravenously) was given 
weekly for 12 weeks. During cis-plati­
num therapy bleomycin was given on 
day 2, 6 hours after vinblastine. Patients 
obtaining complete remission continued 
to receive vinblastine 0.3 mg/kg body 
weight every 4 weeks. Bacille Calmet 
Guerin immunotherapy, as initially de­
scribed by Einhorn, Furnas and 
Powell,7 was not used.
Results
Twelve patients had measurable di­
sease and of these 8 obtained com­
plete remission and 3 partial remission. 
None of those in complete remission 
have relapsed and they have remained 
free of disease for 9, 11, 16, 23, 25, 31, 
35 and 36 months. Of the three patients 
in partial remission, two presented with 
extensive intra-abdominal and pul­
monary disease and one with extensive 
pulmonary disease (Fig. 1). One died 
at 16 months from progressive intra­
abdominal disease. One had complete 
remission of multiple lung lesions but 
had persistent minimal intra-abdominal 
disease for which he received radiation 
therapy. Liver metastases developed 
while he was completing this treatment 
and he is at present receiving further 
chemotherapy. The patient whose chest 
film is shown in Fig. 1 had a partial 
remission. He remains asymptomatic 
30 months later and although he has 
received no therapy for 18 months his 
disease has not progressed.
One patient with a solitary lung me­
tastasis failed to respond to treatment 
so this lesion was excised. His original 
testicular tumour was mainly embry­
onal with teratomatous elements. Only 
teratomatous elements were found in 
the metastatic lesion, this being mainly 
cartilage. He remains free of disease 
15 months after excision of the metas­
tatic tumour. One patient did not have 
measurable disease but was treated 
because of incomplete resection of in­
tra-abdominal lesions. This patient with 
teratocarcinoma at initial presentation 
had a large solid mass in the pelvis, 
extensively involved retroperitoneal 
nodes and a peritoneal cavity filled with
teratomatous cysts. These were all re­
sected but fragm ents of tumour re­
mained adherent to pelvis and bowel. 
He is without evidence of disease 34 
months later.
Ten (77%) of the 13 patients have 
no evidence o f  disease at 9 to 36 
months, 6 of these 2 years or more 
after treatment. One patient died after 
a partial remission of 16 months, one 
remains in partial remission at 30 
months and one is being treated for 
relapse.
Eight patients had an elevated con­
centration of the serum a-fetoprotein, 
or elevated tite r  of the beta subunit of 
human urinary chorionic gonadotropin, 
or both. In all cases of complete remis­
sion these values returned to normal and 
have remained normal. In all three 
patients achieving partial remission, 
these values were grossly elevated in­
itially, but returned to normal despite 
evidence of persisting disease. They 
have remained normal in the patient in 
partial remission but became elevated 
in the two patients who relapsed.
All patients had nausea, vomiting and 
alopecia during the period of induction 
therapy. Severe leukopenia occurred in 
all patients. Although three patients 
required hospitalization for granulocy­
topenia and fever, none had proven 
sepsis. No patients have demonstrated 
impairment of renal function after re­
ceiving cis-platinum or of pulmonary 
function after receiving bleomycin. 
Myalgia occurred frequently as a result 
of giving vinblastine and this was most 
severe during the maintenance phase.
Discussion
From January 1972 until May 1976, 
16 patients with disseminated non­
seminomatous germ cell tumours were 
treated at our institution with a variety 
of chemotherapeutic agents. Three had 
a complete remission and two partial 
remission. These results are similar to 
those of other reports published before 
1976 (Table I8'13). In 1976 Cvitkovic, 
Hayes and Golbey14 reported a com­
plete remission rate of 69% using a 
five-drug combination of vinblastine, 
bleomycin, cyclophosphamide, dactino- 
mycin and cis-platinum. Einhorn, 
Furnas and Powell7 using a three-drug 
combination of vinblastine, bleomycin 
and cis-platinum reported a complete 
remission rate of 75%. Our present 
results using vinblastine, bleomycin and 
cis-platinum are similar and represent 
a notable improvement over our pre­
vious experience. None of the eight 
patients in complete remission have re­
lapsed to date and five of these have 
been in remission for 2 years or more. 
Previous experience with testicular 
cancer indicates that most relapses 
occur within 2 years15,16 so it is likely
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Table I— Results of Treatm ent of Nonseminomatous Germ Cell Tumours before 1976
No. of Complete
Year Author Treatm ent patients remissions,%
1960 Li and associates'* Dactinomycin, methotrexate, 
chlorambucil
23 30
1966 Mackenzie9 Dactinomycin ±  chlorambucil 
±  methotrexate
154 16
1967 W yatt and McAninch10 Methotrexate 10 40
1970 Mendelson and Serpick11 Cyclophosphamide, vincristine, 
methotrexate, fluorouracil
17 29
1970 Kennedy12 Mithramycin 23 22
1975 Samuels, Johnson and Holoye19 Vinblastine, bleomycin 23 39
that many of these patients will be 
cured.
While partial remissions resulting 
from chemotherapy are generally of 
short duration it is of interest that one 
patient has been in partial remission for 
30 months. It seems likely that these 
persisting lesions have undergone ma­
turation to a more benign form as has 
been previously documented.17,18 In pa­
tients obtaining partial response an 
attempt should be made to eradicate 
residual disease by surgery supple­
mented as necessary by radiation ther- 
apy.
One unanswered question is, Should 
retroperitoneal lymphadenectomy be 
performed in patients who appear to 
be in complete remission? Two such 
patients in this series did not receive 
either surgery or irradiation to regional 
nodes. In the series reported by Einhorn 
and Donohue19 lymphadenectomy was 
reserved for those with residual di­
sease. Results to date suggest that fur­
ther therapy, either surgery or irradia­
tion, may be necessary only when re­
sidual disease is suspected or perhaps 
when bulky retroperitoneal disease is 
present initially.
Initial results with the Einhorn re­
gimen suggested a lower response rate 
for teratocarcinoma compared with em­
bryonal carcinoma.19 Further experience 
has shown similar response rates.20 The 
one patient who failed to respond in 
the present series had a primary terato­
carcinoma with predominantly em­
bryonal elements. The persisting metas­
tatic lesion was teratomatous with 
no embryonal component. The one 
patient who died in this series had 
some elements of choriocarcinoma. Al­
though choriocarcinoma in combina­
tion does not appear to worsen prog­
nosis, results obtained in patients with 
pure choriocarcinoma are less good.20 
The present series did not include cases 
of pure seminoma. Einhorn20 has re­
ported complete remission in 9 of 13 
patients with pure seminoma. Although 
irradiation remains the primary mode 
of therapy for such patients, these re­
sults indicate that chemotherapy for dis­
seminated seminoma should be consi­
dered before extensive radiation ther­
apy to bone marrow or to lungs makes 
it difficult to use these chemotherapeu­
tic agents.
Impairment of pulmonary function by 
bleomycin or of renal function by cis- 
platinum was not encountered in our 
series. Attention to hydration and the 
use of mannitol helped to prevent the 
latter. The most serious side effect was 
neutropenia which occurred in all pa­
tients. Our policy was to admit and 
isolate only those patients who were 
febrile and thought to have sepsis. 
Aminoglycosides should not be adminis­
tered in these patients as there is a risk 
of irreversible renal failure when used 
in patients receiving cis-platinum.21
The availability of effective chemo­
therapy for disseminated testicular can­
cer raises the question of its use as 
adjuvant therapy for patients with non­
seminomatous germ cell tumour. The 
risk of recurrence must be weighed 
against the toxicity of adjuvant chemo­
therapy and the fact that over 60% of 
those developing metastases may be 
cured of their disease by subsequent 
chemotherapy. With possible cure rates 
of over 80% there is little indication 
for adjuvant therapy of patients with 
stage I disease. Recurrence is much 
more likely to occur in those with stage 
II disease. If 40% of patients with stage 
II disease relapse and if 60% of these 
can be cured by subsequent chemo­
therapy then an overall survival of 
85% would be expected. This would 
prevent 60% of stage II patients from 
receiving unnecessary chemotherapy. 
To determine if adjuvant therapy can 
improve upon these results will require 
a large randomized trial.
Conclusion
Combination therapy with vin­
blastine, bleomycin and cis-platinum 
gives a complete remission rate of ap­
proximately 70% in patients with dis­
seminated testicular cancer. Almost 
all the remaining patients will obtain 
partial remission and with adjunctive
surgery or radiation therapy, or both, 
some may be converted to complete 
remission. Relapses to date have been 
few in those with a complete remission 
and eventual cure appears a strong 
possibility. Moderate toxicity is as­
sociated with this regimen but it was 
generally well tolerated and no drug- 
related deaths occurred. No permanent 
toxic effects have been noted. This 
combination chemotherapy represents 
a notable advance in the management 
of patients with testicular cancer.
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Surgical Treatment of Carcinoma of the Prostate
C.J. Robson, md, facs, frcs[c]
Prostatic cancer kills more men than 
any other malignant condition except 
that arising from the lung. “Cancer 
Therapy: Prognostic Factors and 
Criteria of Response” predicted 
that there would be approximately 
17 500 deaths due to this disease in 
the United States in 1978.
Surgery is only applicable in stages 
A and B, when the tumour, as shown 
by various tests, such as measurement 
of the acid phosphatase value, technetium 
scanning and radioimmunoassay, is 
confined to the prostate. Ideally, the 
lymph glands along the iliac and 
obturator vessels should first be 
removed and quick-sectioned. If malignant 
cells are found in the lymph glands, 
the disease is considered surgically 
incurable and the procedure should be 
abandoned. If, however, the glands are 
disease free, a total prostatovesiculec- 
tomy should be carried out.
The author also discusses the place 
of palliative surgery, such as 
transurethral resection, in the treatment 
of cancer of the prostate.
Le cancer de la prostate tue plus 
d’hommes que toute autre maladie 
maligne, sauf cedes du poumon. 
“Cancer Therapy: Prognostic Factors 
and Criteria of Response” predisait 
qu'il y aurait approximativement 
17 500 deces attribuables a cette 
maladie aux Etats-Unis, en 1978.
La chirurgie n'est applicable qu'aux 
stades A et B, quand la tumeur, tel
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que demontre par diverses epreuves 
comme la mesure de la phosphatase 
acide, la scintigraphie au technetium 
et le titrage radio-immunologique, 
est confinee a la prostate. Idealement, 
les ganglions lymphatiques le long 
des vaisseaux iliaques et obturateurs 
devraient etre enleves et mis en 
section rapidement. Si des cellules 
malignes sont retrouvees dans les 
ganglions lymphatiques, la maladie est 
consideree chirurgicalement incurable 
et I'intervention devrait etre 
abandonnee. Si, toutefois, les ganglions 
sont sains une prostatovesiculectomie 
totale devrait etre pratiquee.
L’auteur discute egalement du role 
de la chirurgie palliative, telle que 
la resection transuretrale dans le 
traitement du cancer de la prostate.
More men die of prostatic cancer than 
of any other malignant disease with 
the exception of that arising in the 
lung. In those over 75 years of age 
prostatic cancer is the prime killer. 
The statistics in “Cancer Therapy: 
Prognostic Factors and Criteria of Res­
ponse”1 indicated that there would be 
approximately 17 500 deaths due to 
cancer of prostate in 1978.
From a different viewpoint it is 
estimated that 11 % of all carcinomas 
in the male are prostatic in origin, and 
routine autopsies have shown that the 
frequency of prostatic cancer ranges 
from 14% to 46% even up to 90%, 
depending on the criteria for diagnosis 
as well as the thoroughness of the 
examination.
Regarding the management of this 
disease, there is no dogmatic statement 
which cannot be refuted by reference 
to the literature.
Pathology
Mostofi,2,3 in reports of 12 000 au­
topsies performed on patients who 
had had carcinoma of the prostate, 
stated that 99% Of the growths oc­
curred peripherally and at least one 
third of thes^ were multifocal. Fie al­
so pointed out that the grade of lesion 
varied in the same specimen, one area 
showing well-defined adenocarcinoma 
grade I and another less well-defined 
tumour, grades III or IV, according 
to Broders’ classification.4 The growth 
remains localized for a time, then 
spreads through the capsule and hence 
to the lumbar spine and pelvis, usually 
via Batson's plexus of veins. Initial 
spread is by way of the pelvic and 
para-aortic lymph nodes and also by 
the blood stream to other bony sites. 
Indeed, the lung and brain may be 
involved in a carcinomatosis type of 
spread.
Diagnosis
Only 5% to 10% of cancers of the 
prostate are diagnosed when they are 
amenable to surgical cure or treat­
ment. They are usually discovered by 
the physician who finds a nodule or 
induration on routine rectal examina­
tion. The remaining 90% to 95% are 
found because the patient has symp­
toms of bladder neck obstruction, 
which is almost always due to a stage 
C or D lesion (one which has penetrat­
ed the prostatic capsule), or because 
of symptoms due to metastases (e.g., 
bone pain).
In recent years we have added to 
our diagnostic armamentarium three 
aids to staging: (a) the isolation of the 
prostatic fraction of the serum acid 
phosphatase, which is almost always 
diagnostic when the value is elevated; 
(b) the estimation of the bone marrow 
acid phosphatase value as advocated 
by Veenema and associates,5’® who 
showed that elevation of the bone mar­
row acid value indicates extracapsular
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spread of the growth some time be­
fore the serum acid phosphatase con­
centration becomes elevated; and (c) 
the radioimmunoassay for prostatic acid 
phosphatase as developed by Feni- 
more Cooper.712 This assay gives po­
sitive results in 30% of cases in which 
the bone marrow and serum acid phos­
phatase values are normal as estimated 
by other methods. So far, this is the 
most sensitive test we have to detect 
extraprostatic spread of disease.
Normally pedal lymphangiography 
does not show the obturator or in­
ternal iliac nodes which are the first 
to be involved by cancer of the pros­
tate. If these nodes are demonstrated, 
it is almost certainly by retrograde 
filling of these lymphatics due to ob­
struction of the lymph channels in the 
common iliac chain or possibly the 
para-aortic chain.
Prognosis
The prognosis depends on two fac­
tors, stage and grade, in addition to 
the immune response of the host to 
tumour.
Stage
There are four stages of carcinoma 
of the prostate which may be num­
bered 1 to 4 or, as in this paper, 
lettered A to D. In stage A the diag­
nosis is made by microscopic exam­
ination alone. The serum acid phos­
phatase values are normal. The lesion 
cannot be detected clinically. In stage 
B l, the lesion is less than 2 cm in 
diameter. The serum phosphatase val­
ues are normal. In stage B2 lesions 
the growth is confined within the cap­
sule of the prostate and, on clinical 
examination, does not involve the base 
of the bladder or seminal vesicles. In 
stage C the growth has penetrated the 
capsule and invaded the base of the 
bladder or the seminal vesicles, or 
both. In this stage pelvic lymph nodes 
are involved in 50% to 85% of cases 
but the tumour is limited to the pelvis. 
In stage D there are metastases.
Grade
Grading of prostatic carcinoma is 
extremely difficult because of the wide 
variation within the same specimen.13 
It is therefore impossible to grade a 
prostatic carcinoma accurately from 
two or three small needle biopsy speci­
mens. This has been a serious problem 
in assessing the importance of grading 
in various series. Unquestionably, grad­
ing of a tumour should be on the 
basis of the highest grade within the 
specimen and this can only be assessed 
accurately from the whole specimen.
Treatment
Carcinoma of the prostate may be 
divided into two main clinical groups. 
The first comprises stages A and B, 
the second, stages C and D. Tumours 
in stages A and B are potentially cur­
able by total prostatovesiculectomy, 
with or without lymph-node dissection. 
As a result of this procedure, 95% 
or more of patients may become im­
potent and 10% to 20% will have 
some degree of urinary incompetence.
Stages A and B
Stage A .—The management of pa­
tients with stage A lesions is contro­
versial. Many urologists believe that 
the large majority of patients with a 
tumour of this stage will not die of 
their disease and that their life expec­
tancy is equal to a similar age group 
without the disease. We do not sub­
scribe to this belief. We believe that 
stage A tumours should be treated 
like any other operable cancer. Some 
urologists actually base their treatment 
on the percentage of tissue with malig­
nant change and are of the opinion that 
if it is less than 30% , the patient should 
be treated expectantly. Recently, 
the grade of the lesion has been shown 
to have a very important effect on the 
prognosis.1316 If the tumour is a well- 
differentiated adenocarcinoma and re­
peat biopsy specimens of the prostatic 
capsule after 1 month and a transrectal 
needle biopsy specimen of the posterior 
lobe fail to show any remaining disease, 
then these patients should not be sub­
jected to total prostatectomy. On the 
other hand, if the lesion is of high grade 
(and 20% to 50% of them are), we 
agree with Bauer, McGavran and Car­
lin16 that the prognosis even with endo­
crine therapy is poor and that these pa­
tients should be treated by total pros­
tatovesiculectomy if they have no se­
rious concomitant disease and have a 
life expectancy of 10 years or more.
Stage B l .—In a patient with this 
stage of tumour who is younger than 
70 years and who is otherwise in good 
health, the optimum cure rate will be 
achieved by total prostatovesiculecto­
my if the lymph nodes taken from 
the internal iliac and obturator areas 
show no tumour.
Stage B2.—Autopsy series show 
that 6% of patients with these tumours 
have positive nodes (stage C lesions). 
Because of the complications of im­
potence and incontinence, there are 
two groups of urologic surgeons who 
advocate widely divergent treatment. 
One group advocates expectant treat­
ment, in stages A and B lesions, with 
the exception, perhaps, of introducing 
iodine-125 needles directly into the
gland or of external irradiation in 
cases of high-grade tumour.17 For tu­
mours of lower grade, therapy is 
withheld until symptoms develop on the 
premise that many carcinomas of the 
prostate are extremely slow growing.18 
Unfortunately, at present, we cannot 
predict the behaviour of such tumours. 
Grading may be a guide but, as al­
ready noted, is not dependable in bi­
opsy specimens. This is the approach 
now recommended by Whitmore,18 
but considerable time is neces­
sary before a thorough assessment of 
this approach can be completed. On 
the other hand, Jewett19 and workers 
from the Mayo Clinic,20,21 amongst 
others,22 believe that the disease merits 
a radical operation and that the 10- to 
15-year survival justifies this despite 
the complications. It is generally agreed 
that radical or total prostatectomy 
should be reserved for patients who 
normally have at least a 10-year life 
expectancy from the time of operation. 
It is of interest that supplying estro­
gens after total prostatectomy does not 
improve the prognosis.23
Stages C and D .—The second clin­
ical group of cases, stages C and 
D, may require palliative surgery, such 
as a procedure to relieve bladder neck 
obstruction (usually with some degree 
of benign prostatic hypertrophy) which 
has not been relieved by estrogen 
therapy. In some relatively healthy pa­
tients with stage C tumour, the dis­
ease may have extended to the base 
of the bladder and involved the lower 
ends of the ureters producing hydro­
ureter and hydronephrosis and life 
threatening renal failure. In such cases, 
bilateral reimplantation of the ureters 
to a higher site in the bladder may be 
of value.
Surgical Approach
The ideal surgical approach to the 
malignant prostate should: (a) allow 
sampling of the internal iliac and ob­
turator lymph nodes, because if these 
nodes contain malignant cells the dis­
ease is surgically incurable and the 
operation should not be continued; (b) 
allow easy access to the gland itself 
even after a complete transurethral re­
section (i.e., in stage A disease); (c) 
permit accurate and easy anastomosis 
of the bladder to the urethra; (d) keep 
incontinence and impotence to a mini­
mum; and (e) result in minimal mor­
bidity, mortality and hospital stay.
Perineal Exposure
Unless this is done in two steps or 
by two teams, examination of the pel­
vic lymph nodes is not possible. It is 
a most difficult operation if there has
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been a previous transurethral resection 
or enucleation. In our hands the fre­
quency of impotence has been almost 
100% and some degree of inconti­
nence has occurred in about 50% of 
patients.
Retropubic Approach
This can be most difficult technical­
ly, particularly with respect to urethral 
anastomosis and after a previous pros­
tatic operation. The anastomosis can 
be so difficult that some advocate leav­
ing a small portion of prostate behind 
to facilitate it. Byar and Mostofi23 have 
deplored this action because they 
found cancer at the prostatic apex in 
75% of 208 prostates removed for 
?arly carcinoma. The incidence of im­
potence and incontinence is approxi­
mately the same as for perineal prosta­
tectomy.
Total Trans-sacral Prostatectomy
This operation was originally pro­
posed for patients who could not be 
put into the exaggerated lithotomy po­
sition. It allows easy access to the 
prostate, and visualization of the anas­
tomosis is superior to that obtained 
with the retropubic approach but, like 
the perineal approach, it does not allow 
examination of the lymph nodes.
Transpubic Approach
Within the last 4 years this ap­
proach has been used almost exclusive­
ly by the staff of the Toronto General 
Hospital. It allows the extraperitoneal 
removal of the iliac and obturator 
nodes for quick section before mani­
pulation of the prostate. It allows ex­
cellent exposure of the prostate for its 
removal and for anastomosis of the 
bladder to the urethra under direct 
vision. The procedure can be carried 
out by one team. It is the exposure 
of choice, particularly when a prosta­
tic procedure has been done previous­
ly. There is some morbidity due to 
pain in the adductor regions on walk­
ing, but this has seldom persisted more 
than a few weeks; by leaving a small 
bridge of symphysis, this pain can be 
almost eliminated. Stress incontinence 
has been a problem but has been 
solved by fashioning a bladder tube 
to anastomose to the urethra after the 
method of Flocks and Culp.24
From Aug. 1, 1974, to Dec. 31, 
1978, 42 patients with carcinoma of 
the prostate considered to be either 
stage A or B were operated on at 
the Toronto General Hospital. S'ix of 
the patients had malignant cells in 
the nodes on quick section and the 
procedure was terminated; three were
clinically stage A and three stage B. 
Two of these tumours were highly dif­
ferentiated adenocarcinomas, two mod­
erately well differentiated and two 
were anaplastic. There were therefore 
36 patients who underwent radical 
transpubic prostatovesiculectomy. It is 
interesting that about 60% of these 
tumours were understaged, although 
pathologically the lines of resection in 
all cases were clear.
Results
Follow-up on these patients is too 
short to be evaluated statistically, but 
some interesting facts have emerged: 
(a) after the operation 35 of the 36 
patients walked without difficulty. 
Leaving a bridge of symphysis may 
have helped; (b) 3 of the 36 patients 
have persistent stress incontinence re­
quiring a clamp or collecting appa­
ratus. Anastomosis using a bladder 
tube, as described by Flocks and Culp, 
should eliminate this problem; and (c) 
3 of the 36 patients were potent.
Conclusions and Summary
Carcinoma of the prostate is fatal 
for about 17 500 Americans each year, 
and with increasing longevity this in­
cidence will increase. In men who 
have a life expectancy of 10 years 
from the time of presentation and 
who have a lesion which is clin­
ically stage A, B1 or B2, the treatment 
of choice is surgical. In the case of 
a stage A tumour, if the repeat trans­
urethral and needle biopsy specimens 
after 1 month fail to show any 
tumour and the tumour was of low 
grade, then watchful waiting is prob­
ably permissible. On the other hand, 
no matter what size the tumour 
may be, if it is of high grade or if 
repeat biopsy specimens show that the 
tumour is still within the capsule, then 
serious consideration should be given 
to performing a total prostatectomy. 
We believe that surgical extirpation is 
the treatment of choice in patients with 
stage B lesions, either B1 or B2.
The transpubic approach for prosta­
tovesiculectomy is the best one with 
minimal morbidity and complications.
At present we are understaging 
about 60% of our cases of carcinoma 
of the prostate.
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Radiation Therapy for Adenocarcinoma of the Prostate
A.W. Bruce, mb, ch b, frcs( edin), facs, frcs[c],* D.E. Mahan, ph d* and S. Lott, md, dmrt, FRCP[c]f
Forty-eight patients with different 
stages of adenocarcinoma of the 
prostate were treated by external beam 
therapy. Biopsy results are correlated 
with stage of disease, original grade 
of tumour and with the findings on 
examination. The authors discuss the 
significance of histologic progression of 
the disease particularly in relation 
to prognosis. They review the place 
of staging lymphadenectomy before 
radiotherapy and the overall morbidity 
associated with treatment.
Quarante-huit patients souffrant 
d'adenocarcinomes prostatiques a 
differents stades ont ete traites par 
faisceau de rayonnement externe.
On a fait la correlation entre les 
resultats de biopsie et le stade de la 
maladie, le grade initial de la tumeur 
et les constatations de I'examen rectal. 
Les auteurs discutent de la signi- 
ficativite de 1'evolution histologique 
de la maladie en relation, particuliere- 
ment, avec le pronostic. Ils revoient 
le role du classement du stade 
clinique de la maladie par lymphade- 
nectomie avant la radiotherapie, et 
la morbidite globale associee au 
traitement.
Surgical extirpation of early intracap- 
sular adenocarcinoma of the prostate 
is associated with unavoidable morbid­
ity.1,2 Furthermore, all forms of hor­
monal therapy provide control rather 
than cure of this malignant condition. 
Over the past 15 to 20 years there has 
been increasing interest in the role of 
radiation therapy in the treatment of 
patients with potentially curable pro­
static cancer and as a form of pallia­
tion for patients with bone metastases 
associated with localized pain. Adeno­
carcinoma of the prostate is a radio­
sensitive tumour and the introduction 
of external beam therapy and intersti­
tial irradiation allow the delivery of a 
tumoricidal dose of radiation to the 
prostate without damage to the skin 
and other normal tissue. Acceptable 
long-term survival statistics are becom­
ing available from centres using ex­
ternal beam therapy.3 In addition, en­
couraging results of treatment with in­
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terstitial irradiation have been re­
ported.4
The method of assessing local re­
sponse of tumour to radiotherapy is 
still controversial and requires clearer 
definition. The inadequacy of rectal 
examination in the follow-up of pa­
tients with adenocarcinoma of the 
prostate is not well recognized. Despite 
the drawbacks of biopsy this form of 
assessment provides more objective 
evidence of tumour response to radia­
tion therapy. We present biopsy data 
in a selected series of patients with 
carefully staged adenocarcinoma of the 
prostate treated by external beam 
therapy, to review early clinical re­
sults, particularly in relation to biop­
sy findings, and to report on the 
morbidity associated with this particu­
lar form of radiation therapy.
Methods
A modification of the American 
Urological System of staging5 was used 
(Table I) to record the extent of the 
disease. Staging procedures included 
rectal examination, prostatic biopsy, 
technetium-99 bone scanning, radio­
immunoassay to measure serum and 
bone-marrow acid phosphatase values6 
and pelvic lymphadenectomy. Patients 
have to be carefully selected for stag­
ing lymphadenectomy, which was em­
ployed in 63% of the patients studied 
(Table II). Routinely, four biopsy 
specimens (two from each lobe) were 
obtained from the prostate before and 
after treatment. Pathological grading 
of the tissue was carried out using a 
modification of the method recom­
mended by the Veterans Administra­
Table 1—American Urological System for Sta­
ging Adenocarcinoma of the Prostate
Tumour
stage Description
A Incidental finding
A, Focal
A2 Diffuse
B Confined to prostate
B, Small, discrete nodule
Bo Large or multiple nodules
C Localized to periprostatic area
c, No involvement of seminal
C2
vesicles
Involvement of seminal vesicles
D Metastatic disease
D, Pelvic lymph-node metastases
Do Bone or distant lymph-node or
soft tissue metastases
tion Cooperative Urological Research 
Group.7 The grading was performed 
under low magnification (40 to 100X) 
and a histologic description was given 
of the primary and secondary his­
tologic patterns, the primary pattern 
occupying more than 50% of the 
malignant area. Each specimen was 
assigned two numbers, ranging from 1 
to 4 representing the primary and 
secondary histologic fields. These two 
numbers were then combined to give 
an overall pattern score. When the 
pattern score was less than 4, the 
tumour was described as being well 
differentiated, when 5 or 6 moderate­
ly differentiated and when 7 or 8 as 
being anaplastic.
External beam therapy (with cobalt- 
60) was used to treat all patients. In 
those without evidence of lymphatic 
spread the prostate and periprostatic 
area were irradiated with up to 6000 
rads. In patients with positive lymph 
nodes (Di), the whole pelvis was irradi­
ated to a dose of 4000 rads, and the 
prostate and periprostatic area were 
given a further 2000 rads. Both forms 
of treatment were delivered over a 6- 
week period.
Patients
Forty-eight patients were treated as 
described above. Their average age at 
time of treatment was 65.8 years 
(range 49 to 79 years). These patients 
did not receive adjuvant therapy and 
additional treatment was withheld until 
clinical progression was evident.
Following irradiation, biopsies were 
done annually; 105 specimens were 
available for study in addition to the 
original 48 (average 2.2 post-treatment 
biopsies per patient). The mean follow­
up was 40 months (range 14 to 81 
months). The distribution of patients
Table II—Data on 48 Patients with Cancer of 
the Prostate Treated by External Beam 
Therapy
Stage
No. of 
patients
No. of
laparatomies
Average
pattern
score
A2 8 2 4.9
Bi 13 10 3.9
b 2 12 9(3*) 4.9
C 15 6(3*) 5.3
♦Patients with lymph-node metastases, 
average pattern score 5.5.
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by stage is shown in Table II. Follow­
ing lymphadenectomy, six patients 
were restaged Di, three from B2 and 
three from C categories. The average 
pattern score for each stage is also 
given in Table II.
Results
As of Dec. 31, 1978, eight patients 
have died, four from progression of 
their prostatic cancer and four of un­
related causes (two of coronary throm­
bosis, one of atherosclerosis and one 
of lung cancer). One patient was lost 
to follow-up after 46 months. In addi­
tion to the four patients who died of 
adenocarcinoma of the prostate, five 
patients have shown either extension 
of local disease or the development of 
metastases, or both. Table III lists in 
detail the clinical status of these nine 
patients. Seven of the nine patients did 
not have the benefit of a staging 
lymphadenectomy and this may be of 
significance in three of the patients 
who later had metastatic disease and 
in two of the four patients who died. 
In three of these four patients, biopsy 
specimens obtained prior to death 
showed anaplastic carcinoma and the 
fourth patient probably had metastases 
at the time of treatment (common iliac 
lymph nodes showed metastatic dis­
ease). Two of the eight patients with 
A2 disease had metastases. Of the 12 
patients with B2 disease, 2 had exten­
sion of disease, and 5 of 15 patients 
with stage C disease (2 with lymph- 
node metastases) also failed to respond 
to radiation therapy. No patient in 
stage Bi had progression of disease.
A comparison was made between 
rectal examination and follow-up biop­
sy findings. There was an overall dis­
agreement between rectal examination 
and histologic information in 38% 
of the biopsy specimens studied. There 
was a false-positive rate of 47% (nor­
mal biopsy result associated with 
clinically positive rectal examinations) 
and a false-negative rate of 33% 
(biopsy specimens showing tumour as­
sociated with clinically normal rectal 
examinations).
The initial stage of the disease was 
compared with the post-treatment 
biopsy findings at 1-year, 2-year and 
3-year intervals (Table IV). The six pa­
tients with lymph nodes containing 
malignant cells were included and re­
ported under their initial clinical stage. 
At 1-year follow-up, 43% (17 of 40) of 
the biopsy specimens failed to show 
any malignant lesion but after 2 years, 
only 33% (11 of 33) of biopsy speci­
mens were cancer free and after 3 
years, only 28% (5 of 18). Although the 
numbers are small, patients with A2 and 
B disease appeared to respond more
effectively to radiation therapy than 
those with stage C disease.
The original histologic grade of the 
tumour was also compared with the 
post-treatment biopsy findings (Table 
V). Patients with well-differentiated 
neoplasms appear to have a better 
prognosis than those with either a 
moderately well differentiated or an
anaplastic lesion. The 13 patients with 
Bi disease had a pattern score under 
4 indicating a well-differentiated tu­
mour and, as previously noted, in no 
patient has the disease progressed.
The clinical response of the patient 
in relation to change in biopsy findings 
was also studied. The grading method 
used allowed a quantitative evaluation
Table I I I— Clinical Status of Patients Who Had Extension of Prostatic Cancer or Died of the Disease
Original
clinical
stage Laparotomy
Control 
of primary 
tumour Metastases
Death due 
to prostatic 
carcinoma
Remission 
time, mo
Biopsy
pattern score
Original Follow -up
A , No No Yes — 31 5 7
A 2 No Yes Yes Yes 24 4 8
b 2 No Yes Yes — 54 4 Neg
b 2 No No No — 23 7 6
c No No No No 16 4 5
c No No Yes — 24 8 7
c No No Yes Yes 21 7 8
c Yes* Yes Yes Yes 28 4 Neg
c Yes* No Yes Yes 24 4 8
*Lymphnodes positive.
Table IV— Comparison of In itia l Stage of Disease and Postoperative 
Biopsy Findings at 1, 2 and 3 Years after Treatm ent
Follow-up, yr; no. tum o ur-free biopsy specimens /to ta l no.(and % )
In itia l stage 1 2 3
a 2 4 /6  (67) 5 /6  (83) 2 /4  (50)
B 9/21 (43) 5/19 (26) 3/11 (27)
C 4/13 (31) 1/8 (12) 0/3 ( 0 )
17/40 (43) 11/33 (33) 5/18 (28)
Table V—Comparison of Original Histologic Grade and Biopsy Findings at 
1, 2 and 3 Years a fte r Treatment
Follow-up, yr; no. tum our-free biopsy 
specim ens/total no. (and % )
Original grade No. of 
patients 1 2 3
Well d ifferentiated 26 12/21 (57) 7/16 (44) 3 /8  (37)
Moderately well d ifferentiated 12 3/10 (30) 1 /8 (12) 1/7 (14)
Anaplastic 10 2/9 (22) 3 /9  (33) 1 /3  (33)
48 17/40 (43) 11/33 (33) 5 /18 (28)
Table V I— Clinical Response in Relation to Biopsy Findings
Original biopsy
Summary of 
fo llow -up  
biopsy
C linical follow -up
Well Progression
Well differentiated Im provem ent 6 2
No change 13 0
D eterioration 2 3
Moderately well differentiated Im provem ent 6 0
No change 5 0
D eterioration 0 1
Anaplastic Im provem ent 6 1
No change 1 2
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of biopsy material (Table VI). Three 
categories were arbitrarily chosen to 
summarize and compare post-treatment 
biopsy findings with the original his­
tologic descriptions: (a) “improvement” 
represents elimination of tumour or 
consistent reduction in pattern score 
by two or more units, (b) “no change” 
indicates no net increase or decrease 
in pattern score and (c) “deterioration” 
means a consistent increase in pat­
tern score of two or more units.
Of the 26 patients with well-differen­
tiated lesions (pattern scores of 4 
or less) 21 are clinically well without 
evidence of metastases and without 
evidence of local progression. Improve­
ment was demonstrated histologically 
in two patients following radiation 
therapy yet metastases developed in 
one 54 months after completion of 
therapy. This patient did not have a 
staging lymphadenectomy. The other 
patient had metastases at the time of 
therapy and would now, under our 
present protocol, be treated by hor­
mones. Five patients showed increas­
ingly anaplastic biopsy specimens 
after treatment. Two have died of 
cancer, one has had a transurethral 
resection of the prostate and two re­
main well.
Of the 12 patients with moderately 
well-differentiated adenocarcinomas 
(pattern score of 5 to 6), 11 are clinic­
ally well and have shown improve­
ment or no change in their pattern 
score. One patient had deterioration, 
demonstrated histologically, with con­
current progression of disease both 
locally and distally. This patient did 
not have a staging lymphadenectomy.
Finally, of the 10 patients with 
anaplastic histology (pattern scores of 
7 and 8), 7 are clinically well and 3 
have shown progression of disease. 
Two of the three have had persistently 
anaplastic biopsy specimens but one 
has shown local improvement. With an 
average follow-up of 40 months, 35 of 
44 are clinically well.
Complications
We were impressed by the frequency 
of serious side effects. Irritable blad­
der and bowel symptoms following 
radiotherapy occurred in the majority 
of the patients, but these were gen­
erally easily controlled by simple medi­
cations and subsided after completion 
of therapy. We found persistent symp­
toms beyond the 3-month period in only 
five patients (10%). These were in the 
form of irritable bladder or bowel 
symptoms or some form of scrotal, 
penile or thigh edema. We found it 
hard to assess impotence but most of 
the younger patients were potent fol­
lowing therapy. However, in patients
with decreasing libido prior to therapy, 
impotence generally followed. Our 
overall figure for impotence in pa­
tients who were potent before treat­
ment was begun was 54%. We found 
no increase in complication rates for 
those who underwent pelvic lymphade­
nectomy prior to therapy. Lymphoceles 
occurred in two of the patients sub­
jected to lymphadenectomy and drains 
were left in situ following the proce­
dure until drainage had completely 
ceased. There were no cases of bowel 
obstruction. Similar findings have been 
reported by others.4,8,9
Discussion
Rectal examination is an inaccurate 
method of assessing the response erf 
the prostate to radiotherapy. Kurth and 
associates10 and Carlton and associates4 
have reported a 41% frequency of 
normal findings on rectal examination 
associated with positive biopsy results. 
A similar figure, 33%, was found in 
our series. On the other hand, biopsy 
results were negative in 47% of our 
patients with abnormal rectal findings. 
Although a proportion of this discre­
pancy undoubtedly results from the 
inaccuracy inherent in biopsy methods 
(15%),u these results demonstrate that 
it is most difficult to distinguish the 
presence of tumour from the effects 
of radiotherapy by rectal examination 
alone. In the follow-up of these pa­
tients it would appear that the only 
value of rectal examination is in de­
tecting obvious clinical progression of 
disease.
There have been a number of re­
ports related to biopsy findings follow­
ing radiotherapy for localized adeno­
carcinoma of the prostate. As shown in 
Table VII4,10,12-15 there are considerable 
differences in tumour-free biopsy rates 
—from 81% to 35%. Such a large dif­
ference is difficult to explain on the 
basis of either biopsy or radiotherapy 
techniques. Furthermore, Cox and 
Stoffel12 reported an increasing num­
ber of negative biopsy results—from 
34% to 81% over a 30-month period, 
whereas Nachtsheim and associates14 
found the opposite response (71% to 
41% over a 36-month period). Our 
data also showed a decrease in the
number of negative biopsy results with 
time.
When the initial grade of the tumour 
was compared with subsequent his­
tologic patterns, we found that the 
well-differentiated tumour had a much 
greater chance of being eliminated by 
radiotherapy (Table IV). Furthermore, 
although a high percentage (70%) of 
our patients with anaplastic tumours 
showed improvement in grade, total 
elimination of tumour cells was not 
achieved. This result varies, however. 
Kurth and associates10 reported no rela­
tionship in response to radiotherapy 
with different grades of tumour where­
as McLoughlin and associates16 found 
that the results with anaplastic lesions 
were better.
There has been much discussion on 
the prognostic importance of biopsy 
findings. Kurth and colleagues10 found 
a positive correlation between the 
persistence of tumour cells in biopsy 
specimens and the development of 
metastases. However, Cox and Stoffel12 
found no relationship between positive 
biopsy findings and progression of 
disease. In our series, of the nine pa­
tients whose follow-up biopsy speci­
mens either remained anaplastic or be­
came more anaplastic, progression of 
disease was observed in six. On the other 
hand, of the 39 patients whose follow­
up biopsy specimens showed improve­
ment or remained well or moderate­
ly well differentiated, progression was 
noted in only 3. Deterioration of histo­
logic pattern or persistence of anapla­
sia in biopsy specimens as distinct from 
a merely positive biopsy result would 
appear to be a poor prognostic index.
It should be noted that although 
both Kurth and associates10 and Cox 
and Stoffel12 reported on stage C dis­
ease, in the former series less than one 
third of the patients had staging laparo­
tomies and in the latter study no pa­
tient underwent this procedure. In the 
present report, of the seven patients 
in whom distant bone or soft tissue 
metastases developed, only two had 
lymph nodes assessed by laparotomy 
before radiotherapy. In both of these 
cases lymph-node metastases were dis­
covered at operation. Whenever possi­
ble, pelvic lymphadenectomy should
T a b le  V I I — B io p s y  F in d in g s  a f t e r  R a d io t h e r a p y  f o r  L o c a liz e d  A d e n o c a rc in o m a  o f
th e  P r o s ta te
S e r ie s
N o . o f  
p a t ie n ts
T u m o u r  f r e e  
ra te F o l lo w -u p ,  m o
C a r l t o n  a n d  a s s o c ia te s 4 34 65 12 -  30
K u r th  a n d  a s s o c ia te s 10 53 43 32
C o x  a n d  S t o f f e l12 37 81 30
M o l le n k a m p ,  C o o p e r  a n d  K a g a n 13 76 42 12
N a c h ts h e im 14 17 41 36
S e w e ll  a n d  a s s o c ia te s 15 17 35 4 -  38
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be carried out as a staging procedure 
prior to curative radiotherapy.
Unfortunately, it is difficult to com­
pare survival statistics obtained from 
the various treatment modalities (radio­
therapy, surgery, endocrine therapy), 
because of (a) inadequate staging, (b) 
different methods of statistical analysis,
(c) the lack of results from radio­
therapy beyond the 10-year period,
(d) ' the use of adjuvant therapies in 
many series and (e) the long history 
of carcinoma of the prostate. At pres­
ent no one treatment method appears 
to offer a clear advantage over others. 
On the other hand, radiotherapy is 
potentially curative, is associated with 
fewer complications than surgical pro­
cedures and is suitable for the manage­
ment of older patients with localized 
disease. These advantages are appeal­
ing to many. However, the persistence 
of positive biopsy results following 
therapy is worrisome, and opinion 
varies as to the clinical importance of 
this finding and whether additional 
treatment is necessary. Several of our 
patients had positive biopsy results 
but no evidence of clinical progression 
of disease at periods varying from 56 
to 61 months. At present, additional 
therapy is not given unless there is 
objective evidence of extension of dis­
ease locally or distally. More study is
required to define clearly the place 
of radiation therapy in the treatment 
of adenocarcinoma of the prostate.
We wish to thank Dr. G.F. Kipkie for 
his expert review of the pathological ma­
terial.
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Surgical Management of Renal Cell Carcinoma at the 
Vancouver General Hospital: 20-Year Review
L.D. Sullivan , m d , frcs[c], D.D. W estm o re , m b , b s , frcs , fr c s( e d in ) and M.G. M cL o u g h lin , m d , f r c s [c]
Over a 20-year period 143 patients 
with renal cell carcinoma were treated 
surgically at the Vancouver General 
Hospital. The results of simple nephrec­
tomy are compared to those of radical 
nephrectomy. The authors conclude that 
radical nephrectomy (including node 
dissection) is a useful staging proce­
dure but provides little or no long­
term therapeutic benefit over simple 
nephrectomy. They stress the need 
for new adjunctive therapy.
Au cours d’une periode de 20 ans,
143 patients souffrant d’un carcinome
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des cellules renales ont ete traites 
chirurgicalement au Vancouver 
General Hospital. Les resultats de la 
nephrectomie simple sont compares 
a ceux de la nephrectomie radicale.
Les auteurs concluent que la 
nephrectomie radicale (incluant la 
dissection ganglionnaire) est une inter­
vention utile pour classifier le stade 
clinique de la maladie mais qu'elle 
offre peu d'avantage therapeutique 
et aucun de longue duree par rapport 
a la nephrectomie simple. Ils insistent 
sur le besoin de nouveaux traite- 
ments d'appoint.
This study was undertaken to evalu­
ate the possible therapeutic benefits of 
adding ipsilateral node dissection 
(radical nephrectomy) to the standard
en bloc total resection of the contents 
of Gerota’s fascia (termed a “simple” 
nephrectomy in our hospital). We 
found the node dissection to be an 
excellent staging procedure, but it did 
not substantially improve survival in 
our series.
Patients and Methods
Of 243 patients with renal cell carci­
noma seen at the Vancouver General 
Hospital between Jan. 1, 1957 and 
Dec. 31, 1976, 143 were treated sur­
gically by either simple or radical 
nephrectomy.
Before 1967, surgical treatment of 
renal cell carcinoma consisted of sim­
ple nephrectomy (in 55 patients) with 
removal of the contents of Gerota’s 
fascia. In a few patients, some region­
al nodes were examined.
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Since 1967, the standard surgical 
procedure for the condition has been 
radical nephrectomy (in 88 patients), 
emphasizing early ligation of the renal 
vessels, with en bloc dissection of the 
lymphatics from the diaphragm to the 
bifurcation of the aorta and vena cava.
The male:female ratio was 5:2. The 
mean age of patients treated by simple 
nephrectomy was 62 years and by ra­
dical nephrectomy was 56 years. All 
patients were followed up for at least 
2 years and 80% were followed up 
for 5 years.
Staging
Standard staging studies, including 
angiography, were performed in all 
patients who underwent radical neph­
rectomy. In recent years chest tomog­
raphy has been added to these studies.
The Robson staging method was 
used.1,2
There were 62 patients with stage 
1 (tumour confined to kidney) lesions, 
24 with stage 2 (involvement of peri­
nephric fat) lesions, 32 with stage 3 
(involvement of renal vein or regional 
lymph nodes) lesions and 25 with stage 
4 (metastatic spread) lesions.
Results
The survival at 3, 5 and 10 years 
for all potentially curable patients 
(stages 1, 2 and 3) was 66% (63 of 
95), 52% (40 of 77) and 27% (19 of 
71), respectively. These percentages 
are comparable to those in most 
series.1-5
Surprisingly, the survival for stages 
1, 2 and 3 patients combined was ac­
tually shorter for those who had radical 
nephrectomy than for those who un­
derwent simple nephrectomy (Tables 
I and 11). This finding could not be 
explained on the basis of more exten­
sive surgery since the operative mor­
tality was only 1.5%, but was owing 
in part to the fact that only 13 stage 1 
patients who had radical nephrectomy 
had been followed up for 5 years.
The survival for stage 2 and stage 
3 patients was somewhat better with 
radical nephrectomy. Survival of pa­
tients with perirenal invasion (Table 
III) and of those with lymph-node me- 
tastases (Table IV) was slightly im­
proved when radical nephrectomy was 
carried out.
For analysis of survival related to 
the degree of venous invasion, patients 
were considered in four groups: those 
with (a) microvenous invasion, (b) 
invasion of a renal vein tributary, 
(c) invasion of the renal vein and (d) 
invasion of the inferior vena cava. The 
5-year survival in these groups was 
16%, 20%, 27% and 16%, respec­
tively.
There was no benefit from radical 
nephrectomy in patients with invasion 
of the renal vein or one of its tribu­
taries.
Of six patients who had inferior 
vena caval invasion there was only one 
survivor at 5 years. This patient sub­
sequently received irradiation for brain 
metastases. He is alive 7 years after
T a b le  1— Length  of S u rv iv a l of P a tie n ts  Who U n derw ent S im p le  Nephrectom y
No. of pa tien ts 
operated on
S u rv iv a l, y r ;  no. p a tie n ts  su rv iv in g /to ta l 
fo llow ed up at each  in te rv a l (and % )
Stage 3 5 10
1 30 24/26 (92 ) 18/24 (74) 10/21 (48)
2 9 7/ 9 (78 ) 6/ 9 (66 ) 3/ 8 (37 )
3 12 2/10 (20) 2/10 (20 ) 0 / 9 ( 0 )
4 4 1/ 3 (33 ) 0 / 3 (0 ) 0 / 3 ( 0 )
1, 2 , 3 com bined (p o te n tia lly
c u ra b le  p a tie n ts ) 51 33/45 (73 ) 26/43 (60) 13/38 (34)
A ll p a tie n ts 55 34/48 (71 ) 26/46 (57) 13/41 (32)
T a b le  I I— Length  of S u rv iv a l of P a t ie n ts  Who U n derw ent R ad ica l Nephrectom y
No. of pa tien ts 
operated on
S u rv iv a l, y r ;  no. p a tien ts  su rv iv in g /to ta l 
fo llow ed up a t each  in te rv a l (and % )
Stag e 3 5 10
1 32 15/23 (65 ) 4/13 (31 ) 3/13 (23 )
2 15 6/10 (60 ) 6/ 7 (86 ) 2/ 6 (33 )
3 20 9/17 (5 3 ) 4/14 (29 ) 1/14 (  7)
4 21 5/19 (26 ) 4/19 (21 ) 0/18 (  0)
1 , 2, 3 com bined (p o te n tia lly
c u ra b le  p a tie n ts ) 67 30/50 (60 ) 14/34 (41) 6/33 (18 )
A ll  p a tie n ts 88 35/69 (51 ) 18/53 (34) 6/51 (12 )
operation. The mean length of sur­
vival of this group was 16 months and 
the 5-year survival rate was 16%.
In our patients there were 25 with 
stage 4 disease who underwent radical 
nephrectomy. In most cases a sympto­
matic primary tumour was the reason 
for operation. Seven patients in whom 
solitary metastases at other sites had 
been removed previously, were oper­
ated upon for cure. Two had solitary 
lung metastases that were removed fol­
lowing nephrectomy and one had a 
solitary metastasis in the left femur 
treated by amputation. By 5 years only 
four of these patients were alive and 
at 10 years there were no survivors.
Discussion
Several authors have evaluated the 
therapeutic effectiveness of radical 
nephrectomy with node dissection.1,2,5 
Our results suggest that there may be 
some benefit from node dissection in 
stage 2 and stage 3 disease but the 
overall effect is minimal (Tables I 
and II). In this series survival was 
actually shorter in those who had ra­
dical nephrectomy. This is particularly 
important as the operative mortality in 
our series was only 1.5% (one case 
in each group).
While prophylactic node dissection 
seemed to be beneficial if the patient 
had positive nodes the possibility re­
mains that this procedure in the stage 
1 cases may not always be beneficial. 
It is possible that the removal of these 
nodes may alter the immunologic de­
fence mechanism. (The numbers are 
small and of questionable validity since 
they are from different eras with 
changing surgical techniques and pa­
thology.)
Ta b le  I I I — P a tie n ts  w ith  P e r ire n a l In va s io n  
S u rv iv in g  5 Y e a rs  a f te r  N ephrectom y
5-year su rv iv a l
P ro ced ure n o ./ to ta l (and % )
R ad ica l nephrectom y 6/ 7 (86 )
S im p le  nephrectom y 6/ 9 (66 )
To ta l 12/16 (75 )
Ta b le  IV — S u rv iv a l of P a t ie n ts  w ith  Lym ph- 
Node M etastases a fte r  Nephrectom y
5-year
s u rv iv a l , Mean
n o ./to ta l s u rv iv a l
P ro ced ure (and % ) mo ±  SD *
R ad ica l
nephrectom y 1/6 (17 ) 36 ±  35
Sim ple
nephrectom y 0/4 (  0 ) 12 ±  8
’"Standard  d ev ia tio n .
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Radical nephrectomy did not im­
prove the survival of patients with in­
volvement of the renal vein.
Since only one of six patients with 
involvement of the subhepatic vena 
cava was alive at 5 years, extending 
the surgery above the diaphragm and 
into the heart with its attendant risks 
would appear to be contraindicated.
Conclusions
Radical nephrectomy with lymph- 
node dissection remains an excellent 
staging procedure. Morbidity and mor­
tality are similar to those of simple 
nephrectomy. The procedure may con­
fer benefit to patients with involve­
ment of regional nodes.
Surgical therapy seems to have 
reached its limits,3,6 and further ad­
vances will depend upon the develop­
ment of adjunctive systemic modes of 
treatment.
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Management of Primary Bladder Cancer 
by a Multidisciplinary Team
W.E. Collins, md, facs, frcs[c],* G.E. Catton, md, dmrt, FRCP[c],t 
A. H ussey, m d , frcs[c],* R.G. Baker, ph d and J.M. L ast md, dph, fracp$
Results of management of a closed 
series of primary bladder carcinoma over 
a 20-year period by a multidisciplinary 
team are presented. Patients were 
classified by the TNM method before 
treatment. These experiences indicate 
that stage and grade are relevant to 
prognosis and treatment. The TNM 
classification can be precise and 
practical when used diligently by a 
treatment team. Although no new 
methods of treatment are offered, the 
treatment now available may be 
utilized to better effect if programmed 
to allow care of the patients by a team, 
especially if the team explores the 
limits of radiation and surgery in their 
hands.
On presente les resultats obtenus 
sur une periode de 20 ans, par une 
equipe multidisciplinaire dans le 
traitement d’une serie de carcinomes
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primaires de la vessie. Les patients 
ont ete classifies, avant traitement, 
selon la methode TNM. Ces 
experience indiquent que le stade 
et le grade sont pertinents au pro- 
nostic et au traitement. La classifi­
cation TNM peut etre precise et 
pratique lorsqu’efle est utilisee avec 
diligence par une equipe de 
traitement. Bien qu'aucune nouvelle 
methode de traitement ne soit offerte, 
le traitement maintenant disponible 
peut etre utilise avec de meilleurs 
effets s ’il est programme pour 
permettre la prise en charge du 
patient par une equipe, specialement 
si cette equipe explore les limites 
de la radiotherapie et de la chirurgie 
entre ses mains.
This is a report of a closed series of 
807 patients treated for primary blad­
der cancer. Beginning in 1952, all pa­
tients who were admitted for initial 
treatment were included in the series. 
Twelve patients who had not been 
staged prior to treatment were ex­
cluded. All patients were managed by 
a treatment team consisting of urolog­
ists, radiotherapists and a pathologist.*
Method
All tumours were staged by the tu-
*In the original team, the urologists were J.V. Berry and W.E. Collins, the radio­therapists were G. Stoddart and G.E. Catton and the pathologist was E. Liepa.
mour, nodes, metastasis (TN M ) classif- 
cation1 before treatment was initiated. 
This classification, was found to be 
precise and practical.
At the beginning the four primary 
objectives were: (a) to establish the 
limits of transurethral excisional biop­
sy of the tumour; (b) to establish the 
limits of radiation therapy; (c) to dis­
regard lymph nodes at surgery; and 
(d) when cystectomy was indicated, to 
use simple cystectomy and to remove 
the urethra at the same time.
When the data were reviewed in 
1962, it was obvious that many tu­
mours could not be handled by either 
transurethral resection or radiation 
alone. So the uniform treatment pro­
gram was altered and patients with 
high-stage, high-grade tumours were 
managed by combined diversion, irra­
diation and cystourethrectomy.2,3
Since 1962, the uniform treatment 
program has been as follows.2,3 In situ 
carcinoma (TIS) is treated by transure­
thral excisional biopsy. Patients with 
TIS who present with bladder irrita­
tion are treated by combined diver­
sion, irradiation and cystourethrec­
tomy. Patients with tumours classified 
as T1 and T2 are managed by transure­
thral excisional biopsy. Radiation ther­
apy is added when the tumour is ana­
plastic and when there is uncertainty 
that the tumour has been completely 
excised. Patients having T3 tumours are 
handled by staged treatment— laparo-
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tomy with urinary diversion, followed 
by irradiation to the whole pelvis using 
4000 rads over 28 days and, 6 weeks 
later, simple cystourethrectomy. T4a 
tumours are subjected to urinary diver­
sion and irradiation. Total cystectomy 
without irradiation is used for patients 
with squamous cell carcinomas and 
adenocarcinomas of the bladder floor. 
Adenocarcinomas at the vault are re­
moved by extensive partial cystectomy 
with excision of urachus and umbilicus.
Findings
Survival figures are relative to the 
survival of a normal population of 
the same age and sex distribution (i.e., 
actuarily adjusted). Survival accord­
ing to cell type is shown in Table I. 
As seen in Table II, surprisingly few 
tumours, upon recurrence, shifted to a 
higher stage. We have data on only 
74 patients on the shift in grade, which 
is presented in Table III; 39 recurrent 
tumours maintained the same grade as 
the primary tumour, 30 recurrent tu­
mours were of higher grade and 5 re­
current tumours were of lower grade 
than the primary tumour. As seen 
in Table IV the age distribution was 
the usual one with all 10 decades rep­
resented. There did not seem to be 
any significant correlation of age to 
stage (Table V), but correlation of age 
to grade (Table VI) showed that the 
average age of patients with grade 1 
tumours (of low-grade malignancy) is 
64 years, of those with grade 2 tu­
mours (of medium-grade malignancy) 
69 years and of those with grade 3
Table 1— Survival Correlated w ith Tumour 
Cell Type*
No. of
Survival, %
Cell type patients 1 yr 5 yr 10 yr
Transitional cell 725 —  69 56
Squamous cell 20 —  27 17
Adenocarcinoma 6 50 0 0
*ln  56 patients the cell type was not clearly
stated.
tumours (highly malignant) 70 years. 
Survival by age is interesting (Fig. 1); 
the 5-year survival rate of patients 
younger than 40 years was 93%, pa­
tients between 40 and 49 years of age 
76%, between 50 and 59 years 73%, 
between 60 and 69 years 66%, be­
tween 70 and 79 years 57% and of 
those over 80 years of age 60%. The 
10-year survival rates were somewhat 
different: 94% of the patients younger 
than 40 years survived 10 years; 
75% between 40 and 49 years 
survived 10 years, but patients older 
than 50 years had a 10-year survival 
rate which was approximately the 
same, ranging from 51% to 58%. 
The importance of this finding is not 
known.
Survival by grade was what one 
would expect (Table VII). There was 
a direct relationship between grade 
and survival over the 5- and 10-year 
periods. There was similar relationship
FIG. 1— Five- and 10-year survival 
rates by age are presented. Importance of 
these data is not known.
Table I I— Shift to a Higher Stage on 
Recurrence*
Classification of 
primary tumour
No. of 
patients
No. with shift 
to higher stage
TIS 8 2
T l 412 28
T2 159 25
T3 107 10
T4 99 0
*ln 22 patients there was no clear statement 
of stage prior to treatm ent.
Table I I I—Shift in Grade
Grade of Grade of primary tumour
recurrent -----------------------------------------------------------------------------
tumour NS 1 2 3 Total
NS* 56 481 127 69 733
1 0 20 4 1 25
2 0 14 15 0 29
3 0 7 9 4 20
Total 56 522 155 74 807
*N ot stated.
of stage to survival as shown in Table 
VIII.
The site of the tumour in the blad­
der had a definite effect on survival. 
Of 94 patients with tumours involv­
ing the bladder neck and prostate 
45% survived for 5 years and 37% 
for 10 years. Those with tumours else­
where in the bladder fared much better 
with 69% and 57% survival rates, 
respectively.
The presence of metastases had a 
considerable effect on survival.
When patients with T l, T2 and T3 
tumours without metastases (688 pa­
tients) were grouped together, the 5-
Table IV -A g e Distribution*
Age, yr No. of patients
0 - 1 0 1
1 1 -  20 1
2 1 -  30 6
3 1 -  40 20
4 1 -  50 61
5 1 -  60 153
6 1 -  70 230
7 1 -  80 223
8 1 -  90 103
91 -1 0 0 8
*Mean 66.03 yr. On the chart of 1 patient, the
age was not noted.
Table V - -Correlation of Age to Stage*
Classification Average No. of
of tumour age, yr patients
TIS 66 8
T l 63 412
T2 69 159
T3 70 107
T4 68 99
*Stage not noted for 22 patients.
Table VI-—Correlation of Age to Grade
Average No. of
Grade of tumour age, yr patients
X 68 56
1 64 522
2 69 155
3 70 74
Table V II— Survival by Grade*
Grade of No. of
Survival, %
tumour patients 5 yr 10 yr
1 522 83 71
2 155 37 22
3 74 25 13
*Grade not stated for 56 patients.
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year survival rate was 74% and the 
10-year survival rate 62%, but when 
metastases were present (11 patients) 
there was a 2-year survival rate of 
only 27% and only 1 patient survived 
for 3 years. Similarly, patients with T4 
tumours without metastases (80 pa­
tients) had a 5-year survival rate of 
22% and a 10-year rate of 21%. The 
19 patients with T4 tumours who had 
metastases had a 6% 5-year survival 
rate but none of the patients survived 
for 6 years. On the records of nine 
patients there was no evidence that a 
search was made for metastases.
In the charts of 52 patients there 
was no clearly stated opinion as to 
whether initial treatment was curative 
or palliative only, but in the remainder 
there was a clear statement. Treatment 
was a curative attempt in 621 patients; 
79% of these patients survived 5 years 
and 64% survived 10 years. Survival 
by the different treatment methods that 
were used in a curative attempt is 
shown in Table IX. The survival rates 
were quite different in those who had 
palliative treatment only (Table X); in 
this group of 134 patients, 15% sur­
vived 5 years and 11%, surprisingly, 
survived 10 years.
When transurethral resection (TUR) 
was done as a curative measure 85% 
of the 508 patients survived 5 years 
and 71% survived 10 years. When ra­
diation therapy was combined with 
transurethral resection, 5- and 10-year 
survival rates were 64% and 37%, 
respectively. The results of treatment 
by TUR related to stage and grade 
are presented in Table XI.
Thirty-four patients had staged uri­
nary diversion, irradiation of the whole 
pelvis (4000 rads over 28 days) and 
simple cystourethrectomy 6 weeks lat­
er; 57% survived for 5 years and 44% 
for 10 years. Two of these patients had 
T2 tumours, 21 had T3 tumours <»nd 
the remaining 11 had T4a tumours; 
51% of patients with T3 tumours sur­
vived 5 years and 46% survived 10 
years.
The most heartening thing about 
this program has been the disappear­
ance of pain in all patients. When a 
cure was not possible, palliation was 
most effective. We have benefited from 
the experience of Mount4'8 when treat­
ment of the primary tumour is im­
possible. In other situations, trans­
urethral resection of the intravesical tu­
mour was effective. Urinary diversion 
almost always relieves pain. Emer­
gency or salvage cystectomy has been 
necessary only three times. We have 
been impressed with the results of 
low-dose irradiation for hemostasis.
We attempted to assess residual 
bladder irritation in patients after treat­
ment (Table X II). This is important 
because persistent bladder irritation or 
the appearance of bladder irritation 
may indicate that a recurrent in situ 
carcinoma is changing to multiple focal 
invasive cancer.7 The indication's used 
for cytologic examination of the urine 
were irritable bladder, hematuria, ob­
vious bladder cancer, ureteral urines in 
bladder cancer and at follow-up of 
patients with bladder cancer.
The status of the 807 patients at 
the end of the study is set forth in 
Table XIII.
Table X I—Survival following TUR
Stage and grade No. of
Survival, %
of tumour patients* 5 y r 10 yr
T l .G l 362 92 82
T l, G2 24 68 0
T l, G3 7 86 75
T2, G1 93 69 46
T2, G2 
T2, G3
41 50 40
19 46 12
*ln 10 patients who had TUR the intent of 
treatment was not stated.
Table X I I - -Bladder Irritation in 137 Patients 
following Treatment
Degree of No. of
Survival, %
irritation patients 5 yr 10 yr
Mild 103 28 16
Severe 34 33 20
Table X II I—Status of Patients at End of Study
Status
No. of 
patients
Alive and well with no disease 129
Alive with disease 15
Alive, status of disease not stated 24
Died
of disease 222
of other causes, no bladder
cancer 132
of other causes, bladder cancer
present 52
of cancer, status not known 84
of metastases, no bladder
cancer 18
Lost to follow-up (16%) 131
Total 807
Table VIII -Survival by Stage
Classification No. of Average
Survival, %
of tumour patients age, yr 5 yr 10 yr
T1S 8 66 59 52
T l 412 63 90 78
T2 159 69 61 61
T3 107 70 26 27
T4 99 68 19 16
Table IX—Survival after Treatment for Cure*
Treatment
No. of 
patients
Average 
age, yr
Survival, %
5 yr 10 yr
All procedures 621 65 79 64
TUR only 508 65 85 71
Surgery other than TUR 36 64 56 36
Radiation only 14 69 37 40
Radiation +  TUR 29 65 64 37
Radiation 4- other operative procedure 31 61 41 50
TUR =  transurethral resection.
*3 patients were lost to follow-up.
Table X—Survival after Palliative Treatment Only*
Treatment
No. of 
patients
Average 
age, yr 5 yr 10 yr
All procedures 134 69 15 11
TUR only 28 77 16 0
Surgery other than TUR 22 63 11 15
Radiation only 27 71 20 15
Radiation +  TUR 24 73 12 19
Radiation -j- other operative procedure 31 63 17 7
*2 patients did not have either surgery or irradiation
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Summary
Results of the management of a 
closed series of 807 patients with pri­
mary bladder carcinoma by a multi­
disciplinary team are presented. All 
patients were classified by the TNM 
method prior to treatment and, since 
1962, uniform treatment has been 
used. Our experiences indicate that 
stage and grade are relevant to prog­
nosis and treatment. The TNM clas­
sification can be precise and practical 
when used diligently by a treatment 
team. Although no new methods of 
treatment are offered, it is suggested 
that what is available may be utilized 
to better effect if programmed to al­
low care of patients by treatment 
teams, especially if the team explores 
the limits of radiation therapy and 
surgery available to them. As a result: 
(a) patients can face a future without 
pain; (b) most patients can maintain 
the use of their own bladder; (c) when 
surgery or irradiation, or a combina­
tion, is indicated, it can be carried 
out promptly; (d) most T1 and T2 
tumours can be handled by trans­
urethral excisional biopsy; and (e) 
staged urinary diversion, irradiation 
therapy to the whole pelvis (4000 rads
over 28 days) followed 6 weeks later 
by a simple cystourethrectomy yield 5- 
and 10-year survival rates that are at 
least as good as more radical irra­
diation and more radical surgery.
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Directives 
aux collaborateurs
Toute communication initiate doit etre 
adressee aux coredacteurs, CP 8650, 
Ottawa, Ont. K1G 0G8 sous la mention: 
"Le journal canadien de chirurgie".
Les textes originaux des articles et des 
autres communications y compris un 
nombre limite de rapports sur des cas 
speciaux doivent etre rediges en double 
exemplaire, en francais ou en anglais, et 
accompagnes d’une lettre demandant 
leur publication dans le Journal. Veuillez 
les dactylographier sur une seule face 
d’une feuille non reglee avec double 
interligne et grandes marges.
Les principales unites de mesure doivent 
etre exprimees selon le Systeme inter­
national d'unites si c'est possible.
Les illustrations telles que des photo­
graphies d'appareils cliniques, des radio- 
graphies, des photomicrographies, des 
graphiques el des diagrammes doivent 
etre fournies sous la forme d'epreuves 
sur papier glace sans montage, les bor- 
dures intactss, d un format ne depassant 
pas 20 X 25 cm. Chaque illustration doit 
etre munie dune legende dactylogra- 
phiee sur une page separee du texte de 
/'article. S'il s’agit de radiographie, en- 
voyez une copie et non /'original. S’il 
s'agit d'une photomicrographie, indiquez 
le contraste et I ’echelle de I'agrandisse- 
ment. Les lettres qui servent a identifier 
les elements d'une illustration doivent 
etre d'une dimension suffisante afin de 
demeurer visibles lorsque les necessites 
de /'impression imposent une reduction 
de I'image fournie.
II ne faut pas qu'on puisse identifier un 
patient grace a une illustration a moins 
qu'il n'y ait expressement consenti par 
ecrit; faute de permission les traits de 
sa physionomie doivent etre obliteres. 
Les illustrations en couleur ne seront 
publiees qu'aux trais de I'auteur. Si 
/ ’illustration provient d’une autre source, 
il convient d'obtenir tant de I'auteur que 
de lediteur de I'ouvrage dont elle est 
tiree, I'autorisation de s'en servir aux 
fins de la publication.
II faut que les tableaux soient conformes 
au format rectangulaire du Journal et 
rediges sur des feuilles separees du 
texte, un tableau par feuille.
Les references doivent etre citees dans 
le texte au moyen d'un chiffre et grou- 
pees dans I'ordre a la fin de / ’article 
selon la maniere de faire adoptee par 
ce Journal. Les references a des perio- 
diques doivent etre conformes a celles 
qu'adopte / ’Index Medicus.
Un resume qui ne doit pas depasser 125 
mots doit accompagner chaque article 
sur une feuille separee.
A titre d'approbation, un exemplaire du 
manuscrit redige sera envoye a I'auteur 
mais non les epreuves.
SESAP II Question
606. Six weeks ago a 20-year-old man first noted a painless scrotal 
mass. Examination discloses a nontender 5- by 5-cm, smooth, testicular 
mass which does not transilluminate. The best management would 
consist of
(A) an attempt to aspirate fluid from the mass to allow better 
palpation
(B) needle biopsy
(C) orchiectomy through an inguinal incision
(D) examination of the mass through a scrotal incision; excision 
if the mass proves to be a tumor
(E) administration of antibiotics and observation for two to 
four weeks
For the incomplete statement above select the completion that is best 
of the five given.
For the critique of Item 606 see page 486 of this issue.
(Reproduced by permission of the American College of Surgeons from 
SESAP 11 Syllabus: Surgical Education and Self-assessment Program 
No. 2. For enrolment in the Surgical Education and Self-assessment 
Program No. 3 please apply to the American College of Surgeons, 
55 East Erie St., Chicago, IL 60611.)
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CAGS PAPERS
Trans-sphincteric Approach to the Rectum
Charles F McCullogh, md, frcs[c], facs*
In 28 cases the trans-sphincteric 
approach has been used to remove 
lesions of the lower and mid-rectum; 
in 4 cases the combined abdominal and 
trans-sphincteric approach was used. 
Complications were minor and were 
easily treated and the operation was 
well tolerated by poor-risk patients.
No patient had altered anal continence. 
The author emphasizes the need for 
careful identification and reconstruction 
of the anatomical structures.
The trans-sphincteric approach gives 
excellent exposure of the mid- and 
lower rectum and has been particularly 
useful in managing large villous 
adenomas. The trans-sphincteric 
approach alone is not adequate for the 
treatment of cancer, but makes possible 
sphincter-preserving resections of 
lesions that might otherwise be
Dans 28 cas, I’abord trans-sphincterien 
a ete utilise pour I’ablation des lesions 
du rectum moyen ou inferieur; dans 
4 cas, d’abord abdominal et trans- 
sphincterien a ete employe. Les 
complications ont ete banales et furent 
facilement traitees et I’operation 
a ete bien toleree par des patients 
a risque eleve. Aucun patient n’a 
souffert d'une atteinte de la continence 
anale. L'auteur souligne la 
necessity d’une identification et d'une 
reconstruction soigneuses des
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treated by more radical procedures, 
structures anatomiques.
L'abord trans-sphincterien donne une 
excellente exposition du rectum moyen 
et inferieur et il a ete particulierement 
utile dans le traitement des gros 
adenomes villeux. L’abord trans- 
sphincterien seul n'est pas suffisant 
dans le traitement du cancer. Cet abord 
rend possible des resections sans 
atteinte du sphincter, des lesions qui 
devraient autrement etre traitees 
par des interventions plus radicales.
Surgeons operating on a fistula in ano 
are careful to avoid cutting the deep 
portion of the external sphincter ani 
muscle for fear of producing anal in­
continence. In this situation their fears 
are warranted; most of us recall patients 
who have been rendered incontinent 
following such a procedure. Excision 
of the septic fistula allows the muscles 
to retract and become nonfunctional, 
the defect is bridged by scar tissue and 
the patient is left with some degree of 
incontinence. However, obstetricians 
have noted that a complete tear through 
the anal sphincter, caused by uncon­
trolled delivery of the fetal head is 
usually followed by prompt healing and 
complete restoration of anal function 
if the tear is repaired immediately.
Incision through the sphincter 
muscles apparently does not cause in­
continence if the muscles are accurately 
replaced and sutured. Indeed, Bevan1 
in 1917, reported a posterior midline 
approach to the rectum with or with­
out removal of the coccyx, and, in 
1970, Mason2 described a trans-sphinc­
teric approach lateral to the coccyx to 
expose the rectum.
Faced with the problem of managing 
a patient with a large villous adenoma 
of the mid-rectum that was too large 
and too high to be easily removed 
through the anus, yet too low to make
anterior resection possible, I read 
Mason’s accounts2’3 with interest. Biop­
sy of my patient’s tumour had been 
done on several occasions and each 
time the specimen had been reported as 
benign. An abdominoperineal resection 
or an abdominoendorectal resection for 
a lesion that was probably benign was 
not warranted, so the trans-sphincteric 
approach was used. The lesion was 
easily exposed and excised, and it 
proved to be benign. The patient made 
an uncomplicated recovery and was 
fully continent. This experience 
prompted use of the trans-sphincteric 
approach for rectal lesions in other 
cases.
Patients, Surgical Technique
and Results
Between Jan. 1, 1973 and Dec. 31, 
1978, 28 patients were operated on 
using this approach. Their ages ranged 
from 36 to 75 years. The pathological 
diagnosis was benign villous adenoma 
in 11 cases, adenomatous polyp in 8, 
adenomatous polyps with atypia in 2, 
carcinoid tumour in 2 and villous ade­
nocarcinoma in 1. The distal margin 
of the lesions ranged between 3 and 8 
cm from the anal verge. The size of 
the lesions varied from 2 cm in dia­
meter to those completely encircling 
and extending along the rectum for 
several centimetres. The most proximal 
margin of a tumour resected by the 
trans-sphincteric route alone was 13 cm 
from the anal verge.
Of the 28 patients a combined ab­
dominal and trans-sphincteric approach 
was used in 4. In each case the left 
colon, sigmoid and rectum were mobil­
ized by the abdominal approach. The 
rectum and colon including the tumour 
were then delivered and excised 
through a trans-sphincteric exposure 
and a low end-to-end anastomosis was
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easily made. This was done for carci­
noma in two of the four cases. The 
diagnoses in the four cases were “poly­
poid carcinoma” in one, “malignant 
ulcer, 1 cm in diameter” in one, and 
“extensive benign villous adenoma” in 
two.
Twelve of the 28 patients were 
over 60 years of age. Some were obese 
and some, for other medical reasons, 
were not good candidates for surgery. 
Before admission to hospital for oper­
ation, most patients had undergone 
sigmoidoscopy and roentgenography 
after a barium enema. A biopsy of the 
rectal lesion had been done, and the 
distance of the lesion from the anal 
verge had been recorded. The degree 
of anal continence was recorded upon 
admission. Patients were placed on a 
low-residue diet without milk or milk 
products for 72 hours before operation. 
Mechanical bowel preparation was ac­
complished with enemas and laxatives 
and an antibiotic preparation was usual­
ly given—though the necessity for it 
is questionable. (In two cases, no an­
tibiotic was given and no wound infec­
tion occurred.)
At operation patients are placed 
in the prone position with the trunk 
flexed (the jack-knife position). The 
buttocks are taped apart and the 
perineal area and buttocks prepared 
and draped. It is helpful to outline 
the coccyx and lower sacrum and the 
line of incision with a sterile marking 
pencil. The incision is made on 
the left side just lateral to the 
lower sacrum and coccyx and is car­
ried down to the posterior midline at 
the anal verge. It is quite easy to iden­
tify each anatomical structure which 
is carefully tagged with a colour-coded 
clamp applied to a marked suture, be­
fore being incised. This is most im­
portant to ensure exact anatomical 
apposition of structures when the 
wound is being closed. If the muscle 
layers are not tagged at this stage 
accurate apposition may be difficult or 
impossible because the cut ends retract. 
The three parts of the external sphincter 
ani muscle are evident and are tagged. 
The puborectalis muscle and the lower 
innermost part of the levator ani 
muscle are identified and tagged. The 
fourth sacral nerve lies under the 
levator ani muscle and well lateral to 
the incision and can therefore be 
avoided. When the rectum is entered 
by incising the muscular tube and 
mucosa (also tagged), the exposure of 
the mid- and lower rectum is excellent.
On closing, each layer is apposed by 
approximating the colour-coded clamps. 
The muscle layers are closed with in­
terrupted absorbable sutures and the 
skin is closed with interrupted sutures.
Postoperatively, the wound is left
exposed after 24 hours and is kept dry 
with the use of a heat lamp for 10 
minutes twice a day. Sitz baths are 
not given and the area is cleansed as 
required with a cleansing agent. Pa­
tients have noted remarkably little dis­
comfort. They are allowed up the day 
following operation.
Intake is advanced from liquids to a 
full diet over a period of 1 week. 
Rectal thermometers, suppositories and 
digital examination are avoided in the 
early postoperative period. Bowel func­
tion usually begins spontaneously after 
4 to 5 days. Bulk-producing laxatives 
may be used if necessary.
There were three complications of 
the operative procedure in the 24 pa­
tients whose operation was by the 
trans-sphincteric approach alone. One 
patient had a large fecal fistula which 
closed spontaneously after 2 weeks and 
two patients had superficial wound 
abscesses that required simple drainage.
Discussion and Conclusions
It is apparent that because of senility 
or local anal conditions, some patients 
have anal incontinence. This must be 
assessed preoperatively, in order to 
judge the effect of the operation on 
continence. In this study it was found 
that the degree of anal continence was 
unaltered by trans-sphincteric opera­
tions, but, since incontinence was some­
times present, had careful evaluation 
not been made preoperatively, the oper­
ation might have been blamed for 
results which, in fact, were optimal 
for that patient.
Before using the trans-sphincteric 
approach it is particularly important to 
evaluate carefully the rectal lesion in 
question. The trans-sphincteric ap­
proach with local excision is not a 
cancer operation. Therefore, it is im­
portant to remember that the villous 
adenoma may have one or more areas 
of invasive carcinoma within it. In 
assessing a villous adenoma, mobility 
and induration are important factors. 
Although multiple biopsy specimens 
may be reported as benign, only exam­
ination of the entire lesion by the 
pathologist will give the final answer. 
The surgeon must be prepared to do 
a more radical operation if he finds 
evidence of a malignant condition at 
operation. The treatment of small can­
cers by local excision is not a subject 
of discussion in this paper.
The trans-sphincteric approach 
makes possible sphincter preserving re­
section of lesions that might previously 
have been treated more radically. The 
operation is particularly well tolerated 
by poor-risk patients: the three com­
plications in our series were man­
aged without permanent sequelae.
It is emphasized that careful iden­
tification and reconstruction of the 
puborectalis muscle, the external 
sphincter, the levator ani muscle and 
the rectal wall will lead to primary 
healing and maintain continence. When 
attention is paid to these details, this 
operation is safe and well suited to the 
management of a select group of lesions 
in this area.
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Randomized Sequential Trial of Parenteral Nutrition 
in Healing of Colonic Anastomoses in Man
R.M. Preshaw, md, frcs[c], R.P. Attisha, mb, frcs( edin), frcs[c], 
W.J. Hollingsworth, md, frcs[c] and J.D. Todd, md
Adults who underwent elective colonic 
resection with anastomosis for both 
benign and malignant disease were 
randomly assigned to control or treated 
groups. Treated patients received daily 
50 ml/kg of amino acid solution 
containing either 10 or 25 g/dl glucose 
by central or peripheral vein plus 500 ml 
of commercial soybean emulsion for 
24 hours before operation and for 5 
consecutive days after. Patients in 
both groups were examined by roent­
genography after a water-soluble 
contrast enema, between 10 and 14 
days after operation, and the integrity 
of the anastomosis was assessed 
radiologically without knowledge 
of the treatment given.
Results were assessed by sequential 
analysis. After 21 pairs of subjects 
were entered, a boundary was crossed 
making the area favourable to 
treatment inaccessible, and the trial 
was terminated. Forty-seven patients 
were included in the trial: there were 
four anastomotic leaks in 23 control 
subjects and eight leaks in 24 treated 
subjects. The authors conclude that 
intensive perioperative parenteral 
nutrition in patients who undergo routine 
elective colonic resection does not 
improve the rate of healing of colonic 
anastomoses.
Des adultes qui ont subi une 
resection non urgente du colon avec 
anastomose pour des maladies 
benignes ou malignes ont ete assignes 
au hasard a un groupe temoin et 
a un groupe traite. Les patients 
traites ont repu quotidiennement 
par une veine centrale ou peripherique, 
50 ml/kg d’une solution d'acides
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amines contenant 10 ou 25 g/dl de 
glucose plus 500 ml d'une emulsion 
commerciale de soya pendant les 
24 heures qui ont precede I'operation 
et les 5 jours consecutifs qui ont 
suivi. Les patients des deux groupes 
ont passe un examen radiologique 
apres un lavement avec une substance 
de contraste hydrosoluble, de 10 a 
14 jours apres I'operation, et I'integrite 
de I'anastomose a ete evaluee 
radiologiquement sans connaitre le 
traitement.
Les resultats ont ete evalues par 
analyse sequentielle. Apres I'inclusion 
de 21 paires de sujets, on a croise 
une limite rendant inaccessible I'aire 
favorable au traitement, et i'essai 
a ete interrompu. Quarante-sept 
patients ont ete inclus dans I'etude: 
il y a eu quatre fuites anastomotiques 
chez les 23 sujets temoins et huit 
fuites chez les 24 sujets traites.
Les auteurs concluent que I'alimen- 
tation parenterale intensive dans 
la periode peri-operatoire chez les 
patients qui subissent une resection 
non urgente du colon ne semble 
pas affecter la vitesse de guerison 
de I'anastomose colique.
Assessment of anastomotic integrity 
after colonic resection by roentgeno- 
graphically opaque enemas in the post­
operative period has been utilized by 
Goligher1-3 to study details of the sur­
gical technique. We have adapted this 
method to investigate the value of in­
tensive parenteral nutrition in the peri­
operative period in patients subjected 
to elective colonic resection.
Patients and Methods
Eleven general surgeons at two Cal­
gary hospitals permitted us access to 
patients who underwent elective colonic 
resection for benign and malignant di­
sease. We excluded patients older than 
75 years and patients recognized pre- 
operatively to have signs or symptoms 
of congestive cardiac failure. Of 79 
patients interviewed, 8 were excluded 
because of demonstrable cardiac fail­
ure, 7 were judged incapable of provid­
ing informed consent and 17 patients 
refused to enter the trial. The remain­
ing 47 patients were assigned to treated 
or control groups according to the last 
digit of their hospital registration num­
ber: those with odd numbers were 
treated and those with even numbers 
entered the control group.
The 23 control patients were treated 
in the usual manner as ordered by the 
attending surgeon, except that roent­
genography after a water-soluble con­
trast barium enema was performed 
between 10 and 14 days after the 
procedure. This was performed by a ra­
diologist who had no knowledge of the 
treatment given. For the purposes of 
this study, identification of any extra­
vasation of contrast material outside the 
bowel lumen in the area of the an­
astomosis was accepted as a “leak” 
and failure on the part of the radiologist 
to demonstrate extravasation was clas­
sified as “non-leak”.
Treated patients received high vol­
ume, intensive parenteral nutrition 
starting 24 hours before operation and 
continuing for 5 days after operation. 
We found no difference in the fre­
quency of contrast extravasation at the 
area of the anastomosis between the 
two groups. The solutions administered 
were a commercial mixture of L-amino 
acids (Travasol®, 2.5 g/dl) with either 
10 or 25 g/dl glucose. These were ad­
ministered intravenously in a dosage of 
50 ml/kg body weight every 24 hours 
by either peripheral (10 g/dl glucose) or 
central (25 g/dl glucose) vein. Because 
of the poor quality of peripheral veins 
in most subjects, 21 of the 24 treated 
patients had a central venous catheter 
inserted preoperatively for the supple­
mental nutrition, in each case by per­
cutaneous subclavicular puncture. Each 
subject in addition was given 500 ml 
of a commercial soybean emulsion 
(Nutralipid®) intravenously daily. For 
a 70-kg subject, the daily intake by the 
intravenous route was therefore 50 g 
of lipid, 70 g of amino acid protein, 
and either 350 g (peripheral vein) or 
700 g (central vein) of glucose.
Finally four patients (one treated and 
three control) had total nitrogen balance 
studies performed in the perioperative 
period; urine, stool and nasogastric suc­
tion material were analysed for nitrogen 
by the micro-Kjedahl method4 and in­
take was calculated from known values
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of leaks among controls of 30% and 
among treated patients of 15%. A two- 
tailed closed design was selected with 
2a  =  0.05, 1-/3 = 0.95, 61 =  0.80, 
N =  35.
Results
Forty-seven patients were success­
fully entered into the trial and under­
went roentgenography after a water- 
soluble contrast enema between 10 and 
14 days postoperatively. A small pneu­
mothorax developed in one patient 
after an attempt to insert a subclavian 
catheter percutaneously, but this re­
solved spontaneously; there were no 
deaths associated with the trial. In 
one treated patient clinical signs of 
anastomotic disruption developed, con­
firmed radiologically, which required a 
defunctioning colostomy. None of the 
other patients with roentgenographic 
anastomotic leaks received any specific 
therapy.
The trial was terminated after 21 
pairs had been entered; at this point a 
boundary was crossed making the area 
favourable to the treatment inaccessible 
(Fig. 1) and in our opinion it was un­
ethical to continue the trial merely to 
determine if the period of parenteral
Table 1—Comparison of Preoperative and Postoperative Laboratory Values 
in Treated and Control Patients
Measurements
Treated (n =  24) Control (n =  23)
Preop Postopf Preop Postop
Total protein, g/dl 6.1 ±  0.6* 5.8 ±  0.5 6.4 ±  0.4 6.0 ± 0.9
Serum albumin, g/dl 3.7 ±  0.5 3.2 ±  0.7 3.6 ±  0.2 3.3 ± 0.8
Hemoglobin, g/dl 13.1 ±  1.3 12.6 ±  2.3 12.6 ±  1.0 12.5 ± 2.5
Total lymphocytes, X  10°/l 1.18 ±  0.28 1.35 ±  0.14 1.46 ±  0.27 1.31 ± 0.22
Body weight, kg 71.5 ±  5.7 67.6 ±  4.2 73.0 ±  2.3 70.5 ± 5.6
Age, yr 66 ±  4 69 ±  6
*Mean ±  standard error of the mean.
(Postoperative values obtained between day 7 and 12.
Table II—Operative Procedures and Diagnosis in Treated and Control Patients
Procedure Diagnosis
Treated, no. 
(no. with
anastomotic leak)
Control, no. 
(no. with
anastomotic leak)
Right hemicolectomy Cancer 7 (1 ) 5 (1 )
Other 1 (1 ) 1
Segmental resection Cancer 3 (1 ) 2
Diverticulosis 1 (1 ) 2
Other 1
Anterior resection Cancer 7 (3 ) 7 (2 )
Diverticulosis 4 (1 ) 3 (1 )
Other 1
Colectomy with ileo-
rectal anastomosis 1 1
24 (8) 23 (4)
for intravenous fluids and from dietary 
tables.
Each subject was asked for his or her 
estimate of weight loss before admis­
sion, and preoperative and postoper­
ative weights were compared. Total 
lymphocyte counts and hemoglobin, 
total protein and serum albumin values 
were measured before and after oper­
ation. Results were assessed as the 
radiologists’ reports became available. 
Paired subjects were entered into a 
skewed sequential analysis:5 boundaries 
were determined assuming a frequency
FIG. 1—Sequential analysis: pairs of 
subjects entered as described by Armitage.5 
Restricted skew design (two-tailed) with 
2a =  0.05, 1-/3 =  0.95, 61 =  0.80, 
N =  35.
nutrition could be shown to be worse 
than the standard postoperative ther­
apy. In all there were eight radiological­
ly demonstrated “leaks” in 24 treated 
patients and four in 23 controls.
Further analysis of the subgroups 
within this trial provided no further 
useful information. In particular, 19 
patients were identified who claimed a 
weight loss greater than 4.5 kg in 
the 6 months before surgery; as ex­
pected, most of these patients had 
cancer of the large intestine. Of these 
19 subjects, 8 were controls and 2 of 
these demonstrated a leak; of the 
11 patients in the treated group 3 had 
a leak. Mean concentrations of total 
protein, serum albumin and hemo­
globin, and total lymphocyte counts 
were similar in both groups preoper- 
atively and appear little changed post­
operatively (Table I). Table II notes 
the details of the operative procedures 
performed and lesions identified. There 
was no appreciable excess either of 
patients with cancer or of low anterior 
resections in either group.
Fig. 2 shows nitrogen balance in four 
patients, one treated and three controls. 
As expected, the period of intensive 
parenteral nutrition was accompanied 
by a positive nitrogen balance in the 
treated subject, in contrast to the ex­
pected postoperative negative nitrogen 
balance in the three control patients.
Discussion
Major surgery is accompanied by a 
variable period of increased catabolism
F IG . 2—Nitrogen balance in four sub­
jects (selected at random so that one was 
in treated group and three in control 
group). Asterisk indicates postoperative 
roentgenography after contrast enema.
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associated with a negative nitrogen bal­
ance.6,7 It has been claimed that the 
negative nitrogen balance in this period 
can be diminished or even reversed by 
intensive intravenous administration of 
amino acids alone8 or mixtures of 
amino acids plus glucose or lipid.9 It is 
clear that accepted methods of pre­
paring patients for elective colonic sur­
gery combined with current methods 
of postoperative care may allow only 
minimal intake of protein and energy 
sources for as long as 7 to 10 days.
In this trial, we attempted for 6 days 
to give high-volume parenteral nutrition 
with solutions containing amino acids, 
glucose and soybean emulsion to mod­
ify the patient’s response to major 
colonic resection with anastomosis. We 
found that the frequency of leakage 
from these anastomoses in the post­
operative period did not differ in sub­
jects randomly assigned to control or 
treated groups.
Similar trials of intensive perioper­
ative nutrition in patients who undergo 
major surgery have produced conflict­
ing results. Although Abel and col­
leagues,10 by preoperatively identify­
ing malnutrition in patients who under­
went major cardiac surgery, could pre­
dict an increased frequency of com­
plications, they could not show any 
change in the complication rate or the 
duration of hospitalization after 5 days 
of nutritional therapy in the postoper­
ative period. When this study was 
extended to subjects with malignant 
gastrointestinal conditions, intensive pe­
rioperative nutritional supplementation 
failed to lessen the frequency of com­
plications.11 Collins, Oxby and Hill12 
claimed an improvement in the rate of 
healing of perineal sinuses after abdo­
minoperineal excision of the rectum 
in patients receiving parenteral nutri­
tion with amino acids and glucose com­
pared with a control group of patients 
receiving amino acids alone, and an­
other control group of patients who 
had no specific nutritional support. 
Each of these studies used subjective 
methods to identify postoperative com­
plications, and, as far as can be deter­
mined, no attempt was made to conceal 
the method of treatment from the ob­
server assessing the results. In the 
study reported here, the radiologic pre­
sence or absence of a leak at the site
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of the colonic anastomosis was made 
without knowledge of the patient’s 
treatment.
Bozzetti, Terno and Longoni13 found 
that the collagen content of perineal 
biopsy specimens after abdominoperi­
neal excision of the rectum was in­
creased by intensive parenteral nutri­
tion, but they did not present clinical 
data to support their claim that wound 
healing was thereby facilitated. In 
malnourished rats, Steiger and associ­
ates14 recorded an improvement in the 
tensile strength of colonic anastomoses 
when parenteral nutrition was given im­
mediately after operation. Irvin15 con­
firmed this finding in rats who were 
starved to lose one third of their body 
weight, but could find no advantage 
for supplemental nutrition in lesser de­
grees of malnutrition.
It can therefore be argued that 
changes in the rate of healing of colonic 
anastomoses might have been observed 
if we had selected patients who were 
profoundly depleted nutritionally be­
fore operation. We cannot dispute this 
but note that there were no differences 
in the frequency of anastomotic leaks 
in subjects who claimed a preoperative 
weight loss of greater than 4.5 kg 
whether or not they had received pa­
renteral nutrition. It is also clear that 
either more prolonged or more inten­
sive nutritional support might have de­
creased the frequency of anastomotic 
leaks in the treated group. The period 
of nutritional support we selected was 
influenced by the expense of the solu­
tions used, and the real difficulty in de­
ciding whether additional days of 
hospitalization would prove of long­
term benefit to the patient. Fig. 2 sug­
gests that the 6-day period of nutri­
tional supplementation used was suf­
ficient to alter favourably the nitrogen 
balance.
These conclusions refer only to the 
apparent failure of intensive perioper­
ative parenteral nutrition to influence 
the number of postoperative an­
astomotic leaks in patients who under­
go elective colonic resection and should 
not be construed as evidence against the 
use of parenteral nutrition in other cir­
cumstances.
We are grateful to the patients and sur­
geons of Calgary General and Foothills
hospitals who permitted entry into this 
trial, and to the radiologists who read the 
postoperative contrast roentgenograms. 
Micro-Kjeldahl nitrogen analyses were 
performed by Maria Tesanovic of the 
special chemistry department, Foothills 
Hospital.
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Elastin and Granulation Tissue
C. Telfer , b sc,* G.M. Lees, md, FRCs[c],f M. Chambers, m serf 
and H.T.G. Williams, mb, ch b, frcs, facs, frcs[c]§
The contraction of granulation tissue 
is an important factor in wound healing. 
The tract of an abdominal drainage 
tube closes at the rate of 1 mm/h once 
the tube is removed. Specialized 
myofibroblasts are generally believed 
to be responsible for this process and 
the presence of elastin in granulation 
tissue has been debated for many years.
A 3-mm polyethylene tube was 
inserted through the left lobe of the 
liver in 41 rats. A tube of granulation 
tissue formed around the plastic. This 
granulation tissue was isolated, after 
periods ranging from 8 to 20 days, 
by removing the left lobe of the liver 
and scraping away the surrounding 
liver tissue.
Biochemical assay for elastin revealed 
that normal hepatic tissue does not 
contain any detectable amount of 
elastin. All 41 samples of granulation 
tissue contained elastin with a mean 
value of 8.5 x 10-6 g of elastin per 
milligram of tissue. Normal rat aorta 
contains 31.4 x 10~6 g of elastin per 
milligram of tissue.
These tubes of granulation tissue 
were histologically normal and the 
presence of elastin was recognized 
using elastin stains. The exact role of 
elastin in granulation tissue is 
uncertain but this experiment clearly 
demonstrates its generation and 
presence there.
La contraction du tissu de granulation 
est un facteur important dans la 
cicatrisation des blessures. Le passage 
d’un drain abdominal se referme a la 
vitesse de 1 mm/h une fois que le tube 
est retire. On croit generalement
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que des myofibroblastes specialises sont 
responsables de ce processus alors 
que la presence d’elastine dans le tissu 
de granulation est debattu depuis 
plusieurs annees.
Un tube de polyethylene de 3 mm 
a ete insere dans le lobe gauche du 
foie chez 41 rats. Un tube de tissu 
de granulation s'est forme autour du 
plastique. Ce tissu de granulation 
a ete isole apres des periodes allant 
de 8 a 20 jours, par prelevement 
du lobe gauche du foie et raclage du 
tissu hepatique environnant.
La mesure biochimique de I’elastine 
a revele que le tissu hepatique normal ne 
contient aucune quantite decelable 
d’elastine. Les 41 echantillons de tissu 
de granulation contenaient tous de 
I’elastine a la concentration moyenne 
de 8.5 x 10-6 g d’elastine par 
milligramme de tissu. L'aorte du rat 
normal contient 31.4 X 10 6 g d'elastine 
par milligramme de tissu.
Ces tubes de tissu de granulation 
etaient histologiquement normaux et la 
presence d’elastine a ete reconnue 
par des colorants de I’elastine. Le role 
exact de I’elastine dans le tissu de 
granulation est incertain mais cette 
experience demontre clairement 
sa generation et sa presence dans le 
tissu de granulation.
John Hunter was perhaps the first to 
emphasize the importance of wound 
contraction. Since his time, and partic­
ularly in recent years, intensive in­
vestigative effort has been devoted to 
wound healing and early reduction 
(contraction) in the size of a wound.1’6 
After a brief “latent period” of 1 to 2 
days, there is a progressive reduction in 
size of full thickness “granulating” 
wounds so that by 7 days after injury 
the wound size is reduced by 50% to 
60%. This can be admirably demon­
strated in the closure of tracts left after 
removal of a gastrostomy tube. These 
tracts close at the rate of approximately 
1 mm/h and are effectively sealed in 
less than 24 hours, irrespective of the 
size of the tube, so that lost tissue is 
replaced and epithelialization com­
pleted speedily.
The power of a wound to contract 
rests in the granulation tissue but the 
mechanism is incompletely understood. 
Collagen has no innate contractile abil­
ity and wound contraction proceeds 
normally in scorbutic animals.7 More­
over, granulation tissue contains re­
latively little collagen during the stage 
of active wound contraction.4,8 In the 
myofibroblast a potential cellular me­
chanism of contraction exists. The 
evidence supporting the myofibroblast 
theory is strong, both on a pharma­
cologic and ultrastructural (i.e., electron 
microscopic) basis.3-5 However, recent 
work by Ehrlich, Grislis and Hunt2 
suggests that the myofibroblast does not 
have the sole (or even dominant) con­
tractile force.
Until recently, little attention has 
been paid to the part elastin and elastic 
fibres may play in wound contraction. 
Studies have concentrated on the his­
tologic demonstration of elastic tissue 
in healing skin wounds.9-11 The ap­
pearance of the first elastic fibres in 
granulation tissue depends upon such 
variables as staining technique, the 
nature of the tissue under study and 
random sampling errors. Their appear­
ance has been reported as early as 8 
days after wounding by Schwartz10 
and as late as 56 days by Williams.11 
All these studies concentrated on heal­
ing skin wounds and it is theoretically 
possible that “migration” of elastic 
fibres from more lateral unwounded 
skin structures may introduce a source 
of error. We set out to demonstrate 
the presence of elastin in granulation 
tissue from a structure which in its 
normal uninjured state has no chem­
ically detectable elastin.
Materials and Methods
The formation of granulation tissue 
was induced in the liver of 41 adult 
male Wistar rats. Under intraperitoneal 
sodium pentobarbital anesthesia, a mid­
line laparotomy was performed. A 
short piece of polyethylene tubing (dia­
meter 3 mm) was placed through the 
substance of the left lobe of the liver. 
Following this, the liver, with the tube 
in place, was returned to the peritoneal 
cavity. At periods ranging from 8 to 
20 days the animals were sacrificed and 
the segment of liver with the polyethy­
lene tubing was retrieved. The core of 
granulation tissue which had formed 
around the tube was carefully dissected 
from the surrounding normal liver 
(Fig. 1).
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The isolated segment of granulation 
tissue was then studied by light micro­
copy using both elastin and non-elastin 
stains (hematoxylin and eosin, Masson’s 
trichrome and Weigert’s resorcin-fuchsin 
stains). Biochemical assay for elastin 
content was performed on all samples 
using a modification of the method of 
Naum and Morgan12 (employing 5 M 
guanidine hydrochloride followed by 
enzymatic degradation and autoclav­
ing). As a control, the elastin micro­
assay was carried out on 13 normal 
uninjured rat livers. In addition, rat 
aorta, which has a high elastin content, 
was also studied. No attempt was made 
to correlate elastin content with the 
age of the granulation tissue nor to de­
monstrate the presence of oxytalan 
(“pre-elastic”)9 fibres during the early 
stages of granulation tissue formation.
Results
The biochemical assay when applied
FIG. 1—Insertion of polyethylene tube 
in left lobe of liver. Inset to right shows 
isolation of granulation tissue tract from 
surrounding normal liver substance.
to specimens of whole isolated granula­
tion tissue produced consistently posi­
tive results—a mean elastin content of 
8.5 X 10"6 g/mg of tissue (range 0 to 
21.7 X 10'6 g/mg) (Table I). In the 13 
samples of normal uninjured liver no 
elastin could be detected. In the seven 
specimens of rat aorta, the mean value 
of elastin was 31.4 X 10'6 g/mg. The 
three samples with no biochemically 
detectable elastin were obtained at the 
beginning of our study when only a 
small portion of the tissue was assayed. 
We subsequently modified the tech­
nique so that the whole tube of granu­
lation tissue was used in the assay for 
the remaining 38 animals. The histo­
gram (Fig. 2) shows a bell-shaped dis­
tribution of values around the mean.
Examination of stained sections using 
light microscopy confirmed the pre­
sence of apparently normal granulation 
tissue with abundant collagen, new 
vessels and fibroblasts as demonstrated 
in preparations stained with hema­
toxylin and eosin and with Masson’s 
trichrome stain (Figs. 3 and 4). Elastic 
fibres were identified without difficulty 
using Weigert’s resorcin-fuchsin stain.
Table I—Elastin Content in Tissue from 
Normal Uninjured Liver, from Aorta and 
from Granulation Tissue Preparation
Elastin content, 
X lO -6 g/mg
No. of
Tissue samples Mean Range
Liver 13 0 0
Aorta
Granulation
7 31.4 21.5 -  37.9
tissue 41 8.5 0 -21.7
9 -
8-
7-
ELASTIN CONTENT (XlO 0 g/mg of tissue)
FIG. 2—Histogram depicting elastin content in granulation tissue from rat liver. 
Mean content of elastin was 8.5 x 10 6 g/m g of tissue.
The elastin content appeared to be most 
abundant in the more mature granula­
tion tissue. The elastin fibres were not 
uniformly distributed throughout the 
entire thickness of the granulation 
tissue tract but were concentrated 
towards the outside (Fig. 5). To confirm 
that contraction did occur in this expe­
rimental model we inserted the poly­
ethylene tube in the liver substance and 
left it in situ within the peritoneal 
cavity for 10 days as in the usual pre­
paration. Two animals were then ex-
FIG. 3—Granulation tissue preparation 
in rat liver, showing normal hepatic par­
enchyma (at bottom) and granulation tis­
sue with fibroblasts, collagen and new 
vessels (hematoxylin and eosin, reduced by 
52% from x250).
FIG. 4—Granulation tissue preparation 
in rat liver. Cellular elements are present 
including fibroblasts and endothelial cells 
plus collagen fibres (Masson’s trichrome 
stain, reduced by 52% from X250).
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FIG. 5—Granulation tissue preparation. 
Darkly staining elastic fibres are evident 
in bottom half. Same orientation as in 
Figs. 3 and 4 (Weigert’s resorcin-fuchsin 
stain, reduced by 52% from x  250).
plored under general anesthesia, the 
tubes were removed from the liver and 
the peritoneal cavity was closed. Ap­
proximately 10 hours later the animals 
were sacrificed and the liver wound was 
inspected. In both cases no residua!
tract could be identified thereby in­
dicating activity of the contractile 
mechanism of granulation tissue.
Conclusions
Rat liver contains no biochemically 
detectable elastin using the modified 
technique of Naum and Morgan. The 
samples of granulation tissue formed in 
the liver all contained biochemically 
detectable elastin and overall amounts 
were approximately one third of the 
amount of elastin present in the wall 
of the aorta. Histologic examination 
showed that the elastin was concen­
trated in the outer one half of the 
granulation tissue, nearest the host 
tissue. The properties of resiliency, 
elasticity and tensile strength13 suggest 
that elastin could play a role in wound 
contraction.
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Surgical patients don’t always eat
what they get.
Surgical patients are at nutritional risk, 
and picking at their food is only one of the 
factors involved. Fasting before surgery, 
restricted post-op diets, latent 
deficiencies and illness are other causes 
which can put surgical patients under 
severe nutritional stress.
Patients may need more than ‘diet as 
tolerated’ when they’re about to undergo 
surgery, or during convalescence from 
surgery. They need a food that’s 
complete, easy to take, easy to serve, and 
flexible enough to be used in all surgical 
situations.
Predictive Value for Survival of Lymphocytes and 
Polymorphonuclear Leukocytes in Patients with Sepsis
J.A. McC redie, m ch, frcs[c], frcs, frcs(edin), facs,* T.W. Austin, md, FRCP[c],f R.L. Holliday, md, frcs[c]* and W.J. Sibbald, md, FRCP[c]t
To study their value in predicting 
prognosis, tests were performed on 
peripheral blood lymphomononuclear 
cells and polymorphonuclear leukocytes 
in 34 critically ill patients with sepsis. 
Initially, the number of lymphomono­
nuclear cells was reduced by 32% 
compared with healthy control subjects 
and was 42% lower in those who died 
than in survivors. The values remained 
low in those who died. The numbers of 
T and B cells, determined by rosette 
formation using sheep and mouse 
erythrocytes, did not change during the 
period of observation. Initially, K cell 
activity was decreased by 48% compared 
with normal activity. In those younger 
than 65 years, K cell activity was 68% 
lower in patients who later died than in 
survivors. It returned to normal at 
20 to 30 days and decreased in those 
who died. Polymorphonuclear leukocyte 
adherence was decreased by 50% 
compared with healthy control subjects 
and tended to be lower in those who 
died. Chemotactic migration of poly­
morphonuclear leukocytes and intra­
cellular killing of Staphylococcus aureus 
and Pseudomonas aeruginosa were not 
impaired. It was concluded that the 
lymphomononuclear cell count, K cell 
activity and adherence of polymor­
phonuclear leukocytes were decreased 
in patients with sepsis and that the 
values were useful in predicting 
prognosis.
Dans le but d’etudier leur valeur 
previsionnelle pour le pronostic, des
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epreuves ont ete effectuees sur les 
cellules lymphomononucleaires du sang 
peripherique et sur les leucocytes 
polymorphonucleaires chez 34 patients 
critiquement malades souffrant de 
septicemie. A I'origine, le nombre de 
cellules lymphomononucleaires etait 
reduit de 32% comparativement a des 
sujets temoins sains et etait de 42% 
inferieur chez ceux qui sont morts, par 
rapport aux survivants. Ces valeurs 
demeurerent faibles chez ceux qui sont 
decedes. Le nombre de cellules T et B 
determine par la formation de rosettes 
a I'aide d'erythrocytes de mouton et de 
souris n'a pas change durant la periode 
d’observation. Au debut, I’activite 
des cellules K etait reduite de 48% 
comparativement a I'activite normale. 
Chez les patients de moins de 65 ans, 
I’activite des cellules K etait 68% 
plus faibles chez les patients qui sont 
decedes par la suite, que chez les 
survivants. Elle est revenue a la normale 
apres 20 a 30 jours et diminua chez 
ceux qui sont decedes. L’adherence 
des leucocytes polymorphonucleaires 
etait diminuee de 50% par rapport 
aux sujets temoins sains et tendait 
a etre plus faible chez ceux qui sont 
morts. La migration chimiotaxique des 
leucocytes polymorphonucleaires et la 
destruction intracellulaire du 
Staphylococcus aureus et du 
Pseudomonas aeruginosa n'etaient pas 
alterees. On conclut que le compte de 
cellules lymphomononucleaires, I’activite 
des cellules K et I'adherence des 
leucocytes polymorphonucleaires etaient 
diminues chez les patients souffrant de 
septicemie et que ces valeurs etaient 
utiles pour etablir le pronostic.
Innate and adaptive humoral and cel­
lular resistance are important in deter­
mining the establishment and course of 
infections. Immunoglobulins, comple­
ment and polymorphonuclear leuko­
cytes (PMNL) play the major role in 
controlling bacterial sepsis, and T cell 
lymphocytes (T cells) and large mono­
nuclear cells are mainly responsible for 
resistance to viral and fungal infections. 
B cell lymphocytes (B cells), on sensi­
tization by specific bacterial cell anti­
gens, become plasma cells and they in 
turn produce the immunoglobulins.
Patients critically ill with severe bac­
terial infections have abnormalities in 
the number and function of lympho­
cytes and PMNL that could seriously 
affect prognosis. Meakins and as­
sociates1 showed that surgical patients 
who had a decrease in cell-mediated 
immunity had an increase in postoper­
ative infections and mortality when 
compared with healthy control sub­
jects. They determined the delayed hy­
persensitivity response to five recall 
antigens and defined anergy as the abil­
ity to respond to only one or none of 
the antigens. Also, they found that 
polymorphonuclear chemotactic mig­
ration was decreased in anergic pa­
tients.
There is a population of non-T, non- 
B cell lymphocytes that lyse non- 
isogenic cells in the presence of anti­
target cell antibody,2 a reaction known 
as antibody dependent cellular cytotoxi­
city (ADCC). When nucleated target 
cells are used, this reaction is mediated 
by nonimmune lymphocytes known as 
“killer” or K cells. The role of K cells 
in sepsis is not known.
We have determined the number of 
lymphomononuclear (LMN) cells, T 
and B cells, the function of K cells, and 
adherence, chemotaxis and intracellular 
killing of PMNL in the peripheral blood 
of patients critically ill with sepsis. The 
values were determined during the 
course of sepsis to find out if they 
aided in predicting prognosis.
Methods
We studied 34 patients (23 men and 
11 women) with sepsis who were ad­
mitted to the critical care/trauma unit 
of Victoria Hospital, London, Ontario. 
Their ages ranged from 18 to 83 years 
(mean 53 ±  3.2 years). All were critic­
ally ill, had a source of infection and 
a febrile response, and most had posi­
tive results from blood cultures. Pa­
tients with negative results of blood 
cultures were included when they had previously been given antibiotics. 
Most patients had a Swan-Ganz 
catheter inserted to monitor pulmonary 
and systemic hemodynamics. These 
patients had an increased cardiac out­
put and low peripheral resistance, char­
acteristic of sepsis.
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The patients were studied from the 
time of admission to the unit until the 
septic state resolved and they were 
discharged from the unit, or until they 
died. The control group consisted of 
healthy individuals matched with the 
34 patients for age and sex.
Lymphomononuclear Cells
The number of LMN cells in the 
peripheral blood was the total leuko­
cyte count times the percentage of the 
cells in the differential smear. For 
rosette formation, lymphocytes were 
isolated from the peripheral blood 
using Ficoll-Hypaque®. Equal volumes 
of lymphocytes and sheep red blood 
cells were incubated at 37°C for 15 
minutes. The supernate was removed 
and a portion of the residue placed on 
a slide and 200 lymphocytes were 
examined microscopically for rosette 
formation. A rosette was defined as 
the presence of three or more sheep 
erythrocytes in contact with a lym­
phocyte. The results were expressed as 
per cent rosette formation. Early 
rosettes were those present after in­
cubation for 1 hour and total rosettes 
those present after 18 hours. We made 
this distinction because early rosettes 
may be a family of functional T cells 
while the total count identifies all the 
lymphocytes that have T cell markers 
on their surface. B cells were deter­
mined from rosette formation using 
mouse erythrocytes.
The ADCC test was performed as 
described previously.3 Murine P-815 
mastocytoma cells were incubated with 
sodium chromate. Antimastocytoma cell 
antibody was produced in the rabbit. 
Mastocytoma cells labelled with chro- 
mium-51, antibody and peripheral blood 
lymphocytes were incubated for 3 
hours at 37°C. Control samples for 
measurement of maximal release of 
isotope had hydrochloric acid added. 
Isotope release was determined in the 
supernate using a well-type scintillation 
counter.
Lysis was calculated as follows:
%  specific 61Cr ER ~  SR y  
release MR — SR
where ER is experimental release, SR 
is spontaneous release and MR is 
maximal release.
The ratio of the number of lympho­
cytes to mastocytoma cells required to 
lyse 50% of 10 000 cells was defined 
as 1 lytic unit. An increase in lytic 
units signified a decrease in the num­
ber of mastocytoma cells lysed by a 
given number of lymphocytes. The re­
ciprocal of the number of lytic units 
to lyse 50% of 106 mastocytoma cells 
was used so that an increase in value 
signified an increase in ADCC activity.
To correct for lymphopenia, the num­
ber of lytic units per 106 cells was mul­
tiplied by the ratio of LMN cells times 
the total leukocyte count. The results 
were expressed as lytic units times 10s 
mastocytoma cells per millilitre of 
blood.
Polymorphonuclear Leukocytes
Adherence of PMNL was determined 
with heparinized whole blood by the 
method described by MacGregor.4 The 
percentage of cells that adhered to 
nylon fibres was determined by placing 
the cells in a Pasteur pipette (Scien­
tific Products Division, American Hos­
pital Supply Corp., McGraw Park, IL) 
containing 80 mg of fibres packed to 
a height of 15 mm. The value was cal­
culated as follows:
%  adherence = X 100,
where CA is the number of cells in the 
affluent and CE is the number of cells 
in the effluent.
For assays of polymorphonuclear 
leukocytic chemotaxis and intracellular 
killing, isolated cells were suspended in 
Krebs-Ringer phosphate (KRP) solution 
at pH 7.45 containing 0.006 M glucose 
and 0.35% bovine serum albumin 
(Sigma Chemical Co., St. Louis, MO).5
Chemotactic attractant was prepared 
from the bacteria-free supernatant of 
an 18-hour growth of Escherichia coli 
in Medium 199®.6 It was diluted to 25% 
by volume with KRP solution and 
placed in the lower compartment of 
a Boyden chamber (Schleicher & 
Schuell, Inc., Keene, NH). Polymor­
phonuclear leukocytes, 2.5 x  106, were 
placed in the upper compartment which 
was separated from the lower by a 
membrane filter GmbH, pore size 3 
mji (Sartorius Membran Filter, Got­
tingen, West Germany). The chambers 
were incubated for 3 hours in a humid­
ified environment at 37°C. The filters 
were then removed, fixed, stained and 
examined. The average number of cells 
that had migrated to the undersurface 
of the filter membrane was determined 
at a magnification of 440 X in five 
random fields within the area of a 
Whipple micrometre disc (Canlab Ltd., 
Toronto, Ont.). This number was the 
chemotactic migration value.
In the bactericidal experiments, hos­
pital strains of Staphylococcus aureus 
and Pseudomonas aeruginosa were 
grown for 18 hours in trypticase soy 
broth (Difco Laboratories, Detroit, MI). 
The organisms were separated by cen­
trifugation, washed and resuspended in 
0.9% sodium chloride at a concentra­
tion to yield 2.0 x  107 colony forming 
units per millilitre. To 0.1 ml of the 
suspension of organisms was added
0.5 ml of PMNL (2.0 x  107), 0.3 ml of 
KRP and 0.1 ml of AB serum as a 
source of opsonins. The mixture was 
then placed in capped plastic culture 
tubes (Falcon, Oxnard, CA) and agita­
ted at 37°C on an Ames aliquot mixer 
(Fisher Scientific Co. Ltd., Don Mills, 
Ont.). Controls did not contain PMNL 
cells. A zero-time specimen was 
taken and 0.1-ml aliquots were removed 
after incubation for 15, 30, 60 and 120 
minutes. The specimens were diluted 
with distilled water and placed on pour- 
plates. The number of colonies was 
counted after incubation at 37°C for 
24 hours. The assays were performed in 
duplicate and the results expressed as 
the average of the two values.
Comparisons were made between the 
values recorded at the time of admis­
sion to the unit when the patients were 
critically ill and at the time of their 
recovery and discharge or before 
death. Student’s r-test, with Yates’ cor­
rection, was used for the statistical an­
alyses and a probability of less than 5% 
was accepted as significant. Values 
were expressed as the mean ±  stand­
ard error of the mean.
Results
The most frequent origins of the sep­
sis in the 34 patients studied were the 
abdomen, burns and peripheral vascular 
surgery (Table I). The infections were 
mostly bacterial; a few were fungal but 
there were no protozoal or viral infec­
tions. In survivors, the mean interval 
between admission and discharge was 
24 ±  3.4 days; in those who died, it 
was 14.9 ±  4.0 days. The mortality 
was 47% from the complications of un­
controllable sepsis, such as respiratory, 
renal or hepatic failure.
At the time of admission to the unit, 
the number of LMN cells was de­
creased by 32% compared with healthy 
control subjects (P <  0.01) (Table II). 
In survivors, the values had returned to 
normal by the time of discharge from the 
unit but they remained low throughout 
the illness in those who died. The pro­
portion of monocytes present (0 to 5%) 
was not related to survival or death, in­
dicating that lymphopenia was the sig-
Table 1— Origin of Sepsis
Origin
No. of 
patients
Abdomen 6
Burns 5
Peripheral vascular surgery 5
Multiple trauma 4
Pneumonia 4
Gynecologic operations 3
Congestive heart failure 2
Other 5
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Table II— Number of Lymphomononuclear (LMN) Cells, Early T, Total T and B Cells and Function of K Cells in Peripheral Blood of Patients with Sepsis
Upon admission Upon discharge or before death
Controls Survived Died Survived Died
LMN cells, no. 2200 ±  72 1906 ±  360f 1102 ±  151f 2476 ±  460 1210 ±  268
Early T
(34) (16) (18) (16) (18)
cell rosettes, % 54.1 ±  3.5 54.6 ±  2.9 55.9 ±  3.8 62.0 ±  3.0 60.3 ±  4.8
Total T cell
(11) (18) (16) (18) (16)
rosettes, % 64.9 ±  2.9 66.8 ±  2.8 63.3 ±  3.2 66.8 ±  2.8 65.9 ±  3.9
B cell
(10) (18) (16) (18) (16)
rosettes, % 6.9 ±  1.1 11.6 ±  1.8 16.2 ±  2.9 11.1 ±  2.3 11.5 ±  2.8
Kcell
( 8) (17) (15) (16) (13)
activity, lytic units X  10° cells/ml 16.1 ±  1.8* 7.4 ±  2.1* 6.5 ±  1.8J 12.3 ±  5.2 2.0 ±  0.6f
(34) (17) (16) (17) (16)
Probable difference (Student’s /-test) : *P < 0 .0 1 , |P <0.05, fP  < 0 .0 2 .
nificant prognostic factor. Early T and 
total T cell numbers were normal in­
itially and did not change during the 
period of observation (Table II). The 
percentage of B cells was normal and 
tended to increase in those who died 
(Table II). The difference, however, was 
not significant.
K cell activity was decreased by 48% 
at the time of admission (P <  0.01) 
and in the group as a whole was 
similar in those who lived and who died 
(Table II). However, in those under 
65 years of age, there was a greater 
decrease in those who later died than 
in those who survived (P <  0.05, Fig. 
1). This initial value was therefore 
predictive of later death or survival. In 
survivors, there was a return to normal 
at 20 to 30 days; in those who died, 
the final values were 68% lower than 
the initial values (P <  0.02). •
The first values for adherence of 
PMNL were decreased by 50% and 
values in patients who survived did 
not differ from those in patients 
who died (Fig. 2). In patients who
FIG. I—K cell activity in patients with 
sepsis under and over 65 years of age 
(probable difference, Student’s /-test, 
*P >  0.05, ® P <  0.05).
survived, the values had returned to 
normal when they were retested an 
average of 31 days later at the time of 
discharge from the unit. The results 
were the same for both sexes and in 
those younger or older than 65 years. 
Antibiotics, large doses of corticoste­
roids and central intravenous hyper­
alimentation had no effect (Table III).
There was no change in chemotactic 
migration during the period of observa­
tion (Table IV). Intracellular killing of 
S. aureus was not affected by sepsis. 
Killing of P. aeruginosa remained nor­
mal when incubation was for 15, 30 
or 60 minutes but Was increased when 
the incubation time was 120 minutes 
(P <  0.05).
Discussion
We found that sepsis was associated 
with a decrease in the number of LMN 
cells in the peripheral blood. Most of 
the patients in whom the decrease was 
55% (1100/mm3) or in whom a de­
crease persisted ultimately died. The
FIG. 2—Adherence of polymorphonu­
clear leukocytes to nylon fibres deter­
mined in patients with sepsis on admission 
and at time of discharge from unit or be­
fore death (probable difference, Student’s 
/-test, *P <0.01, A =  not significant).
simple observation of the number of 
LMN cells in the peripheral blood was 
extremely useful in indicating the sev­
erity of sepsis, in predicting prognosis 
and in monitoring the clinical course 
of the patient. This finding was in agree­
ment with the observation in untreated 
patients with Hodgkin’s disease that 
patients who died had a LMN cell 
count of less than 1 400/mm.3’7 Similarly 
Meakins and colleagues1 found that the 
lymphocyte count was decreased in an­
ergic surgical patients and that in this 
group of patients there was a high fre­
quency of sepsis and death.
Monitoring of early and total T cells 
and B cells, using rosette formation, 
was of no value in predicting prognosis 
in patients with sepsis. Meakins and 
associates1 found that the percentage 
of T cell rosettes was decreased in 
anergic surgical patients and that those 
with a decrease had a high frequency 
of Subsequent sepsis. The two popula­
tions differed only in that our patients 
had established sepsis, whereas the pa­
tients in the series reported by Meakins 
had infections subsequently.
There are conflicting reports on the 
role of B cells in surgical patients. Gug­
genheim and Buechler,8 working with 
rats, and Hill and colleagues9 found 
that malnutrition caused a decrease in 
the number of B cells, while Wunder,
Table I I I— Effect of Antibiotics, Steroids and 
Central Intravenous Hyperalimentation on 
Percentage Adherence of Polymorphonu­
clear Leukocytes (PMNL) in 34 Patients with 
Sepsis
Treatment Given Not given
Antibiotics 33.7 ±  4.7 31.5 ±  11.1
(24) (10)
Steroids 37.3 ±  6.1 27.9 ±  5.5
Hyperali-
(7 ) (27)
mentation 35.1 ±  7.9 36.7 ±  5.2
(9) (25)
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Table IV— Intracellular Killing (%) of Staphylococcus Aureus and Pseudomonas Aeruginosa by PMNL
Time
Upon admission
Organism (min) Controls Total Survived Died Upon discharge
S .  aureus 15 53.0 ± 13.1 60.3 ±  5.3 57.2 d r 11.3 62.1 ±  5.8 50.0 ±  13.0
30 77.7 ± 7.5 77.8 ±  4.0 77.5 d r 8.7 77.9 ±  4.4 73.9 ±  7.4
60 88.4 ± 4.0 85.5 ±  2.0 83.1 d r 5.7 86.9 ±  3.5 88.9 ±  3.9
120 96.3 ± 1.1 90.5 ±  2.1 89.0 d r 5.8 91.4 ±  1.5 95.9 r t  2.0
P. aeruginosa 15 66.2 ± 6.1 66.7 ±  3.3 65.2 d r 5.1 67.7 ±  4.5 57.2 ±  9.7
30 85.2 ± 4.9 88.5 ±  1.5 85.4 d r 3.5 90.4 ±  1.0 72.6 ±  9.0
60 93.7 ± 2.4 96.7 ±  0.8 94.9 d r 1.8 97.8 ±  0.5 91.9 ±  3.7
4
120 97.7 ± 0.5* 99.3 ±  0.1* 99.5 d r 0.2 99.4 ±  0.1 96.5 ±  1.9
Probable difference (Student’s Z-test): *  P <  0.05.
Stinnett and Alexander10 found no 
change. Our results show that in the 
marked catabolic state associated with 
sepsis, the number of B cells is normal 
and does not change during the course 
of the disease.
In those under 65 years of age, K 
cell activity was decreased in patients 
with systemic sepsis, was lower in those 
who died (P <  0.05) and continued to 
decrease as the general condition dete­
riorated. It has already been noted 
that K cell activity is decreased in 
healthy people older than 65 years.11 
The results of our study indicated that 
sepsis is not associated with major de­
fects in K cell function in the group as 
a whole. The decrease in critically ill 
patients with sepsis may be due to the 
direct toxic effects of the infections on 
the K cells or their progenitors or to 
the marked increase in tissue cata­
bolism. It is not known if improvement 
of K cell activity will also improve the 
prognosis.
It has been assumed that im­
munologic surveillance is performed 
mainly by T cells. There is increasing 
evidence that K, natural killer (NK) and 
large mononuclear cells may play more 
important roles.12 Athymic mice have 
few T cells but do not have an increase 
in non-lymphoreticular cancers. A 
greater number of malignant lymphore- 
ticular tumours and skin cancers are 
found in patients with congenital defi­
ciencies of T and B cells than in the 
normal population but few mesothelial 
or epithelial tumours are found, and 
patients with sarcoidosis and leprosy' 
have fewer T cells but no increase in 
the frequency of cancer. If immu­
nologic surveillance by T cells is im­
portant there should be an increase in 
non-lymphoreticular cancers in these 
patients. T cell deficiency is generally 
associated with an increase in fungal, 
viral and protozoal infections and B cell 
deficiency with an increase in bacterial 
infections. The predominantly bacterial 
infections seen in our study in patients 
with decreased K cell activity suggest
that K cells may also play a role in 
bacterial infections, but to what extent 
we can only speculate.
We found that adherence of PMNL 
was decreased in patients with sepsis. 
Lentnek, Schreiber and MacGregor,13 
however, observed increased adherence 
in patients with inflammatory diseases, 
including localized sepsis. The dif­
ference in results was unlikely to 
be accounted for by differences 
in methodology. They used a lighter 
weight of nylon fibres than we 
did but this should have decreased 
rather than increased adherence. Treat­
ment could affect the results. We 
found that results in males and females 
did not differ and that the use of 
antibiotics, steroids and central intra­
venous hyperalimentation had no effect 
on adherence, suggesting that the 
decrease in PMNL adherence was the 
direct result of sepsis and not of any 
coincidental treatment. Also, since the 
values returned to normal in survivors, 
it is unlikely that the impairment pre­
ceded the illness. The importance of a 
decrease in adherence of PMNL is not 
known. It may indicate that the cell 
is unable to adhere to the capillary 
endothelium prior to its passage through 
the wall of the vessel in response to a 
chemoattractant. For example, alcohol 
causes a decrease in adherence14 and 
also inhibits migration of PMNL into 
Rebuck skin windows. Therefore the 
number of PMNL that reach a septic 
focus may be reduced. Additional 
simultaneous studies are required of 
adherence, migration using the skin 
window technique and chemotactic re­
sponse.
We used heparinized whole blood for 
our studies on adherence of PMNL. The 
effect could therefore be produced by 
PMNL or plasma. MacGregor4 showed 
that the effect of steroids on adherence 
is mediated by plasma, and that washed 
cells adhere normally. We are cur­
rently investigating the effect of plasma 
on adherence.
In contrast to our results, Meakins
and coworkers' found that sepsis caused 
a reduction in chemotactic migration 
of PMNL. The techniques used were 
not similar. We determined the number 
of PMNL that had migrated to the un­
dersurface of the chemotactic mem­
brane after 180 minutes. Maximal mig­
ration was measured at that time.15 
Meakins and his group1 measured the 
distance migrated after 120 minutes, 
in which case it is possible that the 
rate of migration was reduced yet total 
migration could have remained normal. 
Christou, Meakins and MacLean16 found 
that there was a chemotactic inhibitory 
factor in the serum of normal and an­
ergic patients and that there was an 
additional inhibitory factor in those who 
were anergic. They postulated that the 
decrease in chemotaxis they observed in 
anergic patients was responsible for the 
increase in sepsis.
Bactericidal function of PMNL in 
patients with sepsis may be unim­
paired1,17 or decreased.18 We found that 
killing of S. aureus was normal and so 
was killing of P. aeruginosa when in­
cubation was for 15, 30 or 60 minutes. 
It was increased, however, when in­
cubation was for 120 minutes.
We thank Dr. R. MacDonald, Lau­
sanne, Switzerland for setting up the anti­
body-dependent cellular cytotoxicity test, 
Mrs. M. Boisvert for the polymorphonu­
clear cell assays, Mrs. S. Wood for the 
lymphocyte studies and Mrs. M. Alderson 
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the figures.
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is 40 pages long. This controversial sub­
ject certainly deserves an exhaustive dis­
cussion. The approaches of many promi­
nent workers in this field are presented 
in detail along with the rationale of their 
method of management. Millard de­
scribes the period when total resection 
of the maxilla was used, resection of the 
vomer and setback, the years of disap­
proval of these techniques and finally 
presurgical orthodontic treatment for the 
protruding premaxilla. It is apparent that 
controversy still exists and that all the 
questions are not yet answered.
The first 31 chapters consider primary 
deformity and its correction. Millard 
makes it clear that definitive surgery on 
a lip should be performed at the primary 
operation. This is indeed a philosophy 
worth striving for although often difficult 
to achieve.
In the second section on secondary bi­
lateral cleft deformities 23 chapters cover 
the management of these perplexing prob­
lems, many of which have resulted from 
inadequate primary surgery, but many, 
such as a short columella, are inherent 
in the anomaly itself.
The third section on rare clefts is rela­
tively short, particularly so, considering 
that it deals with some of the most dif­
ficult reconstructive problems a surgeon 
faces. It does, however, make the book 
more complete and has a good biblio­
graphy to direct the reader to other 
original articles.
This book goes back to 1957 when the 
“Principles and Art of Plastic Surgery” 
by Sir Harold Gillies and D. Ralph Mil­
lard was published. The artistic presen­
tation is similar in both publications and 
the authority of the authors comes 
through very strongly. Millard has given 
much credit to earlier workers in this 
field and has enriched the book with
many of their pencil portraits. This book 
is not for the novice or uninitiated in the 
field but is a must for every surgical ref­
erence library and should be readily avail­
able for senior residents in plastic sur­
gery.
A.D. Courtemanche, md, frcs[c]
306 Laurel Medical Centre,
888 West 8th Ave.,
Vancouver, BC
CORONARY ARTERY SURGERY. 
John L. Ochsner and Noel L. Mills. 
275 pp. Illust. Lea & Febiger, Philadel­
phia; The Macmillan Company of Can­
ada Limited, Toronto, 1978. $31.25. 
ISBN 0-8121-0620-2.
This book, dealing with the various aspects 
of coronary artery surgery, is very nicely 
laid out with excellent illustrations and 
is easily read. The 15 chapters encompass 
major considerations in preoperative 
evaluation, patient selection and prepara­
tion for surgery, the various operative 
techniques, the major anesthetic consi­
derations, postoperative management, 
combined operations and reoperation. 
Accepted techniques are well described 
in a step-wise fashion while controversial 
techniques are avoided.
Cardiac surgical residents will find 
that the book is an excellent resume of 
the subject. It also contains useful infor­
mation for practising cardiovascular sur­
geons, cardiologists, cardiovascular nurses 
and paramedical personnel especially op­
erating-room nurses.
W.J. Keon, md, frcs[c]
Chief, division of cardiothoracic surgery, 
Ottawa Civic Hospital,
Ottawa, Ont.
continued on page 488
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ORIGINAL CONTRIBUTIONS
Treatment of Carotid Cavernous Fistula by Intravascular 
Occlusion Using a Balloon Catheter
N.A. R ussell , m d , frcs[c ], facs,* M.A. M angan, m d , b CH,f 
W. Pryse-P h il l ip s , md, f r c p [c] |  and L.K. Sharma, m d , fr c s*
The surgical treatment of carotid 
cavernous fistula gradually evolved into 
a “trapping” technique. This technique 
includes ligation of the cervical internal 
carotid artery, clipping of the intra­
cranial portion distal to the fistula and 
often embolization of the isolated 
segment. The development of 
embolization techniques using intra­
vascular balloon catheters greatly 
simplified this treatment.
The authors report a case of 
spontaneous carotid cavernous fistula 
in which obliteration was achieved by 
an intracarotid balloon catheter. This 
was inserted by direct puncture of 
the carotid artery, which had been 
exposed by a simple neck incision. The 
patient's visual acuity was preserved. 
The efficacy, ease and safety of this 
method are emphasized.
Le traitement chirurgical de la fistule 
caverneuse carotidienne a progressive- 
ment evolue vers une technique de 
“piegeage”. Cette technique comprend 
la ligature de I'artere carotide interne 
cervicale, le clip de la partie intra- 
cranienne distale a la fistule et, souvent, 
I’embolisation du segment isole. Le 
developpement des techniques 
d’embolisation utiiisant les catheters 
intravasculaires a ballonets a grandement 
simplifie ce traitement.
From the divisions of * neurosurgery, 
t diagnostic radiology and tneurology,
St. John’s General Hospital and 
Memorial University of Newfoundland, 
St. John’s, Nfld.
Presented at the 45th annual meeting of 
the Royal College of Physicians and 
Surgeons of Canada, Quebec City, PQ, 
Jan. 22, 1976
Reprint requests to: Dr. N.A. Russell,
Ste. 201, Wedgewood Medical Centre, 
Wedgewood Park, St. John’s,
Nfld. A1A 2M7
Les auteurs signalent un cas de 
fistule caverneuse carotidienne 
spontanee ou I'obliteration a ete reussie 
grace a un catheter intracarotidien 
a ballonet. Celui-ci a ete insere par 
ponction directe dans la carotide 
qui avait ete exposee par une simple 
incision du cou. L'acuite visuelle du 
patient a ete preservee. L'efficacite, 
la facilite et la securite de cette 
methode sont soulignees.
The management of carotid cavernous 
fistula has challenged the ingenuity of 
surgeons since Travers1 in 1809 first 
reported the successful treatment of 
such a case by ligation of the common 
carotid artery. In the ensuing years, 
numerous attempts have been made to 
devise a definitive form of treatment. 
These have included embolization 
alone,2 or in combination with “trap­
ping,”3,4 electrothrombosis of the 
sinus5-7 and direct repair of the fistula 
during cardiac standstill.8,9 The most 
successful and widely practised is the 
“trapping” technique described by 
Hamby and Gardner3 and Jaeger.4
The successful use of a balloon 
catheter to occlude a carotid cavernous 
fistula was first reported in 1971 by 
Prolo and Hanberry.10 They used a 
no. 3 French Fogarty balloon catheter, 
passed it through the internal carotid 
artery to the site of the fistula and 
inflated it with positive contrast ma­
terial thus obliterating the fistula. 
Others11-14 have since reported success 
with this method.
The case reported here was treated 
in this way. The fistula remains oblit­
erated 2 years after the procedure and 
the patient has had no ill effects from 
the permanently implanted balloon 
catheter.
Case Report
On July 15, 1975 a 54-year-old, right- 
handed woman experienced severe pain 
in her left eye associated with a loud 
“whooshing” sound in her left ear. The 
pain and noise persisted and after 2 days 
the eye began to close.
She was admitted to the St. John’s 
General Hospital on July 25, 1975.
Examination showed complete loss of 
function of the left third cranial nerve 
and dysesthesia in the distribution of the 
first and second divisions of the fifth 
cranial nerve. There was no exophthalmos. 
Visual acuity was normal. A loud bruit 
could be heard all over the head, maxi­
mally over the left orbit. A diagnosis of 
a spontaneous carotid cavernous fistula 
was made and was confirmed by bilateral 
carotid angiography (Fig. 1).
On Aug. 13, 1975, under general
anesthesia and with electroencephalo- 
graphic (EEG) monitoring, the left cer­
vical carotid bifurcation was exposed. 
Tapes were passed around the internal, 
external and common carotid arteries. A 
16-gauge Angiocath (Desereta Pharma­
ceuticals Canada Ltd., Port Credit, Ont.) 
was inserted into the proximal internal 
carotid artery. An 18-gauge Angiocath 
was then inserted into the bifurcation of 
the artery immediately below this. 
Through the 18-gauge Angiocath, 15 ml 
of Renografin-60® was injected and an­
giograms were made. A no. 3 French 
Fogarty embolectomy catheter was then 
passed by way of the 16-gauge Angiocath 
into the internal carotid artery.
The guide wire was withdrawn and 
enough Renografin-60® was injected to 
allow visualization of the catheter, which 
was maneuvered into the intracavernous 
portion of the carotid artery with fluor­
oscopic control. After the balloon was 
inflated with Renografin-60®, auscultation 
over the left orbit indicated that the bruit 
was no longer audible. Repeat angio­
graphy, however, showed that the fistula 
was only partially occluded. The catheter
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was therefore withdrawn and the 16- 
gauge Angiocath was replaced by a 15- 
gauge one. Through this, a no. 4 French 
Fogarty catheter was inserted and 
threaded easily up to the fistula. Angio­
graphy after inflation of the balloon de­
monstrated that the fistula was totally 
occluded (Fig. 2).
Interestingly, the balloon had herniated 
into the fistula, plugging it and leaving a 
portion of the internal carotid artery 
patent. The Angiocath was withdrawn 
over the catheter, the end of which was 
occluded with two medium-sized clips 
(Ligaclips, Ethicon Sutures Ltd., Peter­
borough, Ont.). The redundant portion of 
the catheter was cut off. The catheter was 
fastened to the artery with a purse-string 
suture and the protruding end buried in 
the undersurface of the sternomastoid 
muscle. The common carotid artery was 
ligated.
Upon awakening from the operation, 
the patient noted that both the pain and 
the bruit had disappeared. After several 
days, the third nerve palsy began to re­
gress, so that 1 week after the operation, 
the patient could open her eye. Visual 
acuity remained normal. Skull roentgeno­
grams taken on Aug. 15, 1975, showed
FIG. I— Carotid arteriogram (subtraction study) demonstrating carotid cavernous 
fistula with brisk shunting via cavernous sinus into ophthalmic vein (white arrow). 
Shunting is also shown occurring through infraophthalmic vein (black arrow) into 
venous channels in nasopharynx.
the contrast-filled balloon unchanged in 
size and position in the left paracellar 
region (Fig. 3). Antibiotic therapy con­
sisting of ampicillin (1 g q6h) and cloxa- 
cillin (1 g q6h) was maintained for 10 days 
after operation. She was discharged from 
hospital on Aug. 30, 1975.
At follow-up examination 2 years later, 
all signs of the fistula were absent and 
there was no neurologic abnormality. 
Skull roentgenograms showed only a 
remnant of contrast material present at 
the site of the balloon (Fig. 4).
D iscussion
The technique described above is a 
simple and safe way of obliterating a 
carotid cavernous fistula. Intraoper­
ative fluoroscopy and angiography allow 
accurate balloon placement and demon­
strate the degree of obliteration of the 
fistula. In our case, the importance 
of fluoroscopy and angiography is 
illustrated by the fact that with the 
initial small balloon, the fistula was 
not completely obliterated, even though 
the bruit had disappeared. In the post­
operative period, the status of the 
contrast-filled balloon can be readily
FIG. 3— Lateral skull roentgenogram 
showing contrast-filled balloon in place.
FIG. 4— Lateral skull roentgenogram 
taken at 2-year follow-up shows only 
remnant of contrast material in presum­
ably deflated balloon.
FIG. 2— Intraoperative carotid arteriogram showing contrast-filled balloon obliter­
ating carotid cavernous fistula. There is some filling of supraclinoid carotid 
(large arrow) and ophthalmic (small arrow) arteries.
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Antiemetic Stemetil shown to haw 
beneficial effect on LOS tone
Aspiration of acid into the lungs remains a 
common cause of death associated with gen­
eral anaesthesia. The lower oesophageal 
s p h in c te r (LO S) is sa id  to be a m ajor 
mechanism which maintains competence of the 
gastro-oesophageal junction, and several drugs 
commonly used during anaesthesia may influ­
ence LOS tone, thereby increasing or decreas­
ing the tendency to regurgitation.
Reporting in the July 1978 issue of the British 
Journal of Anaesthesia, researchers demon­
strated that Stemetil (prochlorperazine) an an­
tiem etic used commonly before and after 
surgery, significantly increases LOS tone with­
out affecting oesophageal pressure. The resul­
tant increase in Barrier Pressure (BP) de­
creases the tendency to regurgitation. The in­
vestigators measured an average increase of 
BP from 2.31 kPa to 3.36 kPa (P<0.005) in 8 
volunteers following the I.V. administration of 
12.5 mg Stemetil.1
This information further enhances Stemetil’s 
reputation as a pharmacologically complete an­
tiemetic. In addition to its effect on LOS tone, 
Stemetil’s multi-level antiemetic action promptly 
stems nausea and vomiting of central or 
peripheral origin. Its anxiolytic action2 inhibits 
cortical impulses associated with “ psychological 
vomiting”. Its C.N.S. action directly blocks the 
chemoreceptor trigger zone,3 4 raising the 
threshold for impulses arriving at the medullary 
vomiting center.
i
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Stemetil in Radiation Sickness
The results of a trial involving 45 patients who 
developed nausea and vomiting following radia­
tion therapy showed that Stemetil was effective 
in all of the patients within 1 -2 days, with good to 
excellent results.
References: Brock-Utne, J. G. et al.: The action of commonly used 
antiemetics on the lower oesophageal sphincter. British Journal of 
Anaesthesia, no. 50, 295-298, July 1978. 2. Peterfy, G. and Pinter, J.: 
Current Therap. Res., 14, (9), 590-598, September 1972. 3. Goodman, 
L. and Gilmour, A.: The Pharmacological Basis of Therapeutics, 5th Ed., 
161, 1975. 4. Today’s Drugs: British Medical Journal, 1, 481, February 
21, 1970. 5. Dutta, A. K.: Study of Prochlorperazine (Stemetil) in radia­
tion sickness, Antiseptic Vol. 73, no. 1, pp 16-18, 1976.
Stemetil was administered in a dosage of 10 mg 
b.i.d. after the onset of nausea and vomiting, 
and was continued for 5-10 days after symp­
toms ceased. The only side effect was drowsi­
ness, which might not have been drug related.5
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Stemetil
prochlorperazine
Indications: nausea and vomiting of various 
etiologies: gastrointestinal disorders, drug 
intolerance, motion and radiation sickness, 
post-operative conditions, pregnancy, vertigo 
and migraines.
Dosage: Adults, oral route - Usual effective 
dosage is 5 to 10 mg, 3 or 4 times daily; in very 
mild cases, a single dose of 5 to 10 mg is often 
adequate. 'Spansule' Capsules: one or two 
every twelve hours. This dosage may be 
increased as required by increments of 10 mg 
every 2 or 3 days until symptoms are 
controlled. For maintenance therapy the dosa­
ge should be reduced to the minimum 
effective dose. Because of the lower pediatric 
dosage requirements, the 'Spansule' Capsules 
are not intended for use in children. Rectal 
route - 1 or 2 suppositories of 25 mg per day. 
Children: oral and rectal routes - up to 10 mg 
per day in divided doses according to body 
weight.
Parenteral route (not to exceed 40 mg per day) 
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Contraindications: Comatose or deeply 
depressed states of the CNS due to hypnotics, 
analgesics, narcotics, alcohol, etc.; hypersen­
sitivity to phenothiazines; blood dyscrasias; 
bone marrow depression; liver damage. 
Warnings and precautions: etiology of vomit­
ing should be established before using the 
drug as its antiemetic action may mask 
symptoms of intracranial pressure or intestinal 
obstruction. Patients with a history of convul­
sive disorders should be given an appropriate 
anticonvulsant while on therapy. Tardive 
dyskinesia may occur in patients on long-term 
therapy. If used with CNS depressants, the 
possibility of an additive effect should be 
considered. Use with great caution in patients 
with glaucoma or prostatic hypertrophy. The 
drug may impair the mental and/or physical 
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car or operating machinery, especially during 
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all medications should be used cautiously in 
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Side effects: extrapyramidal reactions, dis­
turbed temperature regulation and seizures 
have been encountered. Other side effects due 
to phenothiazine derivatives should be borne 
in mind; for complete list, see product 
monograph.
Overdosage: no specific antidote; symptoma­
tic treatment. If a pressor agent is required, 
norepinephrine may be given (not epine­
phrine as it may further depress the blood 
pressure).
Dosage forms: tablets 5, 10 and 25 mg; am­
poules 2 ml/10 mg; liquid 5 mg per teaspoon­
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Complete information upon request
VOLUME 22, NO. 5, SEPTEMBER 1979
followed by plain skull roentgeno­
grams.
We ligated the common carotid 
artery as described in other reports.11*12,14 
This is probably not necessary and 
certainly increases the risk of cerebral 
ischemia.15 The catheter can he ade­
quately fastened to the vessel with a 
purse-string suture and the proximal 
protruding end occluded by metal clips. 
This procedure appears to prevent de­
flation of the balloon, at least until 
thrombosis of the fistula occurs. Intra­
operative EEG monitoring will warn 
of cerebral ischemia. Superficial tem­
poral to middle cerebral artery bypass 
has been used before occlusion of the 
fistula to protect the blood supply to 
the endangered hemisphere (Ford R, 
Richardson P, Anderson D: Unpub­
lished data, 1978).
Two years after operation, skull ro­
entgenograms of our patient showed 
that the balloon had deflated; how­
ever, the patient remained asympto­
matic, suggesting that the fistula had 
been obliterated by thrombus.
A detachable balloon has been 
developed14,16 which can be left in the 
defect in the artery, obliterating the 
fistula while preserving the arterial 
lumen. This happened fortuituously in 
our case, the balloon actually herniat­
ing into the arterial wall defect and 
occluding the fistula, while sparing a 
portion of the lumen of the internal 
carotid artery.
As reported by others,1012 we found 
that the flexible catheter easily nego­
tiated the curves of the carotid artery. 
Our patient’s visual acuity remained 
normal, presumably because of the 
beneficial hemodynamic effect of pre­
serving flow through the ophthalmic 
artery, while at the same time lowering 
intraocular venous pressure.10’17
We found that a no. 4 French 
Fogarty catheter passed easily through 
the 14-gauge Angiocath and that 
direct puncture of the artery with the 
needle was simpler than performing an 
arteriotomy. As we suspected, and as 
subsequently been shown,13 this proce­
dure may be performed by a percuta­
neous technique.
Summary
Occlusion of a carotid cavernous 
fistula was achieved by an intracarotid 
balloon catheter which was inserted 
by direct puncture of the exposed carotid 
artery. The patient’s visual acuity was 
preserved and all symptoms and signs 
of the fistula werq. absent at follow-up 
2 years later, despite collapse of the 
balloon. We suggest, particularly since 
a detachable balloon has recently been 
developed, that this is the preferred 
method of treatment for carotid ca­
vernous fistula.
We thank Mrs. June Wheeler, RN, for
her expert assistance with the procedure
and Mrs. Patricia Sweetapple for typing
the manuscript.
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Percutaneous Transfemoral Retrieval of the “ Runaway”
Ventriculoatrial Shunt
C.E.U. Ekong, mb, bs,* Y.H. Gabriel, mb, bs, frcs[c]* and J.F. Lopez, md, FRCp[c]f
A 22-year-old man with a ventriculoatrial 
shunt was admitted to hospital for 
investigation of headache, nausea and 
vomiting. During a procedure done to 
convert the ventriculoatrial shunt to 
the ventriculoperitoneal type, the shunt 
tubing was inadvertently cut in the 
neck. The atrial end was found to have 
migrated into the right atrium. It was 
recovered by percutaneous cardiac 
catheterization through the femoral 
vein. The patient tolerated the procedure 
well. The authors believe that this 
method of retrieval is easier and 
carries less operative risk than 
previously reported methods.
Un jeune homme de 22 ans porteur 
d'une derivation ventriculo-auriculaire 
a ete hospitalise pour investigation 
d’une cephalee, nausees et 
vomissements. Au cours d’une inter­
vention pratiquee dans le but de 
transformer une derivation ventriculo- 
auriculaire en derivation ventriculo- 
peritoneale, la tubulure de derivation 
fut sectionnee par inadvertance au 
niveau du cou. On s'apercut que 
I’extremite auriculaire avait migre dans 
I'oreillette droite. Elle fut recouvree 
par catheterisme cardiaque percutane 
dans la veine femorale. Le patient 
supporta bien I’intervention. Les auteurs 
croient que cette methode de 
recuperation est plus facile et 
comporte moins de risques operatoires 
que les methodes prealablement 
decrites.
Migration of the atrial catheter into the 
heart is a known,1-5 but relatively un­
common, complication of ventriculo­
atrial shunting. It may occur as 
a result of spontaneous disconnection 
of the catheter from the ventricular 
part or during revision of the shunt. 
In the past this complication has been 
left untreated in the hope that it would 
not cause embolization,4 or has been
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retrieved by thoracotomy or more re­
cently5,6 by cardiac catheterization 
through the internal jugular vein. We 
present the case history of a patient in 
whom the atrial catheter was recovered 
by percutaneous transfemoral cardiac 
catheterization.
Case Report
A 22-year-old man was admitted for the 
10th time to the University Hospital, Sas­
katoon, on Jan. 18, 1978. He complained 
of intermittent headaches, nausea and 
vomiting which had started 1 month ear­
lier. His first hospitalization had been in 
1973 for treatment of a head injury re­
sulting in intracerebral, subdural and epi­
dural hematomas of the right cerebral 
hemisphere. These were removed sur­
gically. Subsequently cerebrospinal fluid 
rhinorrhea developed due to a fistula, 
which was repaired, and later he had 
hydrocephalus, which was treated by in­
serting a ventriculoperitoneal shunt. The 
shunt had been revised several times over 
the years because of blockage of the 
tubing. At the time of this admission a 
ventriculoatrial shunt was in place.
On physical examination the Holter 
shunt reservoir appeared to be emptying 
slowly but filling rapidly, suggesting 
a block of the atrial end, which was 
confirmed by radioisotope scanning. On
FIG. 1— Intraoperative roentgenogram 
of neck and chest (Jan. 23, 1978) made 
after shunt tubing was cut. Upper end of 
distal tubing is seen 10 cm above clavicle 
(higher arrow). New ventriculoperitoneal 
shunt is in situ (lower arrow).
Jan. 23, 1978, the patient underwent oper­
ation to convert the ventriculoatrial shunt 
to a ventriculoperitoneal shunt. During 
the procedure the shunt tubing was in­
advertently cut in the neck. The ventri­
cular end was noted to be patent and 
leaking cerebrospinal fluid. The atrial end 
could not be located. A tunnel was found 
in the subcutaneous tissue from which 
the shunt tubing had retracted inferiorly. 
An intraoperative roentgenogram of the 
neck and chest (Fig. 1) showed the upper 
end of the radiopaque shunt tubing to be 
10 cm cephalad to the right clavicle. Fur­
ther dissection down the tunnel failed to 
discover the shunt tubing. The proximal 
tubing was connected to a Codman Accu- 
flo abdominal shunt tubing (Codman & 
Shurtleff, Inc., Randolph, MA) and placed 
in the peritoneal cavity. On Jan. 25 we 
again attempted to retrieve the tubing by 
dissection in the lower part of the neck, 
but to no avail. An intraoperative roent­
genogram showed the upper end of the 
tubing resting 2 cm cephalad to the 
clavicle (Fig. 2).
On Jan. 26 an open-tipped no. 8 Teflon 
catheter was introduced into the right 
femoral vein under local anesthesia. This 
was passed up to the superior vena cava 
under fluoroscopic control. A curved safe 
T-3 wire guide (Cook Inc., Scarborough, 
Ont.) was then bent double and the loop 
thus formed was passed through the 
catheter until about 6 cm of it protruded
FIG. 2— Intraoperative roentgenogram 
of neck and chest (Jan. 25, 1978) made 
during second attempt to retrieve tubing 
from neck. Top of cut shunt tubing (arrow) 
is now 2 cm cephaled to right clavicle.
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beyond the catheter tip. It was then 
maneuvered as a snare under fluoroscopic 
control until the shunt tubing was trapped 
between the wire and the Teflon catheter 
(Fig. 3). The catheter, wire and shunt 
tubing were then pulled out of the femoral 
vein en bloc. The patient tolerated the 
procedure well. His recovery was smooth 
and he was discharged home on Feb. 4, 
1978.
Discussion
Catheterization of the right atrium 
through the femoral vein is a relatively 
simple procedure, especially in adults. 
Its use for retrieval of cardiac foreign 
bodies was first suggested by Tatsumi 
and Howland.5 By catheterizing the 
heart with a Teflon catheter and using 
a wire snare, a major thoracic opera­
tion is averted. It should be possible 
after a few attempts under fluoroscopic 
control, to anchor the runaway shunt 
catheter to the cardiac catheter by 
trapping it between the wire and 
cardiac catheter.
The first reported case of recovery 
of a shunt catheter from the atrium by 
cardiac catheterization was that of 
Tatsumi and Howland5 who used the 
internal jugular vein from which the 
shunt had escaped. McCulloch and 
Cartledge6 used a flexible rongeur for­
ceps successfully through the same 
vein. We believe that there is a poten­
tial danger in this approach as a throm­
bus may be dislodged and enter the 
heart in the process of catheterization 
or introduction of the rongeur forceps.
Some neurosurgeons prefer to leave 
the catheter in the heart or internal 
jugular vein as long as the patient
has no symptoms. This may be dan­
gerous since septicemia and throm­
boembolic complications may de­
velop.7'9 Cardiac tamponade, erosion 
and penetration of the cardiac wall and 
cardiac arrythmia5 are other well-docu­
mented occurrences. In our opinion a 
free portion of a shunt catheter should 
not be left in the atrium but should be 
removed as soon as possible by femoral 
venous catheterization.
Retrieval of the catheter under fluor­
oscopic control would have been im­
possible if the catheter had not been 
radiopaque. It is, therefore, most im­
portant to use radiopaque atrial shunt 
tubes or tubes with radiopaque markers 
for all ventriculoatrial shunt proce­
dures.
We thank A. Jean MacGregor, assistant 
professor of medicine and medical illus­
trator, for illustrating the retrieval proce­
dure in Fig. 3 and Mrs. M. Faulkner 
for secretarial assistance.
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FIG. 3—Procedure for retrieval: (A) Teflon catheter is placed in right atrium. 
(B) Looped guide wire is placed in right atrium through Teflon catheter. (C) Shunt 
tubing is trapped between catheter and wire and is pulled out.
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A  Major A dvance in Controlling 
Upper Gastrointestinal 
Bleeding
Thgamel
INJECTION
(cimetidiiie)
J5 • *
J >
Rapidly Controls 
Bleeding
In hemorrhage due to 
stress lesions, bleeding stopped 
in most patients within 2-6 hours 
after treatment with 'Tagamet' 
began, and endoscopic reassess­
ment at 24 hours showed that 
57 out of 61 patients (93.4%) had 
stopped bleeding.1
In an additional study with 
'Tagamet' it was concluded "that 
cimetidine is an effective agent for 
controlling bleeding from hemor­
rhagic gastritis, even in situations 
where other medical and surgical 
measures failed".2
Permits Conservative 
Surgical Decisions
"The histamine H 2-receptor 
antagonist, cimetidine, was used 
in 27 patients with erosive gastritis, 
and bleeding ceased in 24. There 
is a prospect that such agents 
will obviate the necessity of total 
gastrectomy in the occasional 
resistant cases in favour of conser­
vative surgery."3
The H2 Receptor 
Antagonist / . ,
,«!% . v
Tagamet
(ciinetidine
Tablets and In jection
(Product Monograph available to practitioners on 
request.)
PHARMACOLOGICAL CLASSIFICATION
Histamine H2-Receptor Antagonist
CHEMISTRY 
Chemical Name:
Cimetidine is N"-cyano-N-methy\-N ’-[2 d( 5-methyl- 
lH-imidazol-4-yl) methyl] thio] ethyl] guanidine. 
Structural Formula:
CH3Xc✓  ch2sch2ch2nhcnhch3 II
H N ^  N N -C  =  N
Molecular Formula: C,oH,6N6S
ACTION
Cimetidine competitively inhibits the action of 
histamine at the histamine H2 receptor, and thus 
represents a new class of pharmacological agents, 
the histamine H2-receptor antagonists.
Cimetidine is not an anticholinergic agent. 
Studies have shown that cimetidine inhibits both 
daytime and nocturnal basal gastric acid secretion. 
Cimetidine also inhibits gastric acid secretion 
stimulated by food, histamine, pentagastrin, caf­
feine and insulin. Its ability to inhibit gastric acid 
secretion via this unique mechanism of action 
permits a new approach to the treatment of acid- 
related gastrointestinal disorders.
Cimetidine is absorbed rapidly after oral adminis­
tration. The plasma half-life is approximately two 
hours. The principal route of excretion is the urine. 
The degree and duration of inhibition of basal 
and stimulated gastric acid secretion is dose- 
related; the data suggest that 80% or higher 
inhibition throughout a 24 hour period can be 
achieved by a dosage regimen of 300 mg four 
times daily given with meals and at bedtime. 
Cimetidine 300 mg reduced total pepsin output as 
a result of the decrease in volume of gastric juice. 
The drug had no effect on the rate of gastric 
emptying or lower esophageal sphincter (LES) 
pressure.
INDICATIONS AND CLINICAL USE
'Tagamet' (cimetidine) is primary therapy for 
conditions where the inhibition of gastric acid 
secretion is likely to be beneficial, such as: 
—Duodenal ulcer 
—Non-malignant gastric ulcer 
—Gastroesophageal reflux disease 
—Management of upper gastrointestinal 
hemorrhage
— Pathological hypersecretion  associated 
with Zollinger-Ellison Syndrome, systemic 
m astocytosis and m ultiple endocrine 
adenomas.
CONTRAINDICATIONS
There are no known contraindications to the use of 
'Tagamet' (cimetidine).
PRECAUTIONS
Use in Pregnancy; Nursing Mothers: There has 
been no experience, to date, with use of 'Tagamet' 
(cimetidine) in pregnant patients. Reproduction 
studies performed in rats, mice and rabbits have 
revealed no evidence of impaired fertility or harm 
to the fetus due to 'Tagamet'. Studies have 
demonstrated that 'Tagamet' crosses the placental 
barrier. It is also secreted in the milk of animals. 
'Tagamet' should be used in pregnant or lactating 
patients or women of childbearing potential only 
when, in the judgment of the physician, the antici­
pated benefits outweigh the potential risks.
Use in Children: Clinical experience in children 
is limited. Therefore, 'Tagamet' (cimetidine) ther­
apy cannot be recommended for children unless, 
in the judgment of the physician, anticipated 
benefits outweigh the potential | risks. In very 
limited experience, 20-40 mg/ kg per day has 
been administered in divided doses by mouth or 
intravenously.
U se in Im paired Renal F u n ctio n : Because 
'Tagamet' (cimetidine) is excreted by the kidney, a 
reduced dosage should normally be administered 
to patients with impaired renal function. (See 
DOSAGE AND ADMINISTRATION)
Drug Interaction: In patients on coumarin- 
type anticoagulants, further prolongation of 
the prothrombin time has been observed with 
concomitant 'Tagamet' administration. For this 
reason, close monitoring is recommended, and 
adjustment of the anticoagulant dose may be
necessary when these drugs are administered 
concomitantly.
Use in Gastric Ulcer: Symptomatic response to 
'Tagamet' does not preclude the presence of a 
gastric malignancy.
ADVERSE REACTIONS
Mild and transient diarrhea, muscular pain, 
dizziness and rash have been reported in a 
small number of patients during treatment with 
'Tagamet' (cimetidine). A few cases of reversible 
confusional states have been reported usually in 
elderly, severely ill patients such as those with 
renal insufficiency or organic brain syndrome. 
Overdosage may have played a role in some 
cases. These confusional states generally cleared 
within 24 hours of drug withdrawal. There have 
been reports that a few patients have developed 
mild non-progressive gynecomastia during pro­
longed treatment. No evidence of induced 
endocrine dysfunction was found, and the con­
dition remained unchanged with continuing 
'Tagamet' treatment. Rare cases of fever and 
intersitial nephritis which cleared on drug with­
drawal, have been reported. Some increases in 
plasma creatinine and serum transaminase have 
been reported.
OVERDOSAGE
In cases reported to date, involving oral ingestion 
of up to 10 grams of 'Tagamet' (cimetidine), no 
untoward effects have been noted and recovery 
has been uneventful.
Treatment: The usual measures to remove un­
absorbed material from the gastrointestinal tract, 
clinical monitoring and supportive therapy should 
be employed. Studies in animals indicate that 
assisted respiration may be of value and that any 
tachycardia may be controlled by administration 
of a beta-blocker.
DOSAGE AND ADMINISTRATION-  
ADULTS
(Experience with 'Tagamet' in children is limited 
and it has not been evaluated in clinical studies— 
s e e  PRECAUTIONS).
In clinical studies 'Tagamet' (cimetidine) has been 
used in divided doses of up to 2400 mg a day.
DUODENAL ULCER
The recommended adult oral dosage for duodenal 
ulcer is 300 mg four times a day, with meals and 
at bedtime.
While healing with 'Tagamet' often occurs during 
the first week or two, treatment should be con­
tinued for at least four weeks unless healing has 
been demonstrated by endoscopic examination. 
While some patients may require concomitant 
antacids initially, 'Tagamet' alone has been shown 
to promote rapid relief of symptoms.
Daily maintenance therapy may be used for those 
patients who would benefit from a reduction of 
gastric acid secretion, as well as those patients 
who are known to suffer frequent recurrence 
of duodenal ulcers. Following healing, mainten­
ance therapy for periods of 6 to 12 months may 
be initiated at a reduced frequency of dosage, 
with the last daily dose taken at bedtime. After 
this period of maintenance, patients should be 
reassessed periodically, preferably by endoscopy.
NON-MALIGNANT GASTRIC ULCER AND 
GASTROESOPHAGEAL R EFLU X  DISEASE
The recommended adult oral dosage for non- 
malignant gastric ulcer and gastroesophageal 
reflux disease is 300 mg four times a day, with 
meals and at bedtime. While healing of non- 
malignant gastric ulcer may occur within the first 
two weeks, treatment should be continued fo r  at 
lea s t six  w eek s  unless healing has been demon­
strated by endoscopic examination.
While some patients may require concomitant 
antacids initially, 'Tagamet' alone has been shown 
to promote rapid relief of symptoms.
MANAGEMENT O F U PPER  
GASTROINTESTINAL HEMORRHAGE
In patients with upper gastrointestinal bleeding 
of sufficient magnitude as to require blood 
transfusions, 'Tagamet' should be administered 
parenterally, preferably by intravenous injection 
or intermittent infusion until 48 hours after active 
bleeding has stopped. At this time an oral dosage 
regimen may be instituted and should be con­
tinued for at least 7-10 days.
Recommended dosage for oral administration:
300 mg every 6 hours.
Recommended dosage for intramuscular injec­
tion administration: 300 mg every 6 hours. Inject 
the entire contents of a 2 ml ampul. 
Recommended dosage for intravenous injec­
tion administration: 300 mg every 6 hours. Dilute 
'Tagamet' in Sodium Chloride Injection (0.9%) (or
other compatible i.v. solution) to a total volume of 
20 ml and inject over 1-2 minutes.
Recommended dosage for intermittent intra­
venous infusion administration: 300 mg every 
6 hours. Dilute 'Tagamet' 300 mg in 100 ml of 
Dextrose Injection (5%) (or other compatible i.v. 
solution) and infuse over 15-20 minutes.
In some patients it may be necessary to increase 
dosage. W hen this is necessary, the increases 
should be made by more frequent administration 
of a 300 mg dose, but total daily'dosage should 
not exceed 2400 mg.
DOSAGE ADJUSTMENT FO R  PATIENTS 
WITH IMPAIRED RENAL FUNCTION
Usage in patients with severely impaired renal 
function has been very limited. Cimetidine half- 
life has been determined in patients with varying 
degrees of renal insufficiency to be:
Creatinine Clearance Cimetidine Half-life 
50-80 ml/min. 2.6 hr.
10-50 ml/min. 2.9 hr.
< 1 0  ml/min. 3.7 hr.
On this basis, the recommended dosage in those 
patients who have creatinine clearance rates 
lower than 10 ml/min., including those who are 
anephric, is 300 mg every 12 hours orally or by 
intravenous or intramuscular injection. Should the 
patient's condition require, the frequency of 
dosing may b e increased to every 8 hours or even 
further with caution.
Hemodialysis: Greater than 80% of a 300 mg intra­
venous dose is cleared in a single 4 hour period of 
hemodialysis. It is completely cleared in an 8  hour 
period.
Peritoneal Dialysis: Peritoneal dialysis does not 
appear to remove cimetidine to any appreciable 
extent.
PATHOLOGICAL H YPERSECRETO RY  
CONDITIONS (eg. Zollinger-Ellison Syndrome) 
Recommended adult oral dosage: 300 mg four 
times a day with meals and at bedtime. In some 
patients, it may be necessary to administer 300 mg 
doses more frequently to control symptoms. 
Dosage should be adjusted to individual patient 
needs, but usually should not exceed 2400 mg per 
day. If intravenous administration is required, the 
dosage schedule should be the same as that rec­
ommended for control of upper gastrointestinal 
bleeding.
SPECIAL CASES
In patients in whom control of gastric acid secre­
tion is desirable, the recommended oral dosage of 
'Tagamet' is 300 mg four times a day, with meals 
and at bedtime. If intravenous administration is 
required, the dosage schedule should be the same 
as that recommended for control of upper gastro­
intestinal bleeding.
Stability of injectable form: Tagamet' Injection 
when added to or diluted with most intravenous 
solutions, such as Sodium Chloride Injection 
(0.9%) or Dextrose Injection (5% or 10%), is stable 
for 48 hours at normal room temperature. 
'Tagamet' Injection should not be refrigerated. 
AVAILABILITY
Tablets: Pale green, circular, biconvex, film 
coated tablets, each containing cimetidine 300 mg 
(monogrammed SK F T13). Bottles of 100 tablets. 
Injection: Each 2 ml dose contains cimetidine 
HC1 eouivalent to 300 mg of cimetidine, in Sterile 
Water for Injection. Preserved with phenol, 0.5%. 
Ampuls of 2 ml, packaged in 10's. 
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Involvement of Small Intestine in Familial Polyposis Coli
D A. W arm ington , m b , b ch , ff  pa th , m r c  path  and R.B. Passi, m d , FACS, frcs[c]
Extracolonic intestinal manifestations 
of familial polyposis coli have been 
described in recent years, but the 
exact frequency is still unknown.
To date the more common sites of 
extracolonic polyposis appear 
to be stomach and duodenum with true 
adenomas being somewhat rare in jeju­
num and ileum. The authors report a 
further two cases of ileal polyposis in 
siblings from a family with familial 
polyposis coli and conclude that 
this condition cannot be 
considered as a disease exclusively 
of the large bowel. They emphasize 
that examination of the upper 
gastrointestinal tract and small 
bowel must be included in the investiga­
tion and follow-up of patients with 
familial polyposis coli.
Les manifestations intestinales extra- 
coliques de la polypose colique 
famiiiale ont ete decrites au cours 
des dernieres annees, mais leur 
frequence exacte demeure inconnue. A 
ce jour, les foyers les plus com- 
muns de polypose extracolique 
semblent etre I’estomac et le duodenum, 
alors que les adenomes veritables 
sont quelque peu rares dans le jejunum 
et I'ileon. Les auteurs signalent deux 
nouveaux cas de polypose ileale 
chez des membres d'une famille 
atteinte de polypose colique famiiiale, 
et ils concluent que cette 
maladie ne peut pas etre consideree 
comme une maladie du gros intestin 
exclusivement. Ils soulignent que 
I'examen des voies gastro-intestinales 
superieures doit etre inclus dans I’in- 
vestigation et le controle ulterieur 
des patients souffrant de polypose 
colique famiiiale.
Familial polyposis coli is a well-known 
condition inherited through autosomal 
dominant transmission and character­
ized by multiple adenomatous polyps 
of the large intestine. The disease may 
be associated with Gardner’s syndrome 
(hyperplasia and neoplasia in other 
tissues) and indeed, it has been sug-
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gested that the two conditions are the 
same disease.1
The existence of extracolonic lesions, 
in the form of stomach and small bowel 
polyposis, in cases of familial polyposis 
coli is a notion which, until recently, 
was not generally accepted. The classic 
concept of familial polyposis has been 
one of large bowel involvement with 
little or no expectation that polyps will 
be present in the rest of the bowel; 
at best the occurrence of polyps in 
the upper gastrointestinal tract of these 
patients was thought to be extremely 
rare, if indeed it ever occurred.2,3
Hauser was the first, in 1895, to 
describe the presence of multiple 
polyps of the stomach and small intes­
tine in a case of familial polyposis coli.4 
Over the next 75 years, sporadic re­
ports of this phenomenon were pub­
lished as is aptly demonstrated in the 
analysis of Hoffman and Goligher5 in 
1971. According to the figures they 
obtained, the commonest sites for extra­
colonic polyp formation were stomach 
and duodenum in 11 and 10 instances 
respectively, followed by jejunum and 
ileum with 5 reported instances in 
each. (These figures represented a fil- 
tered-down analysis of the literature to 
that time, with exclusion of cases not 
clearly examples of familial polyposis.)
More recently, a number of pub-
FIG. 1—Ileal villotubular adenoma 
(hematoxylin and eosin, reduced by 
50% from X100).
lications, from the Japanese group in 
particular, have drawn attention to the 
occurrence of stomach, duodenal and 
small bowel involvement in cases of 
familial polyposis coli.1,68
Whether the generalized polyposis 
represents a variant of the common 
form of the disease as we know it,8 
or whether, as the Japanese workers 
and others have suggested, the ap­
parent dearth of such cases merely 
represents a failure to detect the condi­
tion, are points still to be clarified.
With regard to anatomical distribu­
tion of the extracolonic polyps, recent 
publications support the apparent trend 
indicated by earlier reports that the 
stomach and duodenum are the most 
common sites followed by jejunum and 
ileum. At present, the ileum in cases of 
familial polyposis coli appears to be 
(he least common of these extracolonic 
sites of polyposis. We present a fur­
ther two cases of ileal involvement. 
The patients, a man and a woman, 
were siblings from a family with known 
familial polyposis.
Case Reports
Case 1.—In 1952 at the age of 26 
years, on the basis of existing familial 
polyposis, a 52-year-old man had under-
FIG. 2—Ileal adenoma with admixture 
of normal and abnormal glands (hema­
toxylin and eosin, reduced by 51 % 
from X 100).
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gone colectomy and ileorectal anastomosis. 
Following the operation and in the interim 
period of 26 years, recurring rectal polyps 
were dealt with by means of electrofulgu- 
ration and the patient remained clinically 
well. In February 1978 a segment of bowel 
including a 2.5-cm ileal cuff was removed 
because of a carcinoma found at the up­
per end of the rectal stump. In addition 
to the carcinoma, the rectal mucosa con­
tained numerous polyps, ranging from 2 
to 6 mm in diameter. Close inspection 
of the ileal cuff disclosed a diffuse 
nodularity of the mucosal surface; in­
dividual nodules did not exceed 1 to 2 
mm in size. Histologic examination con­
firmed the presence of a rectal carcinoma 
with involvement of paracolic lymph 
nodes. The rectal polyps were tubular 
adenomas with no evidence of malignant 
change. Sections from the ileal cuff (Figs. 
1 and 2) clearly demonstrated further 
adenoma formation, but now unequiv­
ocally involving small intestinal mucosa. 
The polyps were in close proximity to 
each other, in some instances with only 
a microscopic segment of normal mucosa 
intervening. The majority of the lesions 
were of simple tubular pattern, occasion­
ally with villotubular variation. In each 
instance Paneth cells were readily iden­
tified in adjacent mucosa. Loss of mucosal 
villi was an early feature in some areas 
and the surface of these lesions was 
moderately flat. The overall appearance 
of the small bowel adenomas was iden­
tical to that of their large bowel equiva­
lents. No evidence of malignant change 
was found in the small bowel polyps. 
The intervening segments of ileal mucosa 
were histologically unremarkable.
Case 2.—Following the diagnosis of 
familial polyposis at the age of 15 
years, this 39-year-old woman, the 
sister of the patient in case 1, had 
undergone total colectomy with ileorectal
FIG. 3—Ileal microadenoma (hema­
toxylin and eosin, reduced by 53% 
from X 100).
anastomosis 24 years previously. As was 
the case with her brother, follow-up man­
agement had been that of frequent ob­
servation with fulguration of recurring 
rectal polyps. In March 1978 on the basis 
of dysplastic changes found in several 
polyps recently removed, an abdomino­
perineal resection was performed. Nu­
merous adenomas were present in the 
rectal mucosa and a superficial carcinoma 
was also found on histologic examination. 
The accompanying ileal cuff (2 cm in 
length) demonstrated a patch of mucosal 
granularity measuring 0.3 cm in maximal 
dimension. Histologic examination of 
this granular area (Figs. 3 and 4) dem­
onstrated small bowel tubular adenomas. 
In this instance the ileal lesions were 
not as numerous as in the case of her 
brother and some of the polyps contained 
lymphoid deposits deep to the adenomas. 
Further histologic study of the lesions 
revealed that they were identical to the 
small bowel lesions seen in case 1 and 
to their large bowel counterparts. The 
remainder of the ileal mucosa was free 
of adenomatous change.
Discussion and Conclusions
With regard to the microscopic 
morphology of ileal polyps in cases of 
familial polyposis, previously docu­
mented cases frequently demonstrated 
marked lymphoid hyperplasia, either 
alone or in combination with true 
adenomas.6'7'9,10 Of our two patients, 
the brother had true adenoma forma­
tion while the sister had lymphoid hy­
perplasia in association with adenomas,
FIG. 4—Ileal adenoma with normal 
adjacent small intestinal mucosa (hema­
toxylin and eosin, reduced by 41% from 
X 1 0 0 ) .
but this did not account for false polyp 
formation on its own. (Two other 
members of this family have marked 
ileal lymphoid hyperplasia but without 
true adenoma formation.)
The concept that familial polyposis 
is exclusively a disease of large bowel 
can no longer be accepted1,5"8 and we 
have presented two further cases of 
ileal adenoma formation in patients 
with familial polyposis coli. These 
findings emphasize the need for upper 
gastrointestinal tract and small bowel 
examination, both as part of the ori­
ginal work-up and in the follow-up 
of patients with familial polyposis coli.
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(sodium nitroprusside)
for controlled hypotension during anesthesia 
Rx Summary
‘Nipride’ is only to be used as an infusion with sterile 5% dextrose 
in water without preservatives. Not for direct injection.
Indications
'Nipride' is indicated for producing controlled hypotension during 
anesthesia to reduce bleeding in surgical procedures where deemed 
appropriate. Benefit-risk ratio should be carefully considered on an 
individual basis.
Contraindications
Adequate facilities, equipment and personnel should be available 
for frequent and vigilant monitoring of blood pressure. When the infu­
sion is slowed or stopped, blood pressure usually begins to rise imme­
diately and returns to pretreatment levels within one to ten minutes.
It should be used with caution and initially in low doses in elderly 
patients, since they may be more sensitive to the hypotensive effects 
of the drug.
If, in the clinical situation, stress induced by pain or manipulation 
is reduced or eliminated during 'Nipride' infusion, the patient could 
experience a greater than expected reduction in blood pressure 
unless the rate of infusion is adjusted downward as required.
‘Nipride’ tends to deteriorate in the presence of light. Therefore, the 
infusion bottle should be wrapped with aluminum foil or other opaque 
material. Solutions of 'Nipride' should not be kept or used longer 
than four hours. 'Nipride' in aqueous solution yields the nitroprusside 
ion, which reacts with even minute quantities of a wide variety of 
organic and inorganic substances to form usually highly coloured 
reaction products (blue, green or dark red). If this occurs, the infusion 
should be replaced as quickly as possible.
In the treatment of compensatory hypertension, e.g. arteriovenous 
shunt or coarctation of the aorta. It is also contraindicated in physically 
poor-risk patients (A.S.A. Risk 5), in patients with uncorrected anemia 
or hypovolemia or in those with known inadequate cerebral circulation. 
In patients with liver disease, severe renal disease, Leber’s optic 
atrophy and disease states associated with vitamin B12 deficiency.
Warnings
‘Nipride’ is only to be used as an infusion with sterile 5% dextrose 
in water without preservatives. Not for direct injection. Infusion rates 
greater than 8 ug/kg/minute are virtually never required. If at this 
rate an adequate reduction in blood pressure is not obtained within 
10 minutes, administration of ‘Nipride’ should be stopped.
Fatalities due to cyanide poisoning have occurred following sodium 
nitroprusside administration. One factor is common to all known 
cases, namely that large amounts of nitroprusside were infused at 
high rates. Since detoxification relies upon enzymatic action, the 
rare possibility of deficient or atypical enzymes occurring in humans 
should always be considered. Patients most apt to run into difficul­
ties are those who are resistant to the hypotensive effect or those 
in whom maintenance at the selected blood pressure level is difficult 
or impossible.
Constant attention to the patient’s dose-response characteristics 
is mandatory. If infusion rates are in excess of 8 jig/kg/minute deter­
mine the nature of the response (effective constant response at 
higher dose; tachyphylactic; resistant -  none or less than expected). 
As soon as either tachyphylaxis or resistance is determined the infu­
sion of ‘Nipride’ should be discontinued immediately. In abnormal 
responders it has been noted that metabolic acidosis may occur 
at higher doses.
Caution should be exercised in using 'Nipride' in patients with hypo­
thyroidism or severe renal impairment.
Blood levels of thiocyanate should be determined if treatment is to 
be extended especially in patients with severe renal dysfunction.
As long as blood thiocyanate levels do not exceed 10 m g /100 ml, it is 
probably safe to continue with the infusion. Peritoneal dialysis can 
be helpful if too high levels of thiocyanate are found.
Hypertensive patients are more sensitive to the intravenous effect 
of sodium nitroprusside than are normotensive subjects. Patients 
receiving concomitant antihypertensive medications (especially 
hydralazine or hexamethonium) are more sensitive to the hypotensive 
effect of sodium nitroprusside and the dosage of 'Nipride' should 
be adjusted downward accordingly.
The following Warnings apply to the use of 'Nipride' for controlled 
hypotension during anesthesia:
1. Extreme caution should be exercised in patients who are especially 
poor surgical risks (A.S.A. class 4 and 4E).
2. Tolerance to blood loss, anemia and hypovolemia may be dimin­
ished. If possible, preexisting anemia and hypovolemia should be 
corrected prior to employing controlled hypotension.
3. Hypotensive anesthetic techniques may alter pulmonary ventilation 
perfusion ratio. Patients intolerant of additional dead air space
at ordinary oxygen partial pressure may benefit from higher oxygen 
partial pressure.
4. Resistance and tachyphylaxis occur more frequently in normoten­
sive patients infused with sodium nitroprusside. Induction of delib­
erate hypotension in healthy young individuals may prove to be 
more difficult than in other segments of the population.
5. Upon discontinuance of the sodium nitroprusside infusion for the 
purpose of controlled hypotension during anesthesia a rebound 
hypertension has been observed on rare occasions.
Usage in pregnancy
The safety of 'Nipride' in women who are or who may become preg­
nant has not been established; hence, it should be given only when 
the potential benefits have been weighed against possible hazard 
to mother and fetus.
Usage In children
The safety of 'Nipride' in children has not been established. Clinical 
experience is limited.
Adverse reactions
Nausea, retching, emesis, diaphoresis, apprehension, headache, 
restlessness, agitation, muscle twitching, retrosternal discomfort and 
chest pain, palpitations, dizziness, faintness, weakness, rash, abdo­
minal pain, confusion and somnolence have been noted with too 
rapid reduction in blood pressure. These symptoms rapidly disap­
peared with slowing of the rate of infusion or temporary discontinua­
tion of infusion and did not reappear with continued slower rate 
of administration.
Irritation of the injection site may occur. Methemoglobinemia and 
one case of hypothyroidism following prolonged therapy have been 
reported.
Dosage and administration (for controlled hypotension)
Use of ‘Nipride’ in anesthetized normotensive patients undergoing 
deliberate hypotensive surgery must be restricted to carefully 
selected cases. There is a possibility of an abnormal response 
occurring in normotensive patients. In this event, the infusion of 
‘Nipride’ should be discontinued immediately. (See Warnings).
The contents of a 50 mg ‘Nipride’ vial should be dissolved in 3 ml 
of sterile dextrose in water without preservatives. No other diluent 
should be used. Depending on the desired concentration, all of the 
prepared stock solution should be diluted in 500 or 1000 ml of 5 per­
cent sterile dextrose in water and promptly wrapped in aluminum 
foil or other opaque material. Both stock solution and infusion solu­
tion should be freshly prepared and any unused portion discarded. 
The freshly prepared solution for infusion has a very faint brownish 
tint. If it is highly coloured, it should be discarded. (See Precautions). 
The solution should not be kept or used longer than four hours from 
initial reconstitution. The infusion fluid used for the administration 
of ‘Nipride’ should not be employed as a vehicle for simultaneous 
administration of any other drug.
Nipride' dosage varies considerably from patient to patient, hence 
the need for individual titration. The infusion should be started at 
the lower dosage range, 0.5 ug/kg/m inute and increased by 
0.2 /ig/kg/m inute every 5 minutes until the desired reduction in 
blood pressure is obtained. The blood pressure usually starts to drop 
immediately or at least within a few minutes. Continuous monitoring 
of the blood pressure is necessary. Blood pressure should not be 
allowed to drop at too rapid a rate and systolic pressure should not 
be lowered below 60 mm Hg. 1
Infusion rates greater than 8 /xg/kg/minute should rarely be used.
The maximum recommended dose is 800 fig/minute.
'Nipride' should be administered by an infusion pump, micro-drip 
regulator or any similar device that will allow precise measurement 
of the flow rate. Avoid extravasation. The rate should be adjusted 
to maintain the desired hypotensive effect, as determined by frequent 
blood pressure determinations.
For the use of 'Nipride' in the treatment of hypertensive crises please 
refer to the Product Monograph.
Supply
Nipride' is supplied in 5 ml amber-coloured vials containing the 
equivalent of 50 mg sodium nitroprusside for dilution with 5 percent 
sterile dextrose in water (available in packages of 10).
Product Monograph available on request.
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Early Surgical Management of Acute Cholecystitis
Stuart D. Archibald, md, frcs[c], Nicholas D. Colapinto, md, frcs[c] and
Peter F rost, md, frcs[c]
Between 1971 and 1977, 361 patients 
underwent early elective cholecystec­
tomy for acute cholecystitis, and the 
complications and mortality were 
studied according to the length of 
time from admission to operation. A 
substantially greater proportion of the 
complications, and the only 
deaths, occurred in the patients operated 
upon more than 7 days after admission. 
The mortality rate was 0.6%. Nine 
additional high-risk patients under­
went cholecystostomy. There were 
four postoperative deaths in this group, 
all related to the debilitating under­
lying conditions. The mortality for the 
entire series was 1.6%. These results 
compare favourably with those follow­
ing delayed elective operations for 
acute cholecystitis. Early elective 
operation, using cholecystectomy when 
possible and cholecystostomy when 
necessary, is recommended for general 
use in experienced hands. This practice 
is safe and sound particularly when the 
diagnosis is made more certain pre- 
operatively by the use of intravenous 
cholangiography.
Entre 1971 et 1977, 361 patients ont subi 
une cholecystectomie non urgente 
precoce pour cholecystite aigue, et les 
complications et la mortalite ont ete 
etudiees en fonction de I'intervalle 
ecoule entre I'hospitalisation et 
('operation. Un nombre significativement 
plus grand de complications et les 
seuls deces sont survenus chez 
les patients operes plus de 7 jours 
apres I'hospitalisation. La mortalite a 
ete de 0.6%. Neuf autres patients 
a risque eleve ont subi une cholecys- 
tostomie. II y eut quatre deces post- 
operatoires dans ce groupe, tous relies 
aux maladies debilitantes intercurrentes. 
Pour cette serie, la mortalite globale 
a ete de 1.6%. Ces resultats se 
comparent favorablement a ceux qui 
suivent des operations non urgentes 
retardees pour cholecystite aigue.
Une operation non urgente precoce, 
recourant a la cholecystectomie si
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possible et a la cholecystostomie si 
necessaire est recommandee pour 
utilisation generate entre des mains 
experimentees. Cette pratique est 
sure et valable, surtout lorsque le 
diagnostic est rendu plus certain, 
avant I'operation, par I'emploi de la 
cholangiographie intraveineuse.
There has been continued dispute over 
the timing of operation in the manage­
ment of acute cholecystitis. Three ap­
proaches have been recognized: emer­
gency operation, delayed elective oper­
ation and early elective operation. Op­
eration carried out as an emergency, 
formerly recommended when it was 
thought that the treatment of acute 
cholecystitis ought to parallel that of 
acute appendicitis,1 is now usually 
reserved for salvage of deteriorating 
patients who initially have been man­
aged expectantly.2 Delayed elective 
operation is that performed 6 to 12 
weeks after the conservatively managed 
acute cholecystitis has subsided. Propo­
nents of this approach3 argue that 
operations can then be performed after 
elective investigation, when patients 
have finally recovered from the acute 
cholecystitis and at a time when opera­
tion is easiest. Early elective operation 
consists of definitive surgery, performed 
in the first few days of the acute at­
tack, as soon as the diagnosis is estab­
lished and the patient optimally pre­
pared.4
During the past 9 years at St. 
Michael’s Hospital, Toronto, acute 
cholecystitis has been managed by early 
elective operation and now constitutes 
the most common reason for laparo­
tomy in acute abdominal conditions.
Most cases have been treated by 
cholecystectomy, with cholecystostomy 
reserved for the few patients whose 
general condition was unusually pre­
carious. A review of our experience in 
the 7-year period 1971 to 1977 is 
presented to assess the morbidity and 
mortality associated with this ap­
proach.
Patients and Method
A retrospective review was conducted 
of all patients in whom acute chole­
cystitis was diagnosed between Jan. 1, 
1971 and Dec. 31, 1977, inclusive,
and who underwent operation during 
the acute illness. There were 370 
patients; 211 were female and 159 
were male, giving a femaleimale of 
1.3:1. Their ages ranged from 17 
to 89 years (means 51 years) and 
140 (38%) patients were over 60 
years of age. The diagnosis was made 
clinically. In most recent cases, the 
diagnosis was confirmed preoperatively 
by 2-hour infusion cholangiography,5 
with tomography at the completion of 
the infusion and 6 hours later. At 
operation, the morphologic changes of 
acute cholecystitis were obvious in all 
instances. The patients who had 
cholecystectomy were grouped accord­
ing to the time at which operation 
was performed after admission to hos­
pital. The time of admission to hos­
pital rather than of the onset of symp­
toms was selected as the starting point, 
because the latter could not be ac­
curately determined from the records 
in all cases. In the great majority of 
those for whom this could be ascer­
tained, the duration of symptoms be­
fore hospitalization was less than 24 
hours. In order to determine whether the 
timing of early elective operation sig­
nificantly influenced morbidity or mor­
tality, the 361 patients who underwent 
cholecystectomy were studied in three 
groups: group 1, 199 patients who 
were operated on within 72 hours of 
admission; group 2, 121 patients who 
underwent operation between 72 hours 
and 7 days after admission; and group 
3, 41 patients who were subjected to 
operation more than 7 days after 
admission.
In the last group, the delay of oper­
ation usually occurred in patients ad­
mitted to a nonsurgical service with 
unrecognized cholecystitis, and the 
longest time interval from admission to 
operation was 18 days. Thus group 3 
does not include any patients who had 
“delayed elective operation” as defined 
above.
There were only nine cholecystos- 
tomies, too few to allow analysis by 
groups, and these are considered 
separately.
Results
Intravenous cholangiography was 
performed in 192 patients and gave
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“positive” results in 157 (82%), show­
ing lack of filling of the gallbladder 
but opacification of the extrahepatic 
biliary tree on tomography. Twenty- 
eight studies failed to demonstrate 
either the gallbladder or bile ducts. 
There were no false-positive results. 
Only seven examinations gave false­
negative results, in which the gallblad­
der was opacified, but the diagnosis of 
acute cholecystitis was nevertheless 
confirmed at operation, which was per­
formed because of clinical findings. 
Thus in the cases in which the biliary 
tree was demonstrated, cystic duct ob­
struction was diagnosed with 96% 
accuracy. Only one serious allergic 
reaction occurred and this readily re­
sponded to treatment.
Cholecystectomy alone was per­
formed in 282 patients, and both 
cholecystectomy and exploration of 
the common bile duct in 79 (21%). 
All patients had intraoperative assess­
ment of their extrahepatic ducts and 
an operative cholangiogram was ob­
tained when indicated, using the same 
criteria as in an elective cholecystec­
tomy.
Postoperative complications (Table 
I) were most common in group 3 and 
of similar frequency in groups 1 and 
2. Wound infection was the most fre­
quent complication and was minor in 
all cases. Bile drainage was prolonged 
in four patients; in one patient it was 
due to a dislodged T tube and caused 
peritonitis, requiring reoperation. In 
none of these cases did retained com­
mon bile duct stones coexist. How­
ever, three other patients had retained 
stones. Three patients had either a 
subhepatic or subphrenic abscess. In 
two of these the presentation was in 
the early postoperative period; the 
third patient presented 3 months post- 
operatively with obstructive jaundice 
from extrinsic compression of the com­
mon bile duct (no retained stones were
found). Rare complications were pneu­
monia, atelectasis, myocardial infarc­
tion, pulmonary embolism, septicemia, 
rectus sheath hematoma qnd postoper­
ative urinary retentior. The overall 
complication rate was 11.9%.
The mean hospital stay was 11.1 
days.
There were two deaths in the series, 
both in group 3, giving a mortality 
within the three groups of 0.6%. One 
82-year-old woman died of myocardial 
infarction as the culmination of a 
stormy course which included the de­
velopment of a subphrenic abscess. 
The other patient was an elderly man 
who had a prolonged course of sepsis 
preoperatively, before transfer from 
another hospital. The operation, which 
was undertaken shortly after treat­
ment was instituted for septic 
shock, was followed by multiorgan 
failure.
Nine cholecystostomies were per­
formed, constituting 2.4% of our op­
erations for acute cholecystitis. The 
mean age of patients in this group 
was 69 years. Three of the patients 
were admitted to hospital for another 
reason, and acute cholecystitis devel­
oped during their hospitalization. The 
hospital stay for the other six patients 
averaged 35.8 days. In every case, 
cholecystostomy was done because of 
the very poor general condition of 
the patient. In no instance was chole­
cystostomy performed because of the 
technical difficulty of cholecystectomy. 
Operation was carried out under local 
anesthesia in three patients. Four 
(44%) of the nine patients died post- 
operatively, raising the overall mortali­
ty to 1.6% for the entire series of 
patients.
Discussion
One of the objections to early oper­
ation in acute cholecystitis has been
the performance of unnecessary proce­
dures because of the inability to make 
a definitive diagnosis on clinical 
grounds alone.3 The intravenous cho­
langiogram, in our experience, supplies 
valuable confirmatory evidence of 
cystic duct obstruction in acute chole­
cystitis and may reveal stones within 
the common duct. No inference can 
be drawn from a cholangiogram that 
fails to demonstrate either ducts or 
gallbladder. Using the slow infusion 
technique, adverse reactions to the 
contrast media have been minimal.5 
We do not recommend that intrave­
nous cholangiography supplant opera­
tive cholangiography when the latter 
is otherwise indicated. Some authors6 
have reported that ultrasonography is 
a useful, noninvasive, diagnostic study 
in acute cholecystitis, which can dem­
onstrate stones within the gallbladder, 
and sometimes hydrops, perforation 
and abscess. However, this test does 
not assess gallbladder function or cys­
tic duct obstruction. Its role in acute 
cholecystitis remains undetermined.
An important finding in the present 
series was the absence of damage to 
the hepatic vessels or bile ducts. Simi­
larly, no such injuries were reported 
in other series7,8 when early elective or 
emergency operation2 was employed. 
We found no prohibitive technical dif­
ficulties in doing the definitive sur­
gery. This agrees with the findings 
of others, who have noted the ready 
plane for dissection provided by the 
edema of the acute inflammation, in 
many cases.9 In the uncommon event 
that technical difficulties render chole­
cystectomy or exploration of the com­
mon bile duct too hazardous, chole­
cystostomy, with drainage of the com­
mon bile duct when necessary, pro­
vides a reasonable temporizing proce­
dure.10,11 However, our decision to per­
form a cholecystostomy was made 
preoperatively in every case, based on 
the predicted inability of the patient 
to withstand a more major procedure. 
The deciding factors were the presence 
of other serious medical conditions 
and advanced age. These factors are 
known to increase morbidity and mor­
tality.3’11 In none of the patients who 
died after cholecystostomy was death 
caused by a biliary complication, such 
as inadequate drainage in the presence 
of unrecognized ascending cholangitis, 
a danger previously reported.1214 Some 
surgeons15 have recommended more 
frequent use of cholecystostomy in man­
aging acute cholecystitis. However, with 
this approach, the surgeon cannot as­
sess the biliary tree thoroughly (parti­
cularly when local anesthesia is em­
ployed for the procedure) and there is a 
risk of stones being retained in the
Tab le  l — P ostoperative Com plications A ffe c tin g  361 Patients fo llo w in g  Early  Elective
Cholecystectomy
Complications
1
(n =  199)
Group
2
(n =  121)
3
(n  =  41)
To ta l 
(N  =  361)
Wound infection 11 6 6 23
Prolonged bile drainage 1 1 2 4
R etained common bile  duct stones 2 0 1 3
In traperitoneal abscess 2 0 1 3
Pneum onia or ate lectasis 1 1 1 3
Myocardial in farction 0 0 1 1
Pulm onary embolism 0 1 0 1
Septicemia 0 1 1 2
Rectus sheath hematoma 0 0 1 1
U rin ary  retention 0 1 0 1
M ultiorgan  fa ilu re 0 0 1 1
17 11 15 43
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gallbladder or common bile duct (in 
27% of patients according to one 
report16), or both. Also this operation 
may be attended by specific complica­
tions accounting for significant mor­
bidity and mortality,17 which, in many 
cases, necessitate a second definitive 
procedure.10 For these reasons, the use 
of cholecystostomy in the early elective 
operative management of acute chole­
cystitis should be limited.
Postoperative complications were 
more common in our series when op­
erations were performed more than 
7 days after admission to hospital, 
an observation also made by others.9 
When operations were delayed up to 
7 days after admission there was no 
significant difference in complication 
rates. This supports the concept that 
early elective operations should be 
done as soon as the patient can be 
adequately prepared.8,18 Although 
Wright and Holden18 noted an increase 
in morbidity and mortality if an early 
elective operation was delayed more 
than 4 days after the onset of symp­
toms, and McArthur and associates8 
reported occasional technical difficul­
ties when operating more than 4 days 
after the onset of the disease, neither 
Essenhigh19 nor van der Linden and 
Sunzel20 found any optimal time period 
for early operation. These varied re­
sults may simply reflect the differences 
in criteria used for the timing of oper­
ation. Early elective operation and de­
layed operation have been attended 
by similar complication rates.7,21 How­
ever, when early elective operation is 
performed without delay other than 
that required for proper resuscitation 
and diagnostic measures, the number 
of emergency procedures performed 
while patients are deteriorating will 
decrease. The frequency of unex­
pected urgently performed procedures 
in worsening patients, reported to 
be as high as 30% ,22 is a recognized 
shortcoming of conservative manage­
ment; this may necessitate an increase 
in the number of cholecystostomies 
performed, and consequently an in­
crease in morbidity and mortality.2
One of the advantages, verified in 
the present study, of early operative 
treatment over delayed elective oper­
ation in acute cholecystitis, has been 
the shortened hospital stay7,8,21,23 with 
consequent socioeconomic benefit. Fur­
thermore, elective definitive operation 
carried out early obviates the risk of 
recurrent attacks of cholecystitis,7 each 
with its pain and attendant dangers, 
such as perforation of the gallbladder, 
and avoids the problem of patient 
refusal of a delayed elective operation 
which has been reported in up to 
25% of patients.7
Finally, like others, we have shown 
that early elective operation for acute 
cholecystitis can be performed with 
as low a mortality as delayed elective 
operation.7’10,18
For these reasons, we believe that 
the early elective operative approach to 
to the treatment of acute cholecystitis is 
a safe and sound practice and we ad­
vocate its general use in experienced 
hands. It avoids the dangers associated 
with delay, exposes the patients to no 
increased morbidity or mortality, and, 
when patients are adequately prepared, 
carries a minimal risk of unnecessary 
operation and shortens the period of 
hospitalization, thus reducing cost. We 
believe that cholecystostomy retains a 
place in patients whose general condi­
tion is jeopardized by other serious 
illness, or in the rare instance in which 
technical operative difficulties prohibit 
cholecystectomy.
Summary
Three hundred and sixty-one cases 
of acute cholecystitis were treated by 
definitive early surgery. The complica­
tion rate was 11.9% and the 
mortality 0.6% . Complications and 
mortality were greater when opera­
tion was deferred for more than 7 days 
following admission. Nine high-risk 
patients were treated with cholecystos­
tomy, with a mortality of 44% . Deaths 
were due to the associated conditions. 
Intravenous cholangiography was a 
useful diagnostic adjunct. Our experi­
ence is supported by the recent litera­
ture.
We thank Dr. Donald J. Currie for 
his constructive suggestions in the pre­
paration of the manuscript.
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Aspirin Prophylaxis of Venous Thromboembolic Disease 
following Fracture of the Upper Femur
G .M . Channon, b sc, mb , ch b, frcs( edin)* and A .M . W iley, mb, m ch, frcs, FRcsfc]f
In a prospective study of 51 patients 
with fractures of the femoral neck, 
aspirin was used as a prophylactic 
measure against thromboembolic 
disease.
Thrombi were detected by cuff 
impedence plethysmography, Doppler 
ultrasonography and ascending 
venography. Thrombi were identified 
in 20 (39.2%) of the patients. There 
was no significant difference between 
the frequency with which thrombi 
occurred in men and in women. Blood 
salicylate values were the same for 
patients who had and who did not have 
thrombi. There were no instances of 
pulmonary embolism. The frequency 
of deep vein thrombosis was 
comparable to that in a previous series 
of untreated patients from the same 
centre. It appears from this study that 
in these cases prophylaxis against 
venous thromboembolism using aspirin 
in a dosage of 600 mg b id  is ineffective.
Dans une etude prospective chez 51 
patients souffrant d'une fracture du 
col femoral, I’aspirine a ete utilises 
comme mesure prophylactique des 
accidents thromboemboliques.
Les thrombi ont ete deceles 
par plethysmographie a impedance, 
par ultrasonographie de Doppler 
et par phlebographie ascendante.
Des thrombi ont ete identifies 
chez 20 (39.2%) des patients. II 
n’y a eu aucune difference signi­
ficative entre la frequence des thrombi 
observes chez les hommes et chez 
les femmes. Les salicylemies etaient 
les memes chez les patients qui 
ont eu des thrombi et chez ceux qui
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n’en ont pas eu. II n'y a eu aucun 
cas d'embolie pulmonaire. La frequence 
des thromboses veineuses profondes 
a ete comparable a celle d’une 
serie precedents de patients non 
traites du meme centre. De cette 
presente etude, il semble que I’aspirine 
a la dose de 600 mg deux fois par 
jour soit inefficace comme prophylaxie 
des thromboembolies veineuses 
dans ces cas.
Venous thromboembolism is a frequent 
complication in current surgical prac­
tice, particularly in orthopedic surgery 
after procedures on the hip joint. The 
frequency o f fatal pulmonary embolism 
has been reported as approximately 
2%  after hip arthroplasty1,2 and at 
least 5 % 3,4 after hip fractures. A  fre­
quency of deep vein thrombosis as 
high as 57% has been reported after 
knee surgery5 and 47% after tibial 
fractures.6 In hip surgery the high fre­
quency is due to severe predisposing 
factors including age, obesity, limited 
mobility, reduced venous flow, exten­
sive trauma and the duration o f the 
surgical procedure.7
In recent attempts to prevent this 
condition, drugs that alter platelet ac­
tivity received considerable attention. 
Venous thrombi were thought to be 
formed by the enmeshment o f red 
blood cells in a fibrin lattice. However, 
histologic studies have shown platelet 
aggregates, which suggest that they 
have a role in the initiation o f throm­
bosis.8,9 Some platelet studies support 
this concept.10,11
Of the drugs used to alter platelet 
activity, aspirin has been most often 
studied, because it is easy to use, is in­
expensive and has few side effects. The 
results, however, have been contro­
versial. After general surgical proce­
dures Clagett and associates12 showed 
a beneficial effect of aspirin using 
phlebography for diagnosis. Loew and 
associates13 and Weber, W olff and 
Bromig14 had a similar result in 
patients who underwent general sur­
gery. In studies on orthopedic patients, 
Harris and colleagues15 found aspirin 
as effective as warfarin (using phlebo­
graphy for diagnosis), and Jennings, 
Harris and Sarmiento16 showed clin­
ically that thromboembolic phenomena 
were reduced by using aspirin. Hey 
and associates17 used ultrasonography
and demonstrated a lower rate o f 
thrombosis after giving acetylsalicylic 
acid, and Zekert, Kohn and Vormittag18 
reported a substantial reduction in the 
number of patients who had fatal pul­
monary embolism. More recently, Har­
ris and associates19 have reported a 
protective effect of aspirin after hip 
surgery in men older than 40 years.
However, some workers20,21 believe 
that aspirin does not exert an anti­
thrombotic effect. The Medical Re­
search Council trial22 showed no bene­
ficial effect and this was supported by 
the recent study of Stamatakis and 
associates.23
Our study investigated the effect of 
aspirin prophylaxis on a high-risk group 
of patients who were admitted to To­
ronto Western Hospital with fractures 
o f the femoral neck and trochanteric 
regions. These patients were investi­
gated postoperatively by flow studies 
and venography. We hoped also to 
demonstrate any sex variation that 
might exist in the degree o f protection 
provided by aspirin therapy.
Patients and Methods
All patients admitted to the Toronto 
Western Hospital between Jan. 1, 1978 
and June 30, 1978 with a fracture o f 
the femoral neck or subtrochanteric 
region were considered for inclusion 
in the study. Patients excluded were: 
those with proven peptic ulceration or 
aspirin sensitivity, those receiving anti­
coagulants or steroids for intercurrent 
disease and those receiving a high reg­
ular dose o f aspirin for any condition, 
patients known to have blood dyscrasia 
and those who had undergone surgical 
treatment of varicose veins of the lower 
limb which would make subsequent 
phlebograms difficult to assess. Fifty- 
seven patients entered the study, but 6 
were later dropped (3 died within 10 
days o f operation from unassociated 
conditions, venography could not be 
performed on 2 because of peripheral 
vascular disease and dye sensitivity 
and 1 patient was removed from the 
trial when a history o f peptic ulcera­
tion was obtained from a relative). 
Fifty-one patients (11 men, 40 wom­
en) were therefore available for study. 
Their ages ranged from 47 to 99 years 
(mean 77 years).
On admission, treatment was started
a
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with aspirin (600 mg of buffered ace- 
tylsalicylic acid orally bid). If for any 
reason oral administration was not 
possible before operation, aspirin sup­
positories were given using twice the 
oral dose (1200 mg). Before adminis­
tering the medication we took blood 
samples in a search for unsuspected 
side effects of aspirin and also per­
formed a salicylate assay. The time 
between injury and operation was 
noted. The time spent in hospital be­
fore operation averaged 2.5 days (in­
cluding delays of 9 to 14 days in three 
patients because of general medical 
conditions).
All but five fractures were sustained 
within the home. All types of femoral 
neck fracture were included: subca­
pital (18 fractures), basal (4 fractures) 
and trochanteric or subtrochanteric (29 
fractures). The method of repair used 
was dictated by the current treatment 
practice, so that there were 14 patients 
who underwent femoral head replace­
ment (Austin Moore prosthesis inserted 
by the “Southern exposure” with the 
patient lying on one side) as well as 
those who had internal fixation by nail 
plate (30 patients), Enders nails (5 pa­
tients) and Knowles pins (2 patients).
At operation, the patient position 
used, the presence of anesthetic hypo­
tension and duration of surgery were 
recorded, together with the measured 
blood loss, amount of fluid replaced 
and any tendency for increased 
oozing at the operative site. Hypoten­
sive anesthesia was not employed and 
no other prophylactic anticoagulant 
measure was applied intraoperatively.
In the postoperative period the dura­
tion of bed rest before mobilization was 
recorded. Patients were again given 
aspirin (600 mg bid). Each patient un­
derwent a screening test for platelet 
aggregation with epinephrine to ensure 
that aspirin had been absorbed and to 
demonstrate an alteration in platelet 
activity. Blood was taken for salicylate 
assay 24 hours and 8 days after oper­
ation.
Diagnosis
The diagnosis of deep vein throm­
bosis was made using a combination 
of techniques. The patients were 
assessed clinically on a regular 
basis. If there was any suspicion of 
deep vein thrombosis, venography was 
performed immediately.
If there was no clinical suspicion of 
the presence of a clot, a combined 
flow study and ascending venography 
were done in a 24-hour period 9 days 
after operation, so that we could com­
pare the diagnostic methods. The flow 
study comprised Doppler ultrasono­
graphy and cuff impedence plethysmo­graphy.
Doppler recordings were made from 
the common femoral vein, popliteal 
vein and posterior tibial vein at the 
ankle. Positive results were recorded 
when there was no signal, suggesting 
complete occlusion, or an abnormal 
signal, suggesting obstruction proximal 
to the recording site.
Impedence plethysmography was car­
ried out using a two-cuff technique. 
The presence of deep vein thrombosis 
was diagnosed by variation in the 
maximum venous outflow, which sug­
gests high resistance collateral flow.
The method of venography was es­
sentially that of DeWeese and Rogoff.24 
To overcome the problems associated 
with this technique when used in el­
derly patients, a tilting table with cen­
tre prop was used. Renografin-76® in 
dextrose was infused through an intra­
venous line in the dorsum of the foot. 
Films were taken with the table tilted 
at 30° from the horizontal, and a final 
film was occasionally used with the 
patient in a supine position. The criteria 
for a diagnosis of venous thrombosis 
were: the recognition of a well-defined 
defect, and no visualization of popli­
teal, superficial femoral or common 
femoral veins with good visualization 
of the proximal and distal veins, to­
gether with the presence of collateral 
vessels.
The end point of the study was the 
presence or absence of a deep vein 
thrombosis as diagnosed by veno­
graphy. Patients with venographically 
demonstrated lesions in femoral or pel­
vic veins were given heparin by con­
stant infusion and subsequently re­
ceived anticoagulants orally. If the 
thrombi were confined to calf veins, a 
program of support and mobilization 
was instituted. The presence of proven 
pulmonary emboli (by blood gas meas­
urements and lung scanning) was ac­
cepted as presumptive evidence of deep 
vein thrombosis. Management of these 
patients was carried out according to 
current practices.
For several reasons it was impos­
sible to include a control group in this 
study. Comparable untreated series 
have been reported from this hospital 
in which the patients were managed in 
an identical way under the care of the 
same surgical teams.4,25 They vary only 
in a temporal way from the patients 
in this study and therefore have been 
used for comparison.
Invasive and Noninvasive
Investigations
Although it was not the purpose of 
this study to compare the accuracy of 
noninvasive techniques for studying 
venous flow with that of venography, 
certain conclusions were obvious.
Doppler studies and plethysmography
were carried out by a trained tech­
nician in the flow laboratory associated 
with the cardiovascular unit. All such 
studies were followed within 24 hours 
by venography. The results of the non­
invasive techniques corresponded with 
those of venography in 29 instances, 
but in 10 others (all above the knee) 
a positive result of Doppler study or 
plethysmography, or both, was not 
confirmed by venography (false posi­
tives). On the other hand seven posi­
tive results from venography (all be­
low the knee) were obtained when the 
noninvasive method gave a negative result.
Results
The average operating time for in­
sertion of a Moore prosthesis was 1 
hour, 40 minutes and for a pin-and- 
plate procedure, 2 hours. A number 
of the patients were treated by residents 
in training, while for others the staff 
surgeon performed the operation.
Intraoperative blood loss was calcu­
lated by weighing sponges and was 
similar to that reported in previous 
studies from this centre when no anti­
coagulant was used.25 Excessive oozing 
was not noted and serious wound 
hematomas did not develop.
The patients were mobilized early 
and, on average, were able to sit out 
of bed 5 days after operation. Walking 
on the affected leg was encouraged 
on the 8th day for patients who had had 
a pin-and-plate operation and on the 
14th day for those who had had a 
Moore prosthesis inserted.
Postoperatively the epinephrine ag­
gregation test showed that aspirin had 
altered platelet aggregation in each 
case. Serum salicylate values varied 
considerably ranging from 15 mg/dl 
to 0.1 mg/dl (1.0860 mmol/1 to 0.0072 
mmol/1. In four cases serum concen­
trations were not measurable on at 
least one occasion despite a positive re­
sult from the platelet aggregation study. 
The mean salicylate value was 3.5 mg/ 
dl (0.2534 mmol/1); in those who re­
mained free of thrombi the mean value 
was 3.6 mg/dl (0.2606 mmol/1).
Thrombi were identified venograph­
ically in 20 (39.2%) patients. In four 
patients thrombi formed above the 
knee; two had numerous thrombi in 
the common femoral vein, one had a 
small superficial clot in the superficial 
femoral vein and a fourth had throm­
bus in the deep femoral vein.
Seventeen patients had thrombi in 
the veins below the knee (sural, pero­
neal, anterior and posterior tibial 
veins). In two patients thrombi devel­
oped in the long saphenous vein.
Heparin was given for femoral vein 
lesions. No thrombi were identified 
in the pelvic veins.
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Traditional treatments have all involved a significant risk of dose-related toxicities. The introduction of 
^ PYOPEN'(carbenicillin) was an important therapeutic advance, providing the safety of penicillin, combined with
bactericidal effectiveness against Pseudomonas aeruginosa and other gram-negative organisms.
“...it would appear that carbenicillin is effective in modifying the course of a Pseudomonas 
surface culture in bum patients.” 1
> ■ In severe and overwhelming Pseudomonas infections so often found in burn patients, PYOPEN provides a logical choice
of therapy—effectiveness without dose-related toxicities and the traditional margin of safety common to all penicillins. 
So, for the treatment of Pseudomonas infections in burns... consider PYOPEN.
1. Copeland, Charles E., Carbenic illin  therapy in burn patients, Burn Unit, General Surgery, Mercy Hospital, 
f  P ittsburgh, Pa, U.S.A. Proceedings o f the  Symposium New York, N.Y. Ju ly 12 ,1969,Excerpta Medica Foundation.
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Sex Ratio
Of the 11 men, thrombi formed in 
4 (36.4%); three clots were in calf 
veins and one in the deep femoral vein. 
In 16 (40% ) of the 40 women veno­
graphy gave a positive result, 13 had 
thrombi in calf veins, 3 at higher levels 
(Table I).
No instance of pulmonary embolism 
was recorded during the study.
One patient suffered a cerebrovas­
cular accident 8 days postoperatively 
and a second incident 14 days later. 
The first incident occurred while the 
patient was receiving aspirin.
Discussion
The results of this study suggest that 
aspirin in the dosage that we used has 
no significant effect on the occurrence 
of deep vein thrombosis in patients 
after operation for fracture of the fem­
oral neck. The diagnosis in each case 
was based on venography, which is gen­
erally accepted to be the best diagnostic 
method available. In almost 40% of 
our patients thrombi developed while 
aspirin was being given. In previous 
studies4,25 using the same facilities, sur­
gical teams and diagnostic techniques 
without prophylactic measures, the fre­
quency of thrombosis was 40% and 
49% . These figures are similar to those 
in other reported studies.26,27
We could not demonstrate any sig­
nificant difference in the incidence of 
thrombi between men and women. 
Thrombi developed in 4 (36.4%) of 
11 men in this study compared with 16 
(40%) of 40 women. All the men were 
about 40 years of age. The discrepan­
cy between our figures and those of 
other workers'9 cannot be completely 
accounted for, even allowing for dif­
ferences in the timing of investigation 
and the diagnostic methods used.
Attention has been directed to the 
absence of pulmonary emboli in this 
series. Under the condition of this trial 
an expected figure of 2.3% for pul­
monary embolism did not materialize 
although the number of cases is insuf­
ficient to allow any firm conclusions 
based on statistical significance. How­
ever, it was possible that the “above 
average” intensity of investigation of 
the elderly patients prompted “earlier
than average” use of heparin, with its 
attendant benefits.
This work was financed by a grant 
from the Ontario Geriatric Research So­
ciety to whom we extend our gratitude. 
We also thank Dr. D. Pantalony, hema­
tological service, Toronto Western Hos­
pital, who provided invaluable guidance, 
his staff and technical assistance in the 
platelet studies and aspirin assays.
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In the past, penicillins were not considered as products of first choice in the treatment of anaerobic infections, such as 
bacteroides, and consequently, other potentially more toxic therapeutic agents were used.
Now, PYOPEN* (carbenicillin), one of the newer broad-spectrum semisynthetic penicillins, offers advantages previously 
unavailable in this type of therapy.
Recent studies123 have shown that PYOPEN is effective in 90.3% of cases of intra-abdominal infections due to anaerobic 
and/or mixed gram-negative infections. PYOPEN is not only effective, it is also free from dose-related toxicities, and 
provides the traditional margin of safety common to all penicillins.
So, for relatively safe and convenient therapy for both aerobic and anaerobic infections, whether single or mixed... 
consider PYOPEN.
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Treatment of Unilateral Iliac Artery Disease 
by Femorofemoral Bypass Grafting
Nathan M. Sheiner, md, frcs[c], D avid Ashby, md, frcs[c] and Jack Zeltzer, md
Between Jan. 1, 1970 and June 30, 1977, 
50 men and 23 women underwent 
femorofemoral bypass grafting. The 
average age of the group was 64.7 years. 
The procedure was performed for 
disabling claudication in 50 patients and 
for limb threatening ischemia in 23. 
Knitted Dacron grafts were used in all 
but two patients. The operative mortality 
was 4.1% and the late mortality 21.9%. 
There were six complications related 
to the prostheses, three infected 
grafts and three false aneurysms. 
Thrombosis of the graft occurred in 
15 patients; the graft was successfully 
revised in 2. The cumulative 5-year 
patency rate determined by life-table 
methods was 73.4%. The causes of 
failure appeared to be well defined and 
unilateral iliac artery disease. The 
donor iliac artery, poor runoff through 
a diseased deep femoral artery on the 
recipient side and infection of the 
graft. This study indicates that femoro­
femoral bypass has a definite place in 
the management of patients with 
unilateral iliac artery disease. The 
procedure can be performed on selected 
patients with a low operative mortality 
and an acceptable patency rate.
Entre le 1er janvier 1970 et le 
30 juin 1977, 50 hommes et 23 femmes 
ont subi un pontage femoro-femoral. 
L'age moyen du groupe etait de 
64.7 ans. L'intervention a ete entre- 
prise pour soulager une claudication 
invalidante chez 50 patients ou pour 
corriger une ischemie menacant la 
survie du membre dans 23 cas.
Des greffons de Dacron tricote ont 
ete utilises chez tous les patients, 
sauf deux. La mortalite operatoire a 
ete de 4.1% et la mortalite tardive 
de 21.9%. II y a eu six complications 
reliees a la prothese, trois infections 
du greffon et trois faux §pevrismes. 
Une thrombose du greffon est survenue 
chez 15 patients; le greffon a ete 
repare avec succes dans deux cas. Le 
taux de patence a 5 ans determine 
au moyen de tables actuarielles
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a ete de 73.4%. Les causes d'echecs 
ont semble etre bien definies et 
comprenaient une maladie non reconnue 
de I'artere iliaque donneuse, un 
mauvais ecoulement dans une artere 
femorale profonde maiade du cote 
receveur et I'infection du greffon. Cette 
etude indique que le pontage 
femoro-femoral possede une place 
definie dans le traitement des pa­
tients souffrant de maladie unilateral 
de I'artere iliaque. Cette intervention 
peut etre pratiquee sur des patients 
choisis avec une mortalite ope­
ratoire faible et un taux de 
patence acceptable.
Stenosis or occlusion of one iliac artery 
is usually managed by iliac endarterec­
tomy or aortofemoral bypass grafting. 
Either of these operations can be a 
formidable undertaking in the patient 
with associated disease of the cardiac, 
pulmonary, renal or cerebrovascular 
system. In 1960, McCaughan and 
Kahn1 introduced the principle of a 
crossover graft to treat the patient with 
unilateral occlusive disease of the ilio­
femoral artery. They anastomosed a 
Dacron graft to the left external iliac 
artery and placed the graft in an extra- 
peritoneal plane superior to the bladder 
and then through the right femoral 
canal to the right popliteal artery above 
the knee where the distal anastomosis 
was performed. A third anastomosis 
was then carried out between the graft 
and the proximal end of the right deep 
femoral artery. They proposed this 
crossover procedure as an alternative 
to aortopopliteal bypass in poor-risk 
patients. In 1962, Vetto2 reported the 
use of a femorofemoral subcutaneous 
graft in 10 patients with unilateral iliac 
artery disease. By 1966, he had in­
creased his series to 38 patients and 
had 32 early successes and no late 
graft failure.3 Since these initial reports 
many others have appeared in the lite­
rature and the procedure of femoro­
femoral bypass has achieved relatively 
widespread acceptance.4"15
We started using this procedure in 
January 1970 and have used it increas­
ingly since that time. We now report our 
experience with the procedure over an 
8-year period.
Patient Data
Between Jan. 1, 1970 and June 30,
1977, 50 men (average age 68 years) 
and 23 women (average age 61.8 years) 
underwent femorofemoral bypass graft­
ing. The average age of the entire goup 
was 64.7 years. The age distribution is 
set forth in Table I. Many patients had 
one or more associated conditions 
(Table II) that may have increased the 
morbidity and mortality of conventional 
intra-abdominal revascularization oper­
ations. In the initial years of this study, 
femorofemoral bypass was restricted to 
patients with unilateral iliac disease 
who presented with rest pain, ischemic 
ulcers or gangrene and who were con­
sidered to be poor risks for conven­
tional revascularization procedures be­
cause of the presence of associated di­
seases. In the later years, the indications 
for femorofemoral bypass were ex­
tended to include all patients who 
were over the age of 65 years. Further­
more, disabling claudication was also 
considered an indication. Good-risk 
patients younger than 65 years were 
still operated on by conventional means. 
Of the 73 patients, femorofemoral by-
T a b le  1 - -A g e  D is t r ib u t io n  o f  73 P a t ie n ts  W h o
H a d  F e m o r o fe m o r a l B y p a s s  G r a f t in g
N o . o f  p a t ie n ts
A g e , y r (a n d  % )
4 0 - 4 9 5 (6 .8 )
5 0 - 5 9 18 ( 2 4 .7 )
60 -  69 25 ( 3 4 .3 )
7 0 - 7 9 23 (3 1 .5 )
80 2 ( 2 .7 )
73 (1 0 0 )
T a b le  I I — A s s o c ia te d  D is e a s e s  in  P a t ie n ts  
W h o  H a d  F e m o r o fe m o r a l B y p a s s  G r a f t in g
N o . o f  p a t ie n ts
D is e a s e (a n d  % )
D ia b e te s 23 ( 3 2 )
H y p e r te n s io n 39 (5 3 )
C o ro n a r y  a r t e r y  d is e a s e 56 (7 7 )
C e r e b r o v a s c u la r
in s u f f ic ie n c y 5 ( 7 )
P u lm o n a r y  d is e a s e 20 (2 7 )
C h r o n ic  r e n a l  d is e a s e 8 ( 1 1 )
O th e r 7 ( 1 0 )
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pass was performed in 50 for disabling 
claudication and in 23 for limb-threat­
ening ischemia. Of the latter group, rest 
pain was present in 14, ischemic ulcers 
in 6 and gangrene of one or more toes 
in 3. Four of the 73 patients had pre­
viously undergone unilateral aorto- 
femoral bypass and subsequently di­
sease developed in the opposite iliac 
artery. Three other patients had occlu­
sion of one limb of a previously in­
serted aortobifemoral bypass graft.
Angiographic Findings
In all 73 patients translumbar or re­
trograde femoral arteriograms were 
obtained. Left iliac artery disease was 
present in 40 patients and right iliac 
artery disease in 33 patients. Small ab­
dominal aortic aneurysms were present 
in two patients. There was associated 
femoropopliteal disease in 36 patients.
Operative Technique
The technique of femorofemoral by­
pass has been well described.3,4’li!’15 The 
procedure can be carried out under 
local, epidural or light general anesthe­
sia. The graft can be of autogenous 
saphenous vein or knitted Dacron. In 
the present series, 71 of the grafts were 
8-, 9-, or 10-mm knitted Dacron and 
autogenous saphenous vein in the other 
2. Since approximately 50% of patients 
with iliac artery disease also have ob­
struction of the superficial femoral 
artery, special attention must be paid 
to the deep femoral artery on the re­
cipient side. If this artery is stenotic 
at its orifice, the arteriotomy in the 
common femoral artery should be con­
tinued across the stenotic orifice and 
the bypass graft then tailored to extend 
onto the deep femoral artery as a patch. 
If the disease in the deep femoral artery 
extends distally beyond the first 1.5 cm 
of the vessel then endarterectomy and 
autogenous venous patch angioplasty 
of the deep femoral artery is performed 
and the graft is anastomosed more 
proximally to the common femoral ar­
tery. Alternatively, the graft can be 
anastomosed directly to the deep 
femoral artery.
The tension of the graft when it is 
in place is important. If the graft is too 
short, excessive tension will result in 
traction on both the donor and recipient 
arteries with resultant turbulence and 
possible thrombosis. Excessive tension 
may also cause dehiscence of the an­
astomosis and false aneurysm forma­
tion. If the graft is too long, buckling of 
the graft may occur and this, too, may 
lead to thrombosis.
Operative Procedures
In 68 of the 73 patients, the proce­
dure was limited to a femorofemoral or 
femoral-to-deep femoral artery bypass.
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In three patients, an extended deep 
femoral endarterectomy with saphenous 
vein patch angioplasty was performed 
on the recipient side. In one patient the 
femorofemoral bypass was combined 
with a femoropopliteal vein bypass on 
the recipient side and in one other 
patient, the femorofemoral procedure 
was combined with a femoropopliteal 
vein graft on the donor side.
Results
Mortality
The early (up to 30 days postoper- 
atively) mortality was 4.1% and the 
late mortality 21.9% during a follow­
up period that averaged 35.1 months. 
The causes of death are indicated in 
Table III. Eleven of the 19 deaths 
were due to myocardial infarction.
Complications
The complications of the operation 
are listed in Table IV. In six instances 
the complication involved the graft’ 
three were false aneurysms and three 
were infected grafts. All three infected 
grafts were patent; in one case the 
patient was successfully managed by an 
iliofemoral bypass through the ob­
turator foramen with removal of the 
infected graft but in the other two, 
above-knee amputation was required 
following removal of the infected graft, 
and both patients ultimately died as a 
result of amputation. All three patients 
with false aneurysms underwent suc­
cessful repair of the aneurysms.
Graft Thrombosis
Graft thrombosis was the most com­
mon complication and occurred in 15 
patients—within 30 days in 3, between 
30 days and 1 year in 7, 1 and 2 years 
in 2, 2 and 3 years in 1 and after 3 
years in 2 patients. Of these 15 pa­
tients, successful revision of the graft 
was achieved in 2. Three other patients 
in this group had successful revascular­
ization by another procedure—two by 
axillofemoral bypass and one by aorto- 
femoral bypass. Of the total group of 
73, revascularization ultimately failed 
in 12 patients (10 patients who could 
not be revascularized by either revision 
of the graft or by an alternative proce­
dure and 2 patients in whom a patent 
graft was removed because of infec­
tion). Of this group of 12 patients, 8 
underwent major amputation, above the 
knee in 6 and below the knee in 2.
Relief of Symptoms
All 11 patients with rest pain who 
underwent successful revascularization 
had relief of this symptom. Ischemic 
ulcers healed in all patients who had 
patent grafts, and local amputations 
were successful in managing the three 
patients with gangrenous toes. Of the 50 
patients presenting with intermittent
Table IV— The Early and Late Complications 
of Femorofemoral Bypass
Complication No. of patients
Early
Minor wound infection 3
Major wound infection 
(infected graft) 3
Myocardial infarction 2
Gastrointestinal
bleeding 2
Pneumonia 1
Mesenteric thrombosis 1
Thrombosis of graft 3
Late
False aneurysm 3
Thrombosis of graft 12*
*2 successful revisions.
Table III —The Time and Causes of Death in the 19 Patients Who Died following
Femorofemoral Bypass
Time of death No. of patients Cause No. of patients
0 -  30 d 3 Myocardial infarction 1
Pneumonia 1
Gastrointestinal bleeding 1
31d - 1  yr 4 Myocardial infarction 2
Sepsis 2
1 -  2 yr 3 Myocardial infarction 3
2 -  3 yr 3 Myocardial infarction 2
Aortoenteric fistula 1
> 3  yr 6 Myocardial infarction 3
Carcinoma 1
Cerebrovascular accident 1
Respiratory failure 1
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claudication, 33 of the 46 with patent 
grafts were totally relieved of their 
claudication or demonstrated marked 
improvement. The remaining patients 
improved sufficiently that no further 
operation was required.
Patency Rate
In this series, the two patients who 
had grafts that occluded but were suc­
cessfully revised were considered to 
have patent grafts. The three patients 
who had infected grafts that were re­
moved, though patent, were considered 
to have occluded grafts. The cumulative 
5-year patency rate as determined by 
life-table methods was 73.4% (Fig. 1).
Discussion
A review of several reported series of 
femorofemoral bypass grafting in the 
English literature (Table V) reveals a 
moderate variation in the patency rates 
of these grafts. The 4-year patency rate 
of 53% reported by Eugene, Goldstone 
and Moore8 is somewhat lower than 
those reported in other series. Our 5- 
year cumulative patency rate was 
73.4% and included in the group of 
patients with occluded grafts were three 
patients whose patent grafts were re­
moved because of infection. If we were 
to exclude these three patients the 5- 
year patency rate would exceed 80% 
and would be comparable to the 80.8% 
5-year patency rate reported by Brief 
and associates.5
The causes of failure in our series ap­
pear to be well defined and include Un-
100  -  
9 0  -
5
“  80  -  
<
| 70 <
1  60>
4 0  -
FIG. 1— Cumulative patency of fenioro- 
fenioral grafts determined by life-table 
methods.
recognized disease in the donor iliac 
artery, poor runoff through a diseased 
deep femoral artery on the recipient 
side and infection of the graft. The 
problem of unrecognized iliac artery 
disease on the donor side has been over­
come to a large extent by a more care­
ful angiographic assessment of the 
donor iliac artery with the aid of 
oblique views, and by measuring the 
pressure in the donor iliac artery at 
the time of operation. The problem of 
poor runoff by way of a diseased deep 
femoral artery is currently managed by 
the more frequent use of extended deep 
femoral endarterectomy and of com­
bined femorofemoral and femoropopli- 
teal or femorotibial bypass on the reci­
pient side. Graft infection in our series 
occurred in patients with infected 
ischemic ulcers or gangrenous toes and 
may be prevented by a longer period 
of preoperative antibiotic therapy, 
combined with more intensive local 
therapy to the infected ischemic ulcer.
Conclusion
From our experience we conclude 
that femorofemoral bypass grafting is a 
very satisfactory procedure for man­
aging selected patients with unilateral 
iliac artery disease and can be carried 
out with a relatively low operative mor­
tality and with acceptable long-term 
patency rates.
The indications for this procedure 
have gradually been extended on our 
service and it is now used for: (a) all 
patients with unilateral iliac artery di­
sease who require revascularization 
because of disabling claudication, 
ischemic rest pain, ischemic ulcers or 
gangrene and who are over the age of 
65 years; (b) for patients who are 
younger than 65 but who are consi­
dered poor-risk candidates for conven­
tional revascularization operations be­
cause of severe coronary artery disease, 
chronic obstructive lung disease, ad­
vanced renal disease, cerebrovascular 
disease, etc.; (c) patients in whom intra­
abdominal revascularization is contrain­
dicated because of intra-abdominal sep­
sis or tumour, numerous intra-abdom­
inal adhesions, infection of the upper 
abdominal wall or the presence of a
colostomy; (d) patients who have oc­
clusion of one limb of an aortobi- 
femoral or bi-iliac graft; and (e) pa­
tients who have had unilateral aorto- 
femoral or aortoiliac bypass operation 
and in whom disease subsequently 
develops in the opposite iliac artery.
Addendum
Between July 1, 1977 and July 15, 1978, 
we performed femorofemoral grafting in 
16 men and 7 women. There were no 
operative deaths. Twenty-one of the 23 
grafts remained patent in the early post­
operative period, giving a 30-day patency 
rate of 91.3%. In two patients the graft 
became occluded after the first 30 days 
and one of the grafts was successfully re- 
revised.
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Tab le  V — A  Su m m ary of Som e R e p o rts  o f Fem orofem oral B y p a ss
No. of Le n g th  of
A u th o r p a tie n ts P a te n c y  ra te , % fo llo w -u p
V e tto , 1966:* 38 84 27 mo
S e th i and  asso c ia te s , 197514 27 81.5 26.5 mo
B r ie f  and  asso c ia te s , 1975s 57 80.8
P le c h a  and P o rie s, 1976*3 54 87.4 18 mo
E u g e n e , Goldstone and M oore, 19778 33 53 4 y r
S h e in e r , A sh b y  and Z e ltz e r , p re se n t se r ie s 73 73.4 5 y r
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Testicular Scanning: Its Efficacy in Diagnosing
Intrascrotal Lesions
William L. Orovan, md, Gordon A. McL orie, md, frcs[c]
Radionuclide scanning is a relatively 
new diagnostic aid for evaluating 
intrascrotal lesions. The authors present 
a retrospective analysis of 34 patients 
who underwent testicular scanning 
from 1973 to 1978. While the technique 
may be helpful, misleading results are 
not uncommon and caution should be 
exercised in interpreting the results.
In this series 22% of scans obtained 
in cases of testicular torsion and acute 
epididymitis failed to provide the cor­
rect diagnosis. In view of the serious 
consequence of testicular loss when 
surgical exploration is delayed, testicular 
scanning should not be relied upon 
to the exclusion of other more 
traditional methods.
La scintigraphie isotopique est un 
instrument de diagnostic relativement 
nouveau pour evaluer les lesions 
intrascrotales. Les auteurs presentent 
une analyse retrospective de 34 patients 
qui subirent une scintigraphie des 
testicules entre 1973 et 1978. Bien que 
cette technique puisse etre utile, les 
resultats qui pretent a erreur ne sont pas 
rares et ils devraient etre interprets  
avec circonspection. Dans cette serie, 
22% des scintigraphies effectuees dans 
les cas de torsion d'un testicule et 
d'epididymites aigues n'ont pas reussi 
a etablir le diagnostic exact. En raison 
des consequences serieuses que peut 
entrainer la perte d’un testicule, quand 
I’exploration chirurgicale est retardee,
I’on ne devrait pas se fier aux resultats 
de la scintigraphie des testicules a 
I'exclusion d’autres methodes 
diagnostiques plus traditioneiles.
Radioisotopic scanning for evaluating 
perfusion of the testicles and scrotal 
contents was first proposed by Nadel 
and associates1 in 1973. They used a 
rectilinear scanner and sodium-99m 
pertechnetate and were able to dif­
ferentiate acute testicular torsion,
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characterized by reduced or absent 
testicular perfusion, from acute epi­
didymitis in which perfusion to the 
affected side was markedly increased. 
Subsequent papers2’7 have described 
variations and refinements of the scan­
ning technique and all have sug­
gested that it has a high degree 
of accuracy in diagnosing intrascrotal 
lesions including acute testicular tor­
sion, acute epididymitis, torsion of tes­
ticular or epididymal appendages, tu­
mours, spermatoceles and abscesses.
Accurate and rapid differentiation of 
acute testicular torsion, a condition 
necessitating prompt surgical interven­
tion, from other acute, though nonsur- 
gical, lesions of the scrotum such as 
acute epididymitis is of great benefit 
to the patient in avoiding unnecessary 
exploratory scrotal surgery which is 
often undertaken to exclude acute tes­
ticular torsion in cases that are diag­
nostically difficult.
Patients and Methods
A retrospective analysis was made 
of all patients who had scrotal radio­
nuclide examination to help in the 
diagnosis of intrascrotal lesions at our 
centre from 1973, when the first such 
scan was obtained, to 1978. In that 
5-year period this examination was per­
formed 34 times. The results of scan­
ning in these 34 patients are summar­
ized in Table I. The diagnosis was con­
firmed at operation in 22 patients 
and by clinical follow-up in the re­
maining 12 patients with acute epidi­
dymitis. The patients ranged in age
Table 1—Diagnosis in 34 Patients Who Under­
went Testicular Radionuclide Scanning of the 
Scrotum
Final diagnosis
No. of 
patients
Confirmed 
at operation, 
no.(and % )
Acute testicular
torsion 8 8 (100)
Torsion of appendix 
testis 5 5 (100)
Tumour of testis 6 6 (100)
Acute epididymitis 15 3 (20)
Total 34 22 (65)
from 5 to 74 years; 10 were children 
and 24 were adults. In all cases of 
acute testicular torsion, torsion of an 
appendix testis and acute epididymitis, 
radionuclide scanning was performed 
as part of the initial diagnostic studies. 
Scanning of suspected testicular tu­
mours found on physical examination 
was performed as part of the overall 
preoperative assessment and to evaluate 
the usefulness of the scanning tech­
nique in mass lesions of the testicle.
A standard technique was used in 
which the patient is positioned supine 
under the gamma camera and the scro­
tum isolated and supported from below 
by a thin lead shield designed to ex­
clude background soft tissue activity 
of the thigh from the scanning field. 
The penis is taped to the lower ab­
domen. Technetium-99m (pertechne­
tate) (10 mCi) is injected into an ante- 
cubital vein; perfusion studies are per­
formed at 2-second intervals for 60 
seconds and blood pool images ob­
tained at longer intervals over the next 
5 minutes. Frequently markers are 
placed at the inferior pole of each he- 
miscrotum to aid in anatomic orienta­
tion. Results were interpreted as de­
scribed by Holder and associates7 in 
which the normal pattern of perfusion 
is characterized by a low-level sym­
metrical activity in the perfusion phase 
and an overall intensity similar to the 
thigh on blood pool image or sum­
mation. Acute torsion of the testicle 
is characterized by decreased or ab­
sent perfusion during the dynamic 
phase of the study and a rounded 
“cold” area replaces the testicle on the 
static blood pool image. Acute epidi­
dymitis appears as markedly increased 
perfusion on the involved side with a 
“hot” spot representing the epididy­
mitis on the blood pool image. Tumour 
is seen as a slightly altered, usually 
slightly decreased, area of perfusion in 
an otherwise normally perfused testicle. 
Torsion of an appendix testis gives 
a normal perfusion pattern.
Acute Testicular Torsion
In eight patients the final diagnosis 
was acute torsion of the testicle. All 
of these diagnoses were confirmed at 
operation (Table I). The result of scan-
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ning was misleading in three of the 
eight patients; in two of these three 
operation was performed immediately 
on the basis of clinical diagnosis, and 
in both acute testicular torsion was 
confirmed. In the other patient the 
clinical presentation and laboratory 
findings were equivocal and surgical 
exploration was deferred on the basis 
of testicular scanning which indicated 
the presence of acute epididymitis. The 
patient was subsequently operated 
upon when symptoms failed to resolve 
with conservative therapy; at opera­
tion an infarcted, distorted testicle was 
found which necessitated orchiectomy.
Torsion of Appendix Testis
Five cases of torsion of the appen­
dix testis were diagnosed preoperative- 
ly; in all cases the diagnosis was con­
firmed subsequently at operation. In 
this group operation was performed 
either because the diagnosis was in 
doubt or because of persisting severe 
pain. In four of six scans obtained 
in this group, the results (Table II) 
were at variance with the eventual 
diagnosis. Secondary inflammatory 
changes, though not noted clinically, 
may account in part for the increased 
perfusion noted in three of the six 
scans (Table II).
Tumour of Testis
Six patients with tumour were stud­
ied. These were all nonacute presenta­
tions and testicular scanning was used
as an adjuvant investigative procedure. 
In five patients a mass was delineated 
within the testicle; in four of these 
the mass was slightly hypoperfused 
and in one it was seen as an area of 
slightly increased perfusion. In the 
sixth patient no mass could be defined 
by scanning although subsequent ra­
dical orchiectomy did reveal that a 
2-cm seminomatous tumour was pres­
ent.
Acute epididymitis
Fifteen patients with acute epidi­
dymitis underwent radionuclide scan­
ning; 13 had a pattern of increased 
perfusion. Two patients showed nor­
mally perfused testicles and hemiscrota 
(Table II). Three of these 15 patients 
were subsequently operated upon for 
unresolved pain or abscesses and the 
diagnosis of epididymitis was con­
firmed in all. The remaining 12 were 
followed clinically and in all the con­
dition resolved with antibiotic therapy. 
Nine patients have been followed up 
from 1 to 14 months; in none has 
there been any indication of atrophic 
testicles suggestive of missed torsion.
Discussion
The use of testicular radionuclide 
imaging to aid in the diagnosis of in- 
trascrotal lesions has received wide­
spread attention in the recent surgical 
and radiologic literature. Several previ­
ous reports have attested to its general 
efficacy as a diagnostic aid. Riley and
associates5 have reported a 6% false­
negative scan result in differentiating 
acute torsion of the testicle from acute 
epididymitis, while Williamson8 puts 
the figure at almost 10%.
While we have found this technique 
to be generally helpful, misleading re­
sults are not uncommon. Our own 
experience in this admittedly small se­
ries shows that in the 23 combined 
cases of acute testicular torsion and 
acute epididymitis investigated by ra­
dionuclide scanning, the scan failed 
to suggest the correct diagnosis in 5 
(22%). Of the 22 patients in whom 
the diagnosis was confirmed at oper­
ation, the scans were found to be 
misleading in 7 (32%) (Table III).
In view of our results we would 
urge that caution be exercised in the 
use of this diagnostic modality. We 
would echo the conclusions of Datta 
and Mishkin4 that scrotal imaging 
should be viewed along with all other 
clinical and laboratory data in the 
diagnosis of acute intrascrotal lesions. 
Caution in interpreting the results of 
these scans is particularly important 
in view of the serious result of testi­
cular loss which may occur when 
a diagnosis other than acute torsion is 
made and surgical exploration is thus 
deferred until testicular damage is ir­
reversible and salvage impossible. We 
also stress that no time should be lost 
in waiting for testicular scanning to 
be carried out if the clinical impres­
sion is that the patient requires an im­
mediate scrotal exploration for salvage 
of his testicle, as in the case of testi­
cular torsion.
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Table II—Scan Result Compared with Trial Diagnosis in 34 Patients Who Underwent Testicular
Radionuclide Scanning
Scan result
Final diagnosis
Increased Decreased Normal Expected Per cent
perfusion perfusion perfusion result incorrect
Acute testicular torsion 3 5 0 Decreased 37
Torsion of appendix testis* 3 1 2
perfusion
Normal 66
Tumour of testis 1 4 1
perfusion
Slightly 17
Acute epididymitis
altered
13 0 2 Increased
perfusion 13
*1 patient underwent scanning on 2 occasions.
Table III--Scanning Results Confirmed at Operation
Final diagnosis
Scan
correct
Scan
incorrect
Total no. 
of cases
Scan
errors, %
Acute testicular torsion 5 3 8 37
Torsion of appendix testis 2 3 5 60
Tumour of testis 5 1 6 17
Acute epididymitis 3 0 3 0
15 7 22 32
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Sensory Feedback in a Myoelectric Upper Limb Prosthesis:
a Preliminary Report
R.H. Brittain, m sc, p eng,* W.F. Sauter, CPO[c]f and D.A. G ibson, md, FRCs[c]t
Upper limb prostheses are often 
rejected because they do not provide 
the sensory feedback available from a 
normal hand. A system for providing 
sensory feedback has been developed 
at the University of New Brunswick for 
use with the three-state myoelectric 
controls prepared in the Bioengineering 
Institute there. Strain gauges mounted 
on the forefinger of an electric hand 
provide information which is processed 
electronically to cause a tingling 
sensation in the patient's stump, 
proportional in its intensity to the pinch 
force in the finger.
This system has been used by a 
patient at the Ontario Crippled 
Children's Centre in Toronto, since 
June 1976. She uses it consistently 
with great satisfaction and enthusiasm. 
It gives her a sense of competence 
and confidence she does not have 
without it.
Les protheses des membres superieurs 
sont souvent rejetees parce qu’elles 
sont incapables de procurer la retroaction 
sensitive offerte par une main normale. 
Un systeme capable de procurer une 
retroaction sensitive a ete mis au point 
a I’Universite du Nouveau-Brunswick 
pour utilisation avec les controles 
myoelectrique a trois etats prepares a 
leur Institut de Genie Biomedical. Des 
jauges de tension placees sur I'index 
d’une main electrique procure 
I’information qui est transmise 
electroniquement, causant une sensation 
de fourmillement dans le moignon 
du patient, proportionnelle en intensite 
a la force de compression dans le doigt.
Ce systeme a ete utilise par une 
patiente du Ontario Crippled Children's 
Centre, a Toronto, depuis juin 
1976. Elle I'emploie regulierement 
avec beaucoup de satisfaction et
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d'enthousiasme. Cela lui donne un 
sentiment de competence et de 
confiance qu'elle n'a pas sans lui.
The upper limb is commonly thought 
of as an organ for grasping and moving 
things and its sensory function is for­
gotten. The importance, however, of 
sensory feedback from the hand be­
comes obvious when this feedback is 
impaired by neurologic disease or 
eliminated by amputation.
Many patients with a good upper 
limb prosthesis are quite capable of 
operating it efficiently but prefer not 
to wear it simply because the effort of 
monitoring the terminal device visually 
is too tedious and distracting. The pa­
tient may develop a fair sense of where 
the prosthetic hand is in space from the 
stump sensation, but firmness of grasp 
is difficult to appreciate, even visually.
Professionals concerned with prosthe­
tics have long recognized the need to 
provide sensory feedback, but we have 
not found any record of successful 
fittings. The investigator most active in 
this field is Schmidl1,2 who has de­
veloped experimental feedback systems 
for strength of grip, position sense and 
for switching off rapid movements on 
contact.
A system for providing sensory feed­
back was developed at the Bio-Engi­
neering Institute of the University of 
New Brunswick. It provided, in a myo­
electric limb, for the delivery of a ting­
ling sensation to an area on the stump. 
The strength of this stimulus is propor­
tional to the force of the grasp.
Myoelectric Control with
Sensory Feedback
The sensory feedback system de­
veloped has been made compatible with 
the University of New Brunswick three- 
state myoelectric control system. This 
system allows an amputee to control 
opening and closing of an electrically 
driven terminal device by using the 
myoelectric output from a residual 
muscle in the stump. The myoelectric 
signal is sensed by three electrodes 
mounted in the stump socket and one 
muscle is used to control both opening 
and closing. Electrode paste is not re­
quired with this system.
The sensory feedback system is de­
signed to generate a stimulus signal in 
the form of short pulses of current 
which are delivered to the amputee 
through an additional electrode placed 
in the stump socket. The repetition rate 
or frequency of the pulses is made pro­
portional to the pinch force of the ter­
minal device. The pinch force is sensed 
by miniature strain gauges mounted on 
the forefinger of the device under the 
cosmetic glove. This pinch-force infor­
mation is processed by the system’s 
electronics and is used to control the 
frequency of the stimulator. Applica­
tion of current pulses through the 
stimulating electrode to the skin pro­
duces a tingling sensation which alters 
with changes in the frequency of the 
stimulus. The strength of sensation can 
be adjusted to a comfortable level when 
the system is fitted. This feedback sys­
tem works on a time-sharing basis with 
the myoelectric control unit and, by 
recognizing structural deflections in the 
hand skeleton, delivers a proportionate 
current to the ground reference elec­
trode in the socket.
The control and feedback electronics 
together with the rechargeable battery 
are placed in a single package small 
enough to be enclosed in the forearm of 
a below-elbow prosthesis. The battery 
is sufficient for a normal day’s use.
The engineering challenges met in 
the design of this system include minia­
turization of the electronics package, 
reduction of the battery power required 
to operate it to a minimum and elimin­
ation of interference between the feed­
back electronics and the control sys­
tem electronics. This last challenge was 
the most difficult because of the great 
difference between the extremely small 
myoelectric signals and the stimulating 
signals which were both present at the 
electrodes placed in the stump socket. 
Special switching and sampling tech­
niques were required to prevent the 
stimulating signals from being processed 
by the sensitive myoelectric amplifier. 
The following case report illustrates the 
application of the sensory feedback 
system.
Case Report
In 1967, a 9-year-old girl with a conge­
nital amputation below the left elbow
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attended the amputee clinic at the Ontario 
Crippled Children’s Centre in Toronto. 
Her ulnar stump was 8.9 cm long. She 
was fitted with a conventional prosthesis 
and a Dorrance hand operated by a cable 
harness.
In January 1973, she was supplied with 
a new myoelectrically controlled prosthe­
sis having a rigid polyester resin Munster- 
type socket and a three-state University of 
New Brunswick control system. Within a 
month, the patient became an excellent 
user of the prosthesis in spite of some 
initial problems.
In June 1974, a duplicate prosthesis was 
fitted, but with a feedback system added 
by the Bio-Engineering Institute at the 
University of New Brunswick (Figs. 1 and 
2). Initially, there was some interference 
in the feedback system caused by the 
inner glove pulling on the leads to the 
strain gauges. Stretching of the index 
finger of the inner glove seemed to over­
come this. The leads also were rerouted 
in the hand frame and fixed to it with 
epoxy. Proper calibration of the feedback
FIG. 1—Patient showing natural appear­
ance of prosthesis. Proximal part of pros­
thesis is normally covered by clothing.
system seemed a rather delicate procedure 
but, eventually, the patient could tell pre­
cisely how hard she was gripping.
By September 1974, the patient’s stump 
was covered with a severe rash. She had 
become allergic to the Beckman silver- 
chloride electrodes. The electrolytic en­
vironment created by the feedback current 
and the ever-present saline electrode paste 
tended to aggravate the situation. This 
problem persisted in spite of various med­
ical treatments and replacement of the 
silver electrodes with gold-plated ones. 
Various makes of electrocardiographic 
pastes were tried unsuccessfully. It seemed 
essential to let the skin irritation subside 
before any further attempt at fitting was 
made and, therefore, in June 1975, she 
was supplied with a passive cosmetic pros­
thesis with a socket made of silicone rub­
ber. By February 1976, the skin of her 
stump had healed well and she was fitted 
with a new myoelectric prosthesis with a 
three-state dry control system (without 
feedback). The socket comfort and sus­
pension, which was by a suction valve, 
were excellent and the patient obtained 
good control over this myoelectric hand.
In June 1976, a three-state dry control 
system with feedback was added to this 
satisfactory limb. Again, adjustments to 
the sensitivity of the feedback system had 
to be made over a period of about 2 days.
Since that time, the patient has used 
this hand with great satisfaction.
Discussion
Although the sensory feedback sys­
tem provides the patient with informa­
tion about the force of grasp only and 
does not match a normal hand’s ability 
to distinguish shapes, texture and tem­
perature, it provided our patient with 
a sense of competence and confidence 
she never had without it. Her enthu­
siasm for it more than justified the 
trouble taken to overcome the problem 
of skin sensitivity and her continued 
use of this prosthesis demonstrates that 
sensory feedback in an upper limb pros­
thesis is both practical and valuable.
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Colorectal Neoplasm: a Rare Complication of 
Ureterosigmoidostomy
Serge Dube, md,* J ean-Paul Perreault, md, frcs[c],* Andre Dumont, md|  
and Denis Bernard, md, frcs[c]*
A 24-year-old woman had a rectal 
neoplasm which occurred 20 years 
after she had undergone ureterosigmoi­
dostomy for exstrophy of the bladder. 
Only 41 cases of benign or malignant 
tumours of the large bowel developing 
after ureterosigmoidostomy have 
previously been reported in the literature 
Adenocarcinoma of the colon is most 
frequently found and can develop even 
after urine has been diverted away 
from the colon. The presenting 
symptoms are either those of ureteral 
obstruction or of colorectal neoplasm. 
This rare complication remains 
intriguing and the possible pathogenetic 
mechanisms are discussed.
Les auteurs rapportent un cas de 
neoplasie rectale survenu 20 ans apres 
uretero-sigmoi'dostomie pour extrophie 
vesicale. La revue de la litterature 
fait etat de 41 cas de tumeurs benignes 
ou malignes. La tumeur la plus frequente 
dans ces cas est I’adeno-carcinome 
du colon et elle peut se developper 
meme apres I'interruption de I'uretero- 
sigmoidostomie. Les manifestations 
cliniques peuvent etre celles de 
I’obstruction ureterale ou des tumeurs 
du colon. Cette complication, tout 
en etat rare, demeure problematique 
et les principaux facteurs 
pathogenetiques sont presentes.
Ureterosigmoidostomy as a procedure 
of urinary diversion is associated with 
several complications, namely hyper­
chloremic acidosis, hydronephrosis and 
renal damage from reflux and infec­
tion. Tumour originating at the site 
of ureterocolonic anastomosis is a rare, 
well-recognized but not well-under­
stood phenomenon. Benign and malig­
nant colorectal tumours have been 
reported previously.1'25 We report a case 
of rectal tumour occurring after ure­
terosigmoidostomy and review the lit-
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erature to emphasize that a tumour 
may appear even after urine no longer 
flows into the colon. We also discuss 
the possible pathogenesis of this phe­
nomenon.
Case Report
A 24-year-old white woman was ad­
mitted to hospital in February 1972, 
complaining of intermittent rectal bleed­
ing for the previous 2 years. She had 
also noted changes in her bowel habits. 
At the age of 4 years, she had undergone 
bilateral ureterosigmoidostomy for ex­
strophy of the bladder, which was sub­
sequently resected. At 11 years of age, 
because of deteriorating renal function 
secondary to infection and reflux, her 
ureterosigmoidostomy had been converted 
to an ileal conduit. Both ureters were 
transected at the ureterosigmoid junction 
and the sigmoid colon was closed. For 
the next 12 years she had no problems 
except for the rectal bleeding mentioned 
above.
Upon admission her hemoglobin value 
was 10.4 mg/dl; results of all other 
laboratory tests were normal. Sigmoido­
scopy revealed a sessile, ulcerated lesion
FIG. 1— Detail of polypoid growth 
measuring 1.5 cm in diameter. Inflam­
matory polyp is covered by hyperplastic 
colonic mucosa. Lamina propria and sub­
mucosa show edema and chronic inflam­
matory reaction. At base of lesion, seg­
ment of sectioned ureter is present (ar­
row). (hematoxylin and eosin, reduced by 
27% from X7.15).
(diameter 3 cm) situated 12 cm from the 
anal margin and a large polypoid lesion 
with a broad pedicle (diameter 1 cm) 
18 cm from the anal margin. Biopsy of 
the distal lesion suggested that it was a 
villous tumour. The patient underwent 
anterior resection of the rectum. Her post­
operative course was smooth.
Gross examination of the resected 
specimen showed two polypoid growths, 
measuring 1.5 and 3.5 cm, at the proximal 
end; 6 cm distal to these lesions there 
was a 3-cm ulcerated growth, which on 
macroscopic sectioning was seen to invade 
the muscularis of the rectum. Microscopic 
examination of the 1.5-cm polypoid le­
sion (Fig. 1) showed a non-neoplastic 
polyp covered by hyperplastic colonic 
mucosa; there was underlying edematous 
inflammatory tissue with round cell in­
filtration and numerous blood vessels 
around a fragment of sectioned ureter. 
The larger polypoid lesion (Fig. 2) was 
covered by hyperplastic mucosa; there 
were tubular adenomatous changes (ade­
nomatous polyp), basophilic cytoplasm, 
loss of mucous secretion, areas of pseu­
dostratification of the nuclei and numer­
ous mitoses consistent with intraepithelial 
malignant proliferation. The pedicle was 
not affected. The pedicle itself contained 
some fragments of sectioned ureter. The 
ulcerated lesion (Fig. 3), found 6 cm 
distal to the ureteral stumps, appeared 
to be a moderately differentiated adeno­
carcinoma invading the superficial layers 
of the muscularis propria of the rectum, 
a true Dukes A lesion.26
FIG. 2— Larger polypoid growth. Hy­
perplastic colonic mucosa (arrow 1) cov­
ers this broad-based polypoid lesion. 
Adenomatous changes are present with 
focal cellular atypia consistent with su­
perficial intramucosal malignant prolif­
eration (arrow 2). Fragment of sectioned 
ureter is present at base of polypoid 
growth (arrow 3) (hematoxylin and eosin, 
reduced by 43% from X3-8).
484 VOLUME 22, NO. 5, SEPTEMBER 1979 / THE CANADIAN JOURNAL OF SURGERY
This patient, now 31 years old, is alive 
and well 7 years after operation. At her 
regular follow-up examinations, the anas­
tomotic area has been pliable and sig- 
moidoscopic examinations have shown 
no evidence of tumour recurrence in the 
remaining rectum or sigmoid colon. As 
an interesting corollary, exactly 5 years 
after this patient’s operation we operated 
on her mother for a polypoid adenocar­
cinoma of the sigmoid colon, with a 
good result.
Review of the Literature
Hammer,1 in 1929, reported the first 
case of a neoplasm developing at the 
site of ureterosigmoidostomy 10 years 
after implantation, in a patient with 
exstrophy of the bladder. Forty more 
cases have since been reported in the 
literature.2"25 The sex distribution (Ta­
ble I) shows that males are predomi­
nantly affected. One of the reasons for 
this distribution is the greater fre­
quency of exstrophy of the bladder in 
boys. Of the 42 patients 26 (62%) 
required ureterosigmoidostomy diver­
sion for this condition. Other clinical 
conditions which have been treated by 
surgical diversion are shown in Table 
II. Of the 42 lesions 32 were malig­
nant. Of the malignant tumours, 20
FIG. 3—Ulcerated lesion that was sit­
uated 3 cm distal to ureteral stumps is 
moderately differentiated adenocarcinoma 
which invaded wall of rectum as far as 
superficial portion of muscularis propria 
(arrow) (hematoxylin and eosin, reduced 
by 43% from X9.28).
(62%) were adenocarcinomas of the 
colon, 5 were undifferentiated car­
cinomas, 4 mucinous adenocarcinomas 
and 3 were transitional cell carcino­
mas. The 10 benign lesions were al­
most all adenomatous polyps. The 
high frequency of adenocarcinoma in 
the colon of younger patients is sta­
tistically significant.25 Urdaneta and as­
sociates25 have calculated the frequency 
to be 500 times greater than expected 
in this age group. It is interesting that 
in 62% of the reported cases the pa­
tient was younger than 40 (Fig. 4) 
(mean 38 years), whereas only 7.5% 
of the colonic carcinomas in the gen­
eral population occur before the age 
of 40 years (mean 58 years).27 How­
ever, the frequency of malignant tu­
mours does not seem to be related to 
the period of time after the ureterosig­
moidostomy (Fig. 5).
Discussion
Among the etiologic t factors in­
volved in the formation of tumour at 
the site of ureterosigmoidostomy, two 
particularly have been implicated: the 
presence of urine in the colon and 
mechanical irritation of the ureteral 
stoma.
Possible carcinogens and irritants in 
the urine have been suggested as im­
portant factors. Although S’cott and 
Boyd28 in relatively long-term experi­
ments were unable to demonstrate that 
B-naphthylamine, well recognized as a 
carcinogen, caused malignant degenera­
tion in dogs with ureterosigmoidosto­
my, we could not rule out the role
Table I—Sex Distribution of Benign and 
Malignant Tumours of the Colon and Rectum 
Occurring after Ureterosigmoidostomy
Sex Benign Malignant Total (and % )
Male 8 21 29 (69)
Female 2 11 13 (31)
10 32 42 (100)
played by the urine as a carcinogenic 
factor even though our patient had 
undergone ileal conduit diversion 13 
years earlier. The study of Sommo 
and Traverso29 appears to provide some 
evidence to confirm the importance of 
urine in the histologic modification 
of the colonic mucosa. They studied 
histologic and histochemical changes 
in the bowel mucosa of patients from 
2 to 48 months after ureterosigmoi­
dostomy. They first noted a period 
of proliferation during which the 
glandular epithelium showed marked 
cellular hyperplasia and overproduc­
tion of mucus. This was followed by 
atrophic changes. Undifferentiated cel­
lular elements, which produced little 
mucus, formed solid cords replacing 
the normal glandular cells.
Some patients may lack repair en­
zymes or possess enzymes that con­
sistently lead to miscoding and per­
petuation of an error in DNA produc­
tion and its transcription. As Weis- 
burger30 stressed in discussing the role 
of the diet in colonic neoplasm, urine 
could also modulate the effects of car­
cinogens on the gut by its influence 
on the microflora. Activation of the 
microflora provokes the formation of 
split products that may be carci­
nogenic.
When there are mechanical factors 
causing chronic inflammation, there is 
a need for continuous repair of the 
mucosa which increases the risk of an 
abnormal healing process.
Although urine is diverted from the 
colon, once the cellular changes have 
been initiated their progression can-
FIG. 4— Age distribution of malignant 
ureterocolonic tumours compared to that 
of colonic cancers in general population 
(n =  number of patients).
FIG. 5—Distribution of malignant tu­
mours in relation to time elapsed after 
uterosigmoidostomy.
Table II—Distribution according to Primary Urologic Condition and Differentiation 
into Benign or Malignant Lesions
Primary conditions Benign Malignant Total (and % )
Bladder exstrophy1’2’4- 6'9-1012- 15’17-18'20.21’24'25* 6 20 26 (62%)
Transitional cell carcinoma3’10’11’19'25 2 5 7
Epispadias8 I 1 2
Nonbacterial cystitis10 
Interstitial cystitis25
1 0 1
0 1 1
Squamous cell carcinoma of bladder25 0 1 1
Persistent urinary fistula7'20 0 2 2
Congenital incontinence22 0 1 1
Trauma to bladder15 0 1 1
10 32 42
‘ Includes present study.
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not be limited. In the present case, 
we can witness the progressive res­
ponse of the mucosa to the different 
stresses. At the ureterosigmoidostomy 
junction we found two hyperplastic 
lesions, and in one there were both 
adenomatous and carcinomatous pro­
liferations. The third tumour, found 3 
cm distal to the ureteral stumps, was 
a well-differentiated adenocarcinoma.
There is another possible explana­
tion. In some cases there may be pre­
disposing factors; the mother of our 
patient also had an adenocarcinoma 
of the sigmoid colon. Thus the role 
of the urine, in this case, seems to 
have been an adjuvant in manifesting 
a pre-existing propensity for tumour 
formation.
A number of factors are most likely 
implicated in the pathogenesis of this 
condition and their interrelationships 
lead to a great deal of speculation.
Conclusion
Although ureterosigmoidostomy has 
been replaced to a large extent by 
other methods of urinary diversion, 
those patients who have had the pro­
cedure should be followed up very 
carefully. In the presence of rectal 
bleeding or deteriorating renal func­
tion, patients should be examined by 
intravenous pyelography, roentgenog­
raphy after a barium enema and sig­
moidoscopy. Moreover, if conversion 
to an ileal conduit is indicated, resec­
tion of the colonic segment into which 
the ureters had been implanted should 
be done to prevent tumour forming 
at the site of the ureteral stomas. It 
will be interesting to see if this com­
plication develops more frequently 
with the increasing use of a colonic 
conduit. The colonic mucosa is per­
haps more sensitive to malignant de­
generation than the ileum but with the 
colonic conduit, mechanical trauma 
and stagnation of urine are less 
marked. However, one must be aware 
that these tumours exist and that 
they should be sought when indicated.
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Critique of Item 606 (SESAP II)
In a young man a painless testicular mass which does not transilluminate 
is a neoplasm until proved otherwise. A hydrocele or spermatocele, 
and possibly a hernia, would transilluminate. Preliminary studies should 
include a roentgenogram of the chest, an intravenous pyelogram, and 
an assay for gonadotropins. The preferred response is orchiectomy 
through an inguinal incision. Needle aspiration of fluid or needle 
biopsy is contraindicated because a testicular tumor is usually well 
contained by the tunica albuginea, but once it is entered, the tumor 
spreads rapidly to the scrotum and to the lymph nodes in the groin. 
For the same reason, the incision should not be made through the 
scrotum. The mass as described is very unlikely to be an epididymitis, 
and administration of antibiotics, and observation for two to four 
feeks, are therefore not justified.
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Intraoperative Transmural Myocardial Biopsy:
a Simple Technique
T.A . Salerno, md , frcs[c],* D.P. L in c e , m d , frcs[c],*
S.M. WASAN, MD, M SC, FCAP, FRCP[C]t and E.J.P. C harrette , m d , frcs[c]*
A Tru-cut disposable biopsy needle was 
used in 10 pigs, 3 cadavers and 
63 humans to obtain transmural 
ventricular myocardium for diagnostic 
and research purposes. The technique 
proved simple and safe. In every case 
an adequate amount of full-thickness 
myocardium was obtained which was 
examined by light and electron 
microscopy and used for enzyme studies 
and glycogen measurement.
line aiguille a biopsie jetable 
Tru-cut a ete utilisee chez 10 pores,
3 cadavres et 63 humains pour 
obtenir un prelevement du myocarde 
a travers la paroi du ventricule pour 
fins de diagnostic et de recherche.
La technique s’est averee simple et 
sure. Dans tous les cas, une 
quantite suffisante du myocarde entier 
a ete obtenue et ensuite a ete 
examinee aux microscopes optique 
et electronique et utilisee pour des 
etudes enzymatiques et des mesures 
du glycogene.
Although endomyocardial biopsy can 
be performed by the percutaneous 
route,1-3 transmural myocardial samples 
are more difficult to obtain. Search 
for a simple method led us to use a 
disposable needle which gave uniform­
ly successful results.
Material and Methods
Ten Poland-China pigs were anes­
thetized. The heart was exposed and 
separate biopsy specimens were ob­
tained from left ventricular myocar­
dium using a Tru-cut biopsy needle 
(Travenol Laboratories, Inc., Deerfield, 
IL) (Figs. 1 and 2). The full-thickness 
specimens (0.1 X 1.7 cm) weighing 8 
mg each (Fig. 3) were examined by 
light and electron microscopy, and were
From the departments o f *surgery and t pathology, Queen’s University, Kingston, Ont.
Supported by Ontario Heart Foundation grant 2-4
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used for glycogen measurement and en­
zyme studies.
The need for transmural myocardial 
biopsy specimens for clinical investiga­
tion and diagnostic purposes prompted 
us to try the same needle in three 
cadaver hearts. The technique was 
equally successful. This was followed 
by use of the needle in a series of 63 
patients of whom 55 had elective coro­
nary artery bypass surgery, 5 had valve 
replacement, 2 underwent elective 
closed mitral commissurotomy and 1 
had emergency pericardiectomy. Two 
separate biopsies were done at the 
apex of the left ventricle, at the start 
of cardiopulmonary bypass and again 
following completion of the proximal 
anastomoses just before unclamping 
of the aorta. The puncture site pro­
duced by the needle was closed with 
a simple superficial figure-of-eight su­
ture of 4-0 Prolene (Ethicon Sutures 
Ltd., Peterborough, Ont.).
In the patients who underwent valve 
replacement, the left ventricular biopsy 
was done at the site where the vent is 
usually inserted.
There were no complications asso­
ciated with the biopsy procedure. An 
adequate amount of tissue was ob­
tained in every patient and was used
FIG. 1—Disposable biopsy needle. In­sert shows cutting edge.
FIG. 2—Biopsy needle being positioned before transmural myocardial biopsy.
for clinical research in 60 patients and 
for diagnostic purposes in 3 patients.
Discussion
Endomyocardial biopsy specimens 
can be easily obtained by the percu­
taneous route. The sample, how­
ever, may not be representative of 
the ongoing processes in the other 
layers of the heart. Other techniques 
including the use of the Silverman 
needle,4 the Menghini needle5 and the 
Dobell biopsy gun (Dobell ARC: un­
published data, 1971) have been used 
to obtain a specimen that includes all 
layers of myocardium. The method we 
describe is easy and reproducible. No 
complications have occurred. In every 
case adequate full-thickness tissue 
cores were obtained. Specimens of this 
sort may be of great value in elucidat­
ing the nature of ongoing processes in 
the different layers of the heart. We 
think we have solved a major problem 
for the cardiac surgeon involved in 
clinical research, namely, that of ob­
taining a full-thickness biopsy of the 
myocardium.
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FIG. 3— Core of myocardium obtained with Tru-cut biopsy needle.
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This well-prepared monograph presents 
the proceedings of a conference devoted 
to the diagnostic aspects of pancreatic 
disease. The majority of the papers are 
written in German, but some are in 
English. Various diagnostic tests and pro­
cedures introduced recently are reviewed 
competently by different experts reporting 
their own experiences. Tests for enzymes 
and fetal antigen, ultrasonography, biopsy, 
angiography and cannulation of the pan­
creatic duct through a fiberoptic endo­
scope are some of the diagnostic aids de­
scribed and discussed. With the use of 
these new procedures pancreatic disease 
can be diagnosed accurately.
This text is an excellent, concise state 
of the art review which can be recom­
mended to all interested in pancreatic 
disease.
W. ZlNGG, MD, M SC, FRCSfc]
Division of surgical research,
The Hospital for Sick Children,
Toronto, Ont.
GENERAL SURGICAL OPERATIONS. 
Edited by R.M. Kirk. 412 pp. IHust. 
Churchill Livingstone, Edinburgh; Long­
man Canada Limited, Don Mills, Ont. 
1978. Price not stated. ISBN 0-443- 
01597-X.
This book is essentially a technique text 
but has a unique style. The format of 
each chapter is identical. The author pro­
vides all data under the headings of pre­
operative care, operative techniques, oper­
ative considerations, problems, safeguards 
and access. Most major procedures are 
covered in one to two pages, yet the in­
formation is complete and readable. There 
are only two or three references for each 
section but all are important and provide 
good direction for further reading.
The first 12 of the 27 chapters are de­
voted to abdominal surgery and 9 of these 
are by Kirk himself so that there is good 
continuity. The chapter on anorectal dis­
eases is written by Lord who is a well- 
recognized expert in that field. While there 
were many technical points with which I 
would raise mild objections, only in Lord’s 
chapter did I find two worth pointing out. 
On page 148, there is considerable con­
fusion as to whether the patient is actually 
in the Sims or the lithotomy position. 
The statement that “patients remain in 
hospital for six to ten days after hemor­
rhoidectomy” would certainly raise some 
eyebrows. Also, Lord states that anal
dilatation should be undertaken with 
“caution in the elderly”. This point is not 
emphasized enough since the text indi­
cates that anal dilatation is quite accepta­
ble and the author does not define what 
is meant by “with caution”. The frequen­
cy of incontinence is unacceptably high 
when rectal dilatation is performed in 
patients over 55 years of age.
Chapters 13 to 27 cover every other 
sphere of surgery and, with one exception, 
each chapter has been written by a sepa­
rate author. Included in this block are 
three chapters specifically related to gen­
eral surgery dealing with the breast, en­
docrine system and the head and neck 
respectively. I found the chapter on the 
endocrine system quite brief (three pages). 
Also, in view of the increasing incidence 
of hyperparathyroidism, I thought that a 
half page dealing with this topic and pro­
viding no illustration was inadequate cov­
erage. On the other hand, there are am­
ple articles in the literature dealing with 
this sphere of endocrine surgery.
Orthopedic surgery is rather heavily 
weighted receiving in this text three chap­
ters for a total of 75 pages. Peripheral 
vascular surgery, on the other hand, is 
dealt with in 16 pages; although this 
chapter is brief it is quite well done. 
Similarly, cardiothoracic surgery received 
only 20 pages. Perhaps, the editor could 
justifiably argue that he wished to provide 
only the bare essentials in these two areas 
since the book is oriented towards the 
general surgeon who might possibly have 
to deal with all situations. However, the 
intricate procedures described in the three 
orthopedic chapters indicate that editing 
was poor in these areas. My impression 
was that the chapters on peripheral vas­
cular, cardiothoracic and orthopedic sur­
gery were solicited and then simply in­
serted into the text as received. This is, 
of course, a common problem with mul­
tiple-authored texts. To give Kirk the 
benefit of the doubt, it is possible that 
general surgeons perform more ortho­
pedic surgery than peripheral vascular 
or cardiothoracic surgery in Great Britain. 
Also, the format of these chapters is iden­
tical to that used in the other chapters 
suggesting that some editing was carried 
out.
In summary, this textbook of surgical 
techniques is brief but very complete and 
to the point. Every aspect of surgery 
from ingrown toenails to foreign bodies 
in the eye is covered in cookbook style. 
This renders the text excellent for rapid 
preoperative review of the subject ma­
terial. I particularly like the appropriate 
check lists provided with most of the 
procedures. This text does not replace 
the standard surgical technique books 
such as those of Cooper or Maingot 
but it apparently was not intended to 
compete with them. For the intern, 
the first- or second-year surgical resi­
dent, “General Surgical Operations” is 
an excellent and highly recommended 
book. It might be useful to the surgeon 
located in a small community who must 
perform many types of surgery. Ad­
vanced surgical residents or completely 
trained surgeons would find this text
beneficial only for teaching more junior 
colleagues.
J oel B. F reem a n , m d , c m , frcs[c]
Chief, department of surgery,
Ottawa General Hospital,
Ottawa, Ont.
GENITOURINARY PROBLEMS IN
WOMEN. Jack R. Robertson. 149 pp.
IHust. Charles C Thomas, Publisher,
Springfield, IL, 1978. $16.75. ISBN
0-398-03668-3.
This book consists of an introduction and 
chapters on the history of gynecologic 
urology, anatomy and physiology, meth­
ods of evaluating urinary incontinence, 
the Robertson method, the neglected 
female urethra, vesicovaginal fistula, blad­
der drainage, urinary tract infections, the 
dysfunctional bladder and urethra, and 
pelvic surgery with endoscopic control. It 
is devoted chiefly to the evaluation and 
treatment of urinary incontinence in 
women, the female urethra and vesico­
vaginal fistula. The author presents his 
views on the etiology, pathogenesis and 
treatment of these conditions, often in 
great detail.
The most interesting features of the 
book are the sections devoted to the in­
vestigation and management of urinary 
incontinence in the female. However, it 
is difficult to recognize that stress incon­
tinence is seen within the larger frame­
work of functional and etiologic classifi­
cations of urinary incontinence.
Most urologists believe that the classic 
paper by Marshall, Marchetti and Krantz 
(The correction of stress incontinence by 
simple vesicourethral suspension. Surg 
Gynecol Obstet 88: 509, 1949) remains 
the standard by which other methods for 
investigating and treating stress incon­
tinence are judged. They put forward the 
exceedingly simple etiologic concept 
which formed the basis of treatment. As 
different methods of investigation have 
appeared since 1949, each has developed 
with its own jargon. The result is that 
many different terms are now used to ex­
plain the basic concept of Marshall, Mar­
chetti and Krantz, but these terms are 
related to the different methods of inves­
tigation and not to the underlying pathol­
ogy, thus causing much unnecessary con­
fusion. This book is one example of many.
There are numerous examples in this 
book of its parochial approach. There is 
no mention of Victor Bonney’s paper of 
1923 in the history chapter, a surprising 
omission. No mention is made of attempts 
at surgical treatment of stress incon­
tinence before that of Kelly in 1893. In 
the foreword, it is stated, “urologists 
have concentrated their efforts on the 
male, and most of them know very little 
about the female urethra and bladder”. 
The lack of knowledge of urologic in­
terest in these conditions in the past 30 
years is again surprising. There seems to 
be little recognition that many of these 
problems are now managed by multi­
disciplinary treatment teams. The methods 
presented are undoubtedly successful in
4
t
*
4
F
r
4
4
488 VOLUME 22, NO. 5, SEPTEMBER 1979 / THE CANADIAN JOURNAL OF SURGERY
the hands of the author and are interest­
ing in this context.
W .E . C o l l in s , m d , fr c s [c ], fac s
Ste. 207,
1105 Carling Ave.,
Ottawa, Ont.
A MANUAL OF THORACIC SUR­
GERY. Arndt von Hippel. 247 pp.
Illust. Charles C Thomas, Publisher,
Springfield, IL, 1978. $13.75, cloth-
bound; $8.75, paperbound. ISBN 0-398-
03689-6, clothbound; ISBN 0-398-03690-
X, paperbound.
This book is an expanded version of a 
previous publication, “Chest Tubes and 
Chest Bottles”, by the same author. The 
format is the same, chapters being divided 
into short sections for easy reading. The 
book is written in a flowing narrative 
style and points are illustrated using sim­
ple diagrams and anecdotal “case re­
ports”.
“Chest Tubes and Chest Bottles” has 
been enlarged by adding new chapters on 
the diaphragm, the lung, the blood pump 
(my italics), and pleural effusions; previ­
ous topics have been discussed more fully 
with extra emphasis on diagnosis and 
methods of treatment of thoracic surgical 
disorders. No attempt has been made to 
cover the technical aspects of surgery, 
although detailed methodology for pleural 
aspiration and insertion of chest tubes is 
given. The technique of closed needle 
biopsy of the pleura is not mentioned.
This expanded text attempts to deal 
with thoracic physiology and surgery as 
they relate to closed chest drainage. How­
ever, to describe the diaphragm as a 
muscle sandwich, the respiratory system 
as the air pump, or the heart as the blood 
pump seems rather simplistic. Physiologic 
misconceptions in the text may be the 
result of this oversimplification, detract- 
isg from the book’s quality as do some 
errors of omission.
The chapters on chest tubes and bottles, 
almost unchanged from the previous pub­
lication, are very good. Included are 
indications for insertion of tubes, de­
tailed technique for introduction and an 
excellent diagram illustrating an easy way 
to secure the tube—always, I think, one 
of the most difficult parts of the proce­
dure. There is also a useful section on 
“trouble shooting” problems that may oc­
cur while the chest tube is in place.
The book is aimed at “less experienced, 
or more highly specialized thoracic sur­
geons”. Although the author relates his 
personal experience rather than giving 
a didactic review of the literature, I think 
most thoracic surgeons will find it over­
simplified. It would, however, make ex­
cellent reading for practitioners who only 
occasionally deal with chest tubes and bot­
tles, and for all nurses who care for 
patients who have undergone thoracic 
surgery.
D. St u b b in g , m b , b s  
Ambrose cardiorespiratory unit, 
Department of medicine,
McMaster University,
Hamilton, Ont.
PLASTIC AND RECONSTRUCTIVE 
SURGERY OF THE FACE AND 
NECK. Proceedings of the Second In­
ternational Symposium. Volume 1: 
Aesthetic Surgery. Edited by George A. 
Sisson and M. Eugene Tardy, Jr. 236 
pp. Illust. Grune & Stratton, Inc., New 
York; Longman Canada Limited, Don 
Mills, Ont., 1977. $45.65. ISBN 0-8089- 
0941-X.
PLASTIC AND RECONSTRUCTIVE 
SURGERY OF THE FACE AND 
NECK. Proceedings of the Second In­
ternational Symposium. Volume 2: Re­
habilitative Surgery. Edited by George 
A. Sisson and M. Eugene Tardy, Jr. 
348 pp. Illust. Grune & Stratton, Inc., 
New York; Longman Canada Limited, 
Don Mills, Ont., 1977. $59.40, ISBN 
0-8089-0956-8.
In 1975 the American Academy of Facial 
Plastic and Reconstructive Surgery hosted 
the second international symposium on 
the subject for which this Academy was 
named. Inevitably these two volumes are a 
summary of the proceedings, containing 
some papers in full and others greatly 
shortened. The panel discussions have also 
been included. The books are thus neither 
detailed enough to explain the latest tech­
niques nor broad enough to be used as 
general reference works.
The illustrations are the greatest draw­
back to these two books. Preoperative 
and postoperative pictures have been taken 
from different angles, different distances 
and under different lighting, so that a 
true comparison is impossible. Indeed the 
majority of comparative pictures are use­
less.
Half the first volume on aesthetic sur­
gery is devoted to rhinoplasty. An experi­
enced rhinoplastic surgeon may gain a 
few tips but no basic techniques are dis­
cussed. A very short section is devoted 
to rhytidectomy and most postoperative 
photographs were taken at such a short 
interval after operation that they are of 
no use. The segment on the orbit dis­
cusses blepharoplasty and devotes a sub­
stantial chapter to supraorbital ridge re­
duction. Again it is difficult to tell the 
difference between preoperative and 
postoperative appearances. Otoplasty is 
limited to three pages on one technique.
The second volume on rehabilitative 
surgery covers many subjects from the 
head and cancer to laryngeal prominence 
reduction for trans-sexual patients. As in 
the first volume the photographs are poor 
and distorted. Often they show change 
but no improvement for the patient. Many 
chapters consist of case reports only. In­
deed one chapter is a case report of one 
patient and an old technique for recon­
struction of the temporomandibular joint. 
A new superior pharyngeal flap technique 
(which is not new) is described based on 
five patients! Many of the best and most 
modern techniques such as in microtia 
correction, traumatic ear reconstruction 
or electrical burns of the mouth seem to
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The recovery of patients in shock is often complicated by a pattern of deteriorating pul­
monary function, commonly described as shock lung. This pulmonary insufficiency 
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be omitted and possibly are unknown to 
the authors.
In summary there is little value in 
these two volumes apart from historical 
interest for those who attended this sym­
posium.
I an R. Mu n r o , m b , b chir , frcs[c] 
Division of plastic surgery,
The Hospital for Sick Children,
Toronto, Ont.
T H E  SECOND INTERNATIONAL 
SYMPOSIUM ON MALIGNANT HY- 
PERTHEMIA. Proceedings of a Sym­
posium Held in Denver, Colorado, April 
1-3, 1977. Edited by J. Antonio Aldrete 
and Beverley A. Britt. 560 pp. Illust. 
Grime & Stratton, Inc., New York, 
1978. $25.50. ISBN 0-8089-1073-6.
Malignant hypermia has become recog­
nized as one of the principal causes 
of death in patients who are anesthetized 
for surgical procedures. The syndrome is 
rare with prevalence ranging from, 1 in 
14 000 to 1 in 110 000 but is inherited 
as an autosomal dominant characteristic. 
Therefore, every surgeon and anesthetist 
should be acquainted with the recent ad­
vances in etiology, detection, prevention 
and management of this condition.
The first international symposium was 
held in Toronto in May 1971. Since then, 
much new knowledge has accumulated on 
the subject. We can be proud that some 
of the most fruitful research in this field 
has been performed in Canada.
This text is divided into sections on 
muscle physiology and biochemistry, diag­
nostic and predictive tests, clinical ob­
servations, studies in pigs exhibiting the 
porcine stress syndrome (a condition sim­
ilar to malignant hyperthermia in hu­
mans) and the current treatment of this 
affliction.
The main site of the disease is in 
skeletal muscle where the regulation of 
calcium ion distribution is abnormal. 
Muscle samples from susceptible individu­
als show increased contraction in response 
to a wide variety of stimuli including 
anesthetic agents and various forms of 
stress. The exposure of malignant hyper­
thermic muscle to halothane, succinyl- 
choline and some other anesthetic agents 
in vivo leads to a sudden release of cal­
cium ions into the myoplasm which pro­
duces all of the clinical features of the 
syndrome. Recent studies suggest that the 
“membrane disorder” responsible for the 
disease may be present elsewhere in the 
human body including cardiac muscle.
All individuals susceptible to malignant 
hyperthermia have an underlying muscle 
disease and two predisposing myopathies 
have been defined; the commoner myo­
pathy affects young boys whose physical 
abnormalities include short stature, cryp­
torchidism, pectus carinatum, antimon- 
goloid slant of the palpebral fissures, 
ptosis, webbed neck, low set ears, kyphosis, 
lordosis and weakness of the serrati mus­
cles. Malignant hyperthermia is also 
known to be associated with osteogenesis 
imperfecta.
Clinically, the syndrome develops dur­
ing the administration of anesthesia 
usually in response to such potent agents 
as halothane or succinylcholine. However, 
many different types of drugs have been 
shown to precipitate the condition. Even 
the use of regional anesthesia does not 
always ensure protection. The usual symp­
toms are tachypnea, tachycardia, hyper­
tension, cardiac arrhythmias, hypotension 
and a rapid increase in body tempera­
ture of approximately 2°C/h; muscle 
rigidity may or may not be present. Labo­
ratory studies show severe metabolic and 
respiratory acidosis, hyperkalemia, hyper­
glycemia and hypercalcemia followed by 
hypocalemia, myoglobinurea and a 
marked increase in the metabolic rate 
and in oxygen consumption. The patient 
may become comatose, convulse, experi­
ence cardiac arrhythmias or sudden car­
diac arrest. The condition may be further 
complicated by disseminated intravascular 
coagulation, renal failure or sepsis.
Proper management depends on the 
detection of susceptible persons so that 
steps can be taken to prevent the use 
of agents which may trigger the syn­
drome. Immediate appropriate therapy at 
the first signs of the syndrome will often 
abort an attack and thus reduce mortal­
ity.
This text reviews and evaluates vari­
ous tests that have been used to screen 
individuals for the condition when a 
family history of death during or fol­
lowing anesthesia alerts the anesthetist or 
surgeon to the possibility that other fam­
ily members may be afflicted. Creatinine 
phosphokinase values will generally be 
higher in susceptible persons. However, 
false-positive and false-negative results can 
occur.
Once suspected, muscle biopsy will 
generally confirm the diagnosis. A posi­
tive result from the caffeine or halothane 
contracture test indicates susceptibility to 
the syndrome. After additional trial studies 
have been completed measurement of 
serum inorganic pyrophosphate concen­
trations may be valuable.
Anesthesia can be administered to sus­
ceptible patients providing that agents 
known to trigger the condition are 
avoided. Once the clinical signs have been 
recognized during anesthesia, the use of 
the responsible agents should be discon­
tinued immediately and cooling proce­
dures instituted. The lactic acidosis, elec­
trolyte imbalance, disseminated intravas­
cular coagulation and anuria should be 
treated vigorously.
The main message delivered by this 
excellent collection of papers is that by 
the utilization of current knowledge this 
rare syndrome can be detected and effec­
tively treated or prevented with a con­
sequent reduction in perioperative mortal­
ity.
A new drug, dantrolene sodium, which 
lowers the myoplasmic calcium concen­
tration, promises to be a most effective 
agent in treating malignant hyperthermia.
492 VOLUME 22, NO. 5, SEPTEMBER 1979 / THE CANADIAN JOURNAL OF SURGERY
The impressive papers, featuring graph­
ic illustrations on the anatomy, biochem­
istry and pathophysiology of skeletal 
muscle deserve special commendation and 
should be of interest to those concerned 
with muscle related diseases.
This book is recommended to all physi­
cians as a source of information on the 
complex subject of malignant hyper­
thermia. However, this book is not easy 
to read. Assimilation of the information 
requires time and concentration.
John H. F eindel, md, cm , frcp[c]
Head,
Department of anesthesia,
Halifax Infirmary,
Halifax, NS
SHAW’S TEXTBOOK OF OPERATIVE 
GYNECOLOGY. 4th ed. Revised by 
John Hawkins and Christopher N. 
Hudson. 547 pp. Illust. Churchill Living­
stone, Edinburgh; Longman Canada 
Limited, Don Mills, Ont., 1977. $98. 
ISBN 0-443-01394-2.
Henry Gage, writing in “The Science of 
Political Economy” in 1898, said: “The 
value of a thing is the amount of labour­
ing or work that its possession will save 
the possessor.” Using this criterion, Shaw’s 
book is not a good purchase for the prac­
tising gynecologist. However, it can be 
recommended for medical libraries cater­
ing to students and prospective specialists.
To dispense with its main liability: 
the publisher’s brochure states that in 
recent years there has been greater em­
phasis on the medical and endocrinologic 
aspects of modern gynecology, yet gyne­
cologists still require the traditional skills 
of surgery. I agree with that statement, 
but neither this book nor any other I’ve 
seen will ensure this heritage. Why do 
authors and publishers of surgical texts 
continue to fantasize on this point? No 
one can ever learn surgical technique 
from a book. The techniques the surgeon 
uses are those taught during the residency 
period.
The artist’s drawings in this book are 
typical of those seen in surgical texts. 
They are grossly inadequate. One would 
need the genius of Michelangelo, the in­
novative spirit of Leonardo da Vinci and 
a touch of Picasso to illustrate the flow­
ing dynamics of a surgical operation. 
Authors of surgical texts should stop de­
ceiving themselves that it can be done.
This book does have some merits. Stu­
dents and residents will benefit from the 
chapters on anatomy, preoperative prepa­
ration and postoperative complications. 
There are also sound discussions on the 
basic gynecologic diseases. Moreover, 
since this is an operative textbook, it 
provides the nonspecialist reader with a 
general idea of the surgical approach to 
these problems.
There is an adequate section on laparo­
scopy. I heartily concur with the author 
that one eye in the pelvis is often better 
than two fingers in the vagina. But I 
disagree on one technical point. The au­
thor advises surgeons to make an incision 
at the inferior margin of the umbilicus. 
This is a potentially hazardous location.
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The umbilicus is not the entrance to 
the pelvis. The aorta lies directly beneath 
it and several reports in the medical liter­
ature discuss injuries to this vessel result­
ing from laparoscopy. More injuries will 
occur in future if surgeons continue to 
use this site. Why not use the true en­
trance to the pelvis? This is three fingers’ 
width below the umbilicus. And the short 
transverse incision in this location can 
hardly be seen a few weeks later.
I found a glaring example of British 
conservatism in the chapter dealing with 
hysterectomy for benign conditions, in 
which the author suggests the preserva­
tion of healthy ovaries for any woman 
under 50 years of age. I cannot see much 
sense in this approach in Canada. Most 
ovaries have lost their usefulness several 
years before this age. I can understand 
why this advice is offered in England— 
estrogen therapy for menopause is not as 
well accepted in Britain as it is in North 
America. There must be tens of thousands 
of women needlessly suffering from senile 
vaginitis in that country. But such advice 
for Canadian readers is questionable.
To end on a positive note, practising 
gynecologists have a good track record 
in avoiding bladder, ureter and bowel in­
juries, but should they experience trouble 
in this area, the chapters in this text deal­
ing with these problems give good advice. 
Similarly the sections on diagnostic radio­
logy and chemotherapy also help to re­
fresh the memory.
Texts such as this obviously have some 
merit, but whether the book is worth
$98 to the practising gynecologist is de­
batable.
K.F. Walker, md, frcs[c]
6150 Valley Way,
Niagara Falls, Ont.
TRAUMA OF THE CHEST. The Coven­
try Conference 1977. Edited by W.G. 
Williams and R.E. Smith. 266 pp. Illust. 
John Wright & Sons Ltd., Bristol; Year 
Book Medical Publishers, Inc., Chicago, 
1977. $22.10, paperbound. ISBN 0-7236- 
0484-3.
At a time when the frequency of chest 
trauma associated with motor vehicle 
accidents is diminishing, due to the use 
of seat belts and lower speed limits, there 
has been a resurgence of interest in the 
topic, as evidenced by new books deal­
ing exclusively with chest trauma.
The fourth Coventry Conference was 
devoted to trauma of the chest, and this 
book is the proceedings of that confer­
ence.
The three previous conferences covered 
surgery of the esophagus, of the lung and 
of the heart. At the fourth conference au­
thorities from Europe, Great Britain, and 
United States and Canada discussed in 
detail their experiences with various as­
pects of chest trauma. The book is not in­
tended to be a reference nor a review of 
all facets of thoracic injuries, but com­
prises papers and discussions of se­
lected topics. The topics include flail 
chest, injuries to the aorta and great ves­
sels, rupture of the bronchus, post-trau­
matic pulmonary insufficiency, penetrat-
The Newfoundland Cancer Treatment and 
Research Foundation 
and
Faculty of Medicine,
Memorial University of Newfoundland
MEDICAL DIRECTOR 
SENIOR FACULTY MEMBER
Specialists in the area of Oncology are invited to apply 
for joint appointment as Medical Director of the New­
foundland Cancer Treatment and Research Foundation 
and a Senior Faculty Member in the Faculty of Medi­
cine, Memorial University of Newfoundland.
The appointee will be responsible for directing provin­
cial cancer treatment and control programs to be 
carried out by the Foundation, major hospitals, and the 
Faculty of Medicine. This program will serve a popula­
tion of approximately 550,000 people and will be based 
at the Health Sciences Centre which houses both a 
newly-equipped radiotherapy facility within the General 
Hospital, and the Faculty of Medicine. Other hospitals 
in St. John's and regional hospitals throughout the 
province will play an active role in the operation of 
the program. The Director w ill have a medical staff 
appointment to the appropriate hospital or hospitals. 
As a senior Faculty Member the apointee will make 
a major contribution to the development of teaching 
programs at the undergraduate, postgraduate, and con­
tinuing medical education levels. He w ill be expected 
to foster the further development of research in the 
area of oncology.
Enquiries should be directed to the Chairman 
of the Search Committee:
Dr. K. B. Roberts
Room 5360, Health Science Centre 
St. John's, Newfoundland 
Canada A1B 3V6
THE CANADIAN JOURNAL OF SURGERY 493
ADVERTISERS' INDEX
American College of Surgeons
Sesap III 446
Ayerst Laboratories
Pyopen 467, 469, 471, 473 , 489
Boehringer Ingelheim (Canada) Ltd.
Persantine 429, 430 
Trasylo l 482, 483
Bristol M yers (Canada) Ltd.
Stadol 400, 401
Canadian Association of 
General Surgeons
443
Davis & Geek
Dexon-S Outside Back Cover
S urgilene  402
Ethicon Sutures Ltd.
Proximate Inside Front Cover 
V icry l Inside Back Cover
Hoffmann-La Roche Ltd.
Nlpride 462 , 463
Merck Sharp & Dohme Canada Ltd.
Flexeril 406, 407, 408
Poulenc Ltd.
Stem etil 454 , 455
Robins Canada Ltd., A.H.
A llb ee  C/550 398
Ross Laboratories
Ensure 442, 443
Smith Kline & French Canada Ltd.
Tagam et 458, 459
Upjohn Company of Canada, The
Dalacin C  444, 445 
Gelfoam  478, 479 
S o lu -M ed rol 490, 491, 492
Winthrop Laboratories
M arcaine 416, 417
ing chest wounds and physical and chem­
ical injuries to the lung.
Particularly interesting are the diver­
gent views on the management of flail 
chest, with renewed interest being shown 
in open reduction and fixation as exem­
plified in a well-documented paper by 
Dr. F. Paris from Valencia, Spain. Trin- 
kle’s remarks on the pathophysiology of 
flail chest are cogent and reflect the 
experimental and clinical work he has 
carried out in San Antonio emphasizing 
the underlying pulmonary pathology 
rather than the unstable chest wall.
Also included is an extremely com­
plete, somewhat tedious, review of trau­
matic diaphragmatic hernias. This review 
contains a well-researched bibliography.
The section on penetrating wounds of 
the chest, discussed by Platt from Dallas 
and Trinkle, reflects their extensive ex­
perience with this type of injury in
Texas. While their methods of approach, 
particularly in the management of cardiac 
injuries, differ slightly, their views are
valuable to anyone who may be required 
to manage such injuries.
It is hoped that the excellent papers 
on post-traumatic pulmonary insuffici­
ency will finally lay to rest the slick, 
but inappropriate, term “shock lung”. The 
relative roles of excessive crystalloid
fluid replacement and sepsis in the de­
velopment of this condition are thorough­
ly detailed.
The print used and the layout of this 
soft cover book do not make for particu­
larly easy reading, but there is a wealth 
of information to be gleaned from some 
of the papers, and, as such, the book 
should be of interest to anyone dealing 
with chest trauma.
H J. Sachs, m d , frcs[c]
Division of cardiothoracic surgery, 
Ottawa Civic Hospital,
Ottawa, Ont.
URINARY SYSTEM MALFORMA­
TIONS IN CHILDREN. Proceedings of 
the International Pediatric Urological 
Seminar, Philadelphia, 1976. The Na­
tional Foundation— March of Dimes. 
Birth Defects: Original Articles Series, 
Volume XIII, Number 5, 1977. Edited 
by Daniel Bergsma and John W. 
Duckett. 481 pp. IUust. Alan R. Liss, 
Inc., New York, 1977. $50. ISBN 
0-8451-1014-4.
This book is a compilation of papers and 
comments, most of which were presented 
at a seminar on malformations of the 
urinary system in children. Many of the 
book’s contributors are well known for 
their work on congenital anomalies and 
surgery of the urinary tract.
The book is divided into nine logical 
sections, ranging from megaureters to 
urethral valves, prune-belly syndrome, 
neuropathic bladder, exstrophy, hypospa­
dias, reflux and cryptorchidism. It offers 
a clear, concise summary in many cases 
of the authors’ views on these subjects. 
At the end of each section is a discussion 
by some of the eminent contributors to 
the field.
The physical appearance of the text
does not compare with the glossy, slick 
texts recently published on pediatric 
surgery or reconstructive surgery of the 
urinary tract. However, on close reading, 
the roentgenograms are well reproduced 
and the charts and tables are accurate 
and well presented. The index, although 
accurate, is only six pages long and could 
be expanded.
As with the publication of any pro­
ceedings, the text bespeaks a familiarity 
with the topics presented. A surgeon with 
limited experience in urinary malforma­
tions in children and their management 
might be confused by some of the arti­
cles. However, for any surgeon familiar 
with these malformations, this publication 
will be of immense interest and use. .It 
should be present in the hospital library 
of any institution where pediatric surgery 
is performed.
J.F . SCHILLINGER, MD, FRCS[C]
Chief, division of urology,
Children’s Hospital of Eastern Ontario, 
Ottawa, Ont.
THE YEAR BOOK OF ORTHOPEDICS 
AND TRAUMATIC SURGERY. 1977. 
Edited by Mark B. Coventry. 429 pp. 
lllust. Year Book Medical Publishers, 
Inc., Chicago, 1977. $25.25. ISBN
0-8151-1876-7.
This year book follows the routine format 
of previous editions, updated to reflect 
the current interests in orthopedic and 
traumatic surgery. One is always im­
pressed by the progressive improvement 
in quality of the abstract selections in 
succeeding years, a particularly difficult 
assignment for the editor.
The major attractions of the year book 
series are the reader’s enjoyment in the 
rapid scanning of a choice selection of 
abstracts from a multitude of journals 
and the inherent satisfaction of having 
a glimpse at the world-wide orthopedic 
scene in “Reader’s Digest” form. Such 
abstracts are easily perused, demand 
minimal concentration and readily arouse 
the curiosity of the practising physician, 
the academician or the trainee. As an­
ticipated, specific interest in a certain 
title invariably prompts the reader to 
search out the full article from the given 
reference.
The editorial comments on each article 
are especially worth while, the remarks 
of Coventry, the editor, being particularly 
relevant and appropriately critical.
The changing emphasis in orthopedic 
surgery is again reflected in this edition. 
More space is now devoted to orthopedic 
research, the popular trend of the 1970s. 
Less space is allocated to such subjects as 
prosthetics.
For relaxed reading in the field of 
orthopedic surgery, this book is good 
value. For the academic pursuit of a de­
tailed subject, it has very limited use.
J ames J. W ile y , m d , frcs[c]
Orthopedic clinic,
Children’s Hospital of Eastern Ontario, 
Ottawa, Ont.
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